JP2014015397A - External parasite controlling agent for animals - Google Patents
External parasite controlling agent for animals Download PDFInfo
- Publication number
- JP2014015397A JP2014015397A JP2011153870A JP2011153870A JP2014015397A JP 2014015397 A JP2014015397 A JP 2014015397A JP 2011153870 A JP2011153870 A JP 2011153870A JP 2011153870 A JP2011153870 A JP 2011153870A JP 2014015397 A JP2014015397 A JP 2014015397A
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- unsubstituted
- formula
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 70
- 244000045947 parasite Species 0.000 title abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 52
- 239000004480 active ingredient Substances 0.000 claims abstract description 36
- 150000002391 heterocyclic compounds Chemical class 0.000 claims abstract description 27
- 208000015181 infectious disease Diseases 0.000 claims abstract description 19
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 12
- 244000078703 ectoparasite Species 0.000 claims description 59
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 50
- 239000003795 chemical substances by application Substances 0.000 claims description 50
- 125000001424 substituent group Chemical group 0.000 claims description 43
- 125000004432 carbon atom Chemical group C* 0.000 claims description 31
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 29
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 27
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 21
- 125000005843 halogen group Chemical group 0.000 claims description 21
- 125000000623 heterocyclic group Chemical group 0.000 claims description 21
- 229910052799 carbon Inorganic materials 0.000 claims description 20
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims description 19
- 125000002252 acyl group Chemical group 0.000 claims description 15
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 13
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 13
- 125000003277 amino group Chemical group 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 238000006467 substitution reaction Methods 0.000 claims description 10
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 7
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 6
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims description 6
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 claims description 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 241000255925 Diptera Species 0.000 abstract description 21
- 241001674048 Phthiraptera Species 0.000 abstract description 16
- 241000258242 Siphonaptera Species 0.000 abstract description 11
- 230000001276 controlling effect Effects 0.000 abstract 4
- -1 pyridine compound Chemical class 0.000 description 280
- 238000012360 testing method Methods 0.000 description 38
- 241000238876 Acari Species 0.000 description 37
- 241000258924 Ctenocephalides felis Species 0.000 description 25
- 241000894007 species Species 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 241000282326 Felis catus Species 0.000 description 18
- 241000283690 Bos taurus Species 0.000 description 16
- 241000607479 Yersinia pestis Species 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 241000282472 Canis lupus familiaris Species 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 241000287828 Gallus gallus Species 0.000 description 11
- 235000013330 chicken meat Nutrition 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 241000238631 Hexapoda Species 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 9
- 230000000749 insecticidal effect Effects 0.000 description 8
- 206010063409 Acarodermatitis Diseases 0.000 description 7
- 241001128004 Demodex Species 0.000 description 7
- 241000447727 Scabies Species 0.000 description 7
- 241000255626 Tabanus <genus> Species 0.000 description 7
- 208000007502 anemia Diseases 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 150000002430 hydrocarbons Chemical group 0.000 description 7
- 208000005687 scabies Diseases 0.000 description 7
- 206010061217 Infestation Diseases 0.000 description 6
- 241000257162 Lucilia <blowfly> Species 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- 241000509416 Sarcoptes Species 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 208000001840 Dandruff Diseases 0.000 description 5
- 241000179420 Haemaphysalis longicornis Species 0.000 description 5
- 208000030852 Parasitic disease Diseases 0.000 description 5
- 241000255628 Tabanidae Species 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 4
- 241000271566 Aves Species 0.000 description 4
- 241000282465 Canis Species 0.000 description 4
- 241001124179 Chrysops Species 0.000 description 4
- 241000322653 Goniodes Species 0.000 description 4
- 241001113970 Linognathus Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000238680 Rhipicephalus microplus Species 0.000 description 4
- 241000282898 Sus scrofa Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 230000000507 anthelmentic effect Effects 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 201000008680 babesiosis Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 3
- 125000006163 5-membered heteroaryl group Chemical group 0.000 description 3
- 125000006164 6-membered heteroaryl group Chemical group 0.000 description 3
- 241001307956 Chorioptes bovis Species 0.000 description 3
- 241000490513 Ctenocephalides canis Species 0.000 description 3
- 241000144210 Culex pipiens pallens Species 0.000 description 3
- 241000256057 Culex quinquefasciatus Species 0.000 description 3
- 241001506909 Culicoides arakawae Species 0.000 description 3
- 241001481695 Dermanyssus gallinae Species 0.000 description 3
- 241000283086 Equidae Species 0.000 description 3
- 239000005899 Fipronil Substances 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241001480796 Haemaphysalis Species 0.000 description 3
- 241001053172 Haemaphysalis flava Species 0.000 description 3
- 241000894446 Ixodes nipponensis Species 0.000 description 3
- 241000610560 Ixodes ovatus Species 0.000 description 3
- 241001480847 Ixodes persulcatus Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000257159 Musca domestica Species 0.000 description 3
- 241001481703 Rhipicephalus <genus> Species 0.000 description 3
- 241001481704 Rhipicephalus appendiculatus Species 0.000 description 3
- 241001481696 Rhipicephalus sanguineus Species 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 241000256103 Simuliidae Species 0.000 description 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Aalpha Natural products C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 3
- 229940013764 fipronil Drugs 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 125000003367 polycyclic group Chemical group 0.000 description 3
- 125000003226 pyrazolyl group Chemical group 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 125000000168 pyrrolyl group Chemical group 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 2
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 description 2
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N 1-Pyrroline Chemical group C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 2
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 2
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 2
- 125000006028 1-methyl-2-butenyl group Chemical group 0.000 description 2
- 125000006021 1-methyl-2-propenyl group Chemical group 0.000 description 2
- 125000006023 1-pentenyl group Chemical group 0.000 description 2
- 125000006017 1-propenyl group Chemical group 0.000 description 2
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 2
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 2
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 2
- 125000006040 2-hexenyl group Chemical group 0.000 description 2
- 125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 2
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 2
- 125000006024 2-pentenyl group Chemical group 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 2
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 2
- 125000006041 3-hexenyl group Chemical group 0.000 description 2
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical group C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 description 2
- 125000006042 4-hexenyl group Chemical group 0.000 description 2
- 125000006043 5-hexenyl group Chemical group 0.000 description 2
- VSVKOUBCDZYAQY-UHFFFAOYSA-N 7-chloro-1,2-benzothiazole Chemical compound ClC1=CC=CC2=C1SN=C2 VSVKOUBCDZYAQY-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000256173 Aedes albopictus Species 0.000 description 2
- 241000546183 Aedes togoi Species 0.000 description 2
- 208000000230 African Trypanosomiasis Diseases 0.000 description 2
- 241000713131 Aino virus Species 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 241000238679 Amblyomma Species 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 241000711404 Avian avulavirus 1 Species 0.000 description 2
- 241001466447 Babesia gibsoni Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000120506 Bluetongue virus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- 241000983417 Chrysomya bezziana Species 0.000 description 2
- 241001299893 Chuzan virus Species 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000322611 Cuclotogaster Species 0.000 description 2
- 241000256060 Culex tritaeniorhynchus Species 0.000 description 2
- 241001128002 Demodex canis Species 0.000 description 2
- 108010002156 Depsipeptides Proteins 0.000 description 2
- 241001480824 Dermacentor Species 0.000 description 2
- 241000577477 Dermacentor reticulatus Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000322646 Felicola Species 0.000 description 2
- 241000710781 Flaviviridae Species 0.000 description 2
- 241001660203 Gasterophilus Species 0.000 description 2
- 241000692264 Gasterophilus haemorrhoidalis Species 0.000 description 2
- 241001660201 Gasterophilus intestinalis Species 0.000 description 2
- 241001194754 Gasterophilus nasalis Species 0.000 description 2
- 241000510076 Gasterophilus nigricornis Species 0.000 description 2
- 241001409617 Haemaphysalis megaspinosa Species 0.000 description 2
- 241000257232 Haematobia irritans Species 0.000 description 2
- 241000562487 Haematobosca stimulans Species 0.000 description 2
- 241000670091 Haematopinus suis Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000543830 Hypoderma bovis Species 0.000 description 2
- 241000257174 Hypoderma lineatum Species 0.000 description 2
- 241000238681 Ixodes Species 0.000 description 2
- 241000238703 Ixodes scapularis Species 0.000 description 2
- 241000710842 Japanese encephalitis virus Species 0.000 description 2
- 241001416380 Laelaps Species 0.000 description 2
- 241000257164 Lucilia illustris Species 0.000 description 2
- 241000322738 Menacanthus Species 0.000 description 2
- 241000257229 Musca <genus> Species 0.000 description 2
- 241000257226 Muscidae Species 0.000 description 2
- 241000238887 Ornithodoros Species 0.000 description 2
- 241000273374 Ornithonyssus sylviarum Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000790252 Otodectes cynotis Species 0.000 description 2
- 241000283898 Ovis Species 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 241001649231 Psoroptidae Species 0.000 description 2
- 241000702247 Reoviridae Species 0.000 description 2
- 241000509427 Sarcoptes scabiei Species 0.000 description 2
- 241000555745 Sciuridae Species 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 241000255632 Tabanus atratus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000000895 acaricidal effect Effects 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 238000001720 action spectrum Methods 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 208000006730 anaplasmosis Diseases 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229940125716 antipyretic agent Drugs 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 2
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 125000006015 bromomethoxy group Chemical group 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 2
- 210000000078 claw Anatomy 0.000 description 2
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 244000079386 endoparasite Species 0.000 description 2
- 230000000967 entomopathogenic effect Effects 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 125000005290 ethynyloxy group Chemical group C(#C)O* 0.000 description 2
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 125000000262 haloalkenyl group Chemical group 0.000 description 2
- 125000005291 haloalkenyloxy group Chemical group 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 208000029080 human African trypanosomiasis Diseases 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000003971 isoxazolinyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000006606 n-butoxy group Chemical group 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- DSOOGBGKEWZRIH-UHFFFAOYSA-N nereistoxin Chemical compound CN(C)C1CSSC1 DSOOGBGKEWZRIH-UHFFFAOYSA-N 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000000018 receptor agonist Substances 0.000 description 2
- 229940044601 receptor agonist Drugs 0.000 description 2
- 210000001991 scapula Anatomy 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 125000003808 silyl group Chemical class [H][Si]([H])([H])[*] 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 201000002612 sleeping sickness Diseases 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000004306 triazinyl group Chemical group 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 235000012431 wafers Nutrition 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N γ Benzene hexachloride Chemical compound ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 2
- CXBMCYHAMVGWJQ-CABCVRRESA-N (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-CABCVRRESA-N 0.000 description 1
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 description 1
- YATDSXRLIUJOQN-SVRRBLITSA-N (2,3,4,5,6-pentafluorophenyl)methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=C(F)C(F)=C1F YATDSXRLIUJOQN-SVRRBLITSA-N 0.000 description 1
- AGMMRUPNXPWLGF-AATRIKPKSA-N (2,3,5,6-tetrafluoro-4-methylphenyl)methyl 2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound CC1(C)C(/C=C/C)C1C(=O)OCC1=C(F)C(F)=C(C)C(F)=C1F AGMMRUPNXPWLGF-AATRIKPKSA-N 0.000 description 1
- MIZYPRIEDMSCAC-UHFFFAOYSA-N (2-methyl-4-oxo-3-prop-2-enylcyclopent-2-en-1-yl) 2,2,3,3-tetramethylcyclopropane-1-carboxylate Chemical compound CC1=C(CC=C)C(=O)CC1OC(=O)C1C(C)(C)C1(C)C MIZYPRIEDMSCAC-UHFFFAOYSA-N 0.000 description 1
- LZTIMERBDGGAJD-SNAWJCMRSA-N (2e)-2-(nitromethylidene)-1,3-thiazinane Chemical compound [O-][N+](=O)\C=C1/NCCCS1 LZTIMERBDGGAJD-SNAWJCMRSA-N 0.000 description 1
- RLLPVAHGXHCWKJ-MJGOQNOKSA-N (3-phenoxyphenyl)methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-MJGOQNOKSA-N 0.000 description 1
- MGRRXBWTLBJEMS-YADHBBJMSA-N (5-benzylfuran-3-yl)methyl (1r,3r)-3-(cyclopentylidenemethyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C([C@H]1C([C@@H]1C(=O)OCC=1C=C(CC=2C=CC=CC=2)OC=1)(C)C)=C1CCCC1 MGRRXBWTLBJEMS-YADHBBJMSA-N 0.000 description 1
- YSEUOPNOQRVVDY-OGEJUEGTSA-N (5-benzylfuran-3-yl)methyl (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 YSEUOPNOQRVVDY-OGEJUEGTSA-N 0.000 description 1
- 125000006624 (C1-C6) alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 description 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 1
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 1
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 1
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- IQVNEKKDSLOHHK-FNCQTZNRSA-N (E,E)-hydramethylnon Chemical compound N1CC(C)(C)CNC1=NN=C(/C=C/C=1C=CC(=CC=1)C(F)(F)F)\C=C\C1=CC=C(C(F)(F)F)C=C1 IQVNEKKDSLOHHK-FNCQTZNRSA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- PCKNFPQPGUWFHO-SXBRIOAWSA-N (Z)-flucycloxuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1)=CC=C1CO\N=C(C=1C=CC(Cl)=CC=1)\C1CC1 PCKNFPQPGUWFHO-SXBRIOAWSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical compound C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 description 1
- 125000001359 1,2,3-triazol-4-yl group Chemical group [H]N1N=NC([*])=C1[H] 0.000 description 1
- 125000001506 1,2,3-triazol-5-yl group Chemical group [H]N1N=NC([H])=C1[*] 0.000 description 1
- 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 1
- 125000004515 1,2,4-thiadiazol-3-yl group Chemical group S1N=C(N=C1)* 0.000 description 1
- 125000001305 1,2,4-triazol-3-yl group Chemical group [H]N1N=C([*])N=C1[H] 0.000 description 1
- 125000001414 1,2,4-triazol-5-yl group Chemical group [H]N1N=C([H])N=C1[*] 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- 125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 description 1
- RURQAJURNPMSSK-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3-{[2-(4-ethoxyphenyl)-3,3,3-trifluoropropoxy]methyl}benzene Chemical compound C1=CC(OCC)=CC=C1C(C(F)(F)F)COCC1=CC=CC(OC=2C=CC(Cl)=CC=2)=C1 RURQAJURNPMSSK-UHFFFAOYSA-N 0.000 description 1
- XDLSSUZZUVTQCF-UHFFFAOYSA-N 1-[1,2,2,2-tetrachloro-1-[4-(trichloromethoxy)phenyl]ethyl]-4-(trichloromethoxy)benzene Chemical compound ClC(OC1=CC=C(C(C2=CC=C(OC(Cl)(Cl)Cl)C=C2)(C(Cl)(Cl)Cl)Cl)C=C1)(Cl)Cl XDLSSUZZUVTQCF-UHFFFAOYSA-N 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004797 2,2,2-trichloroethoxy group Chemical group ClC(CO*)(Cl)Cl 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000004565 2,3-dihydrobenzofuran-4-yl group Chemical group O1CCC2=C1C=CC=C2* 0.000 description 1
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 1
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical class C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 description 1
- SWBHWUYHHJCADA-UHFFFAOYSA-N 3-(2-chlorophenyl)-6-(2,6-difluorophenyl)-1,2,4,5-tetrazine Chemical compound FC1=CC=CC(F)=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 SWBHWUYHHJCADA-UHFFFAOYSA-N 0.000 description 1
- GDSLUYKCPYECNN-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[(4-fluorophenyl)methyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC=C(C=C2)F)C=CC=1 GDSLUYKCPYECNN-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 239000003148 4 aminobutyric acid receptor blocking agent Substances 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- QDFVXXBCJYNKKC-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)-4-cyclopropylbutyl]-1-fluoro-2-phenoxybenzene Chemical compound C1=C(OC=2C=CC=CC=2)C(F)=CC=C1CCCC(C=1C=CC(Cl)=CC=1)C1CC1 QDFVXXBCJYNKKC-UHFFFAOYSA-N 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- ZPDKTVJZFVWAOC-UHFFFAOYSA-N 4-hydroxy-1,3,2,4lambda5-dioxathiaphosphetane 4-oxide Chemical class S1OP(O1)(O)=O ZPDKTVJZFVWAOC-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- XJFIKRXIJXAJGH-UHFFFAOYSA-N 5-chloro-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical group ClC1=CC=C2NC(=O)NC2=N1 XJFIKRXIJXAJGH-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- NQPDXQQQCQDHHW-UHFFFAOYSA-N 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole Chemical compound ClC=1C=C2NC(SC)=NC2=CC=1OC1=CC=CC(Cl)=C1Cl NQPDXQQQCQDHHW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 125000005330 8 membered heterocyclic group Chemical group 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 239000005875 Acetamiprid Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005652 Acrinathrin Substances 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 241000256111 Aedes <genus> Species 0.000 description 1
- 241000256118 Aedes aegypti Species 0.000 description 1
- 241001222053 Akabane virus Species 0.000 description 1
- 239000005877 Alpha-Cypermethrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000501461 Amblycera Species 0.000 description 1
- 241000238682 Amblyomma americanum Species 0.000 description 1
- 241001480735 Amblyomma cajennense Species 0.000 description 1
- 241001480736 Amblyomma hebraeum Species 0.000 description 1
- 241001480737 Amblyomma maculatum Species 0.000 description 1
- 241001480834 Amblyomma variegatum Species 0.000 description 1
- 241000606665 Anaplasma marginale Species 0.000 description 1
- 241000605280 Anaplasma platys Species 0.000 description 1
- 241000256186 Anopheles <genus> Species 0.000 description 1
- 241000256182 Anopheles gambiae Species 0.000 description 1
- 241000132163 Anopheles maculipennis Species 0.000 description 1
- 241001279740 Anopheles sinensis Species 0.000 description 1
- 241001427556 Anoplura Species 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000726096 Aratinga Species 0.000 description 1
- 241000232553 Archaeopsylla erinacei Species 0.000 description 1
- 241001480748 Argas Species 0.000 description 1
- 241001480752 Argas persicus Species 0.000 description 1
- 241001480754 Argas reflexus Species 0.000 description 1
- 241000238888 Argasidae Species 0.000 description 1
- 241000557851 Armigeres subalbatus Species 0.000 description 1
- 241000238708 Astigmata Species 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- 241000223840 Babesia bigemina Species 0.000 description 1
- 241000223838 Babesia bovis Species 0.000 description 1
- 241000223846 Babesia canis Species 0.000 description 1
- 241001145184 Babesia ovata Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 239000005884 Beta-Cyfluthrin Substances 0.000 description 1
- 239000005653 Bifenazate Substances 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- 241000238678 Boophilus Species 0.000 description 1
- 241000322475 Bovicola Species 0.000 description 1
- 241000322476 Bovicola bovis Species 0.000 description 1
- 241001283755 Bovicola caprae Species 0.000 description 1
- 241000463528 Bovicola limbata Species 0.000 description 1
- 241001113967 Bovicola ovis Species 0.000 description 1
- 241001034435 Brevipalpus obovatus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- KWGUFOITWDSNQY-UHFFFAOYSA-N Bromophos-ethyl Chemical group CCOP(=S)(OCC)OC1=CC(Cl)=C(Br)C=C1Cl KWGUFOITWDSNQY-UHFFFAOYSA-N 0.000 description 1
- MYTVVMGUDBRCDJ-UHFFFAOYSA-N Bufencarb Chemical compound CCCC(C)C1=CC=CC(OC(=O)NC)=C1.CCC(CC)C1=CC=CC(OC(=O)NC)=C1 MYTVVMGUDBRCDJ-UHFFFAOYSA-N 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- SLZWBCGZQRRUNG-UHFFFAOYSA-N Butacarb Chemical compound CNC(=O)OC1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1 SLZWBCGZQRRUNG-UHFFFAOYSA-N 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 1
- 241000257160 Calliphora Species 0.000 description 1
- 241001266382 Calliphora lata Species 0.000 description 1
- 241000257161 Calliphoridae Species 0.000 description 1
- 241001260702 Candidatus Mycoplasma haemominutum Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEDTXTNSFWUXGQ-UHFFFAOYSA-N Carbophenothion Chemical compound CCOP(=S)(OCC)SCSC1=CC=C(Cl)C=C1 VEDTXTNSFWUXGQ-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000498856 Ceratophyllidae Species 0.000 description 1
- 241001098608 Ceratophyllus Species 0.000 description 1
- 241001397514 Ceratophyllus anisus Species 0.000 description 1
- 241001609899 Ceratophyllus gallinae Species 0.000 description 1
- 241000256135 Chironomus thummi Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 239000005886 Chlorantraniliprole Substances 0.000 description 1
- STUSTWKEFDQFFZ-UHFFFAOYSA-N Chlordimeform Chemical compound CN(C)C=NC1=CC=C(Cl)C=C1C STUSTWKEFDQFFZ-UHFFFAOYSA-N 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 239000005945 Chlorpyrifos-methyl Substances 0.000 description 1
- 239000005887 Chromafenozide Substances 0.000 description 1
- 241000191839 Chrysomya Species 0.000 description 1
- 241001262789 Chrysomya chloropyga Species 0.000 description 1
- 241001574870 Chrysops caecutiens Species 0.000 description 1
- 241001327638 Cimex lectularius Species 0.000 description 1
- 241001414835 Cimicidae Species 0.000 description 1
- BXFKSFAJVGVDEJ-UHFFFAOYSA-N ClC(Cl)=C(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)Cl Chemical compound ClC(Cl)=C(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)Cl BXFKSFAJVGVDEJ-UHFFFAOYSA-N 0.000 description 1
- 239000005888 Clothianidin Substances 0.000 description 1
- 241000609059 Columbicola Species 0.000 description 1
- 241000608917 Columbicola columbae Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000258922 Ctenocephalides Species 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- 241000633318 Culex pipiens molestus Species 0.000 description 1
- 241000256061 Culex tarsalis Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 241001209418 Culicoides oxystoma Species 0.000 description 1
- 241000692095 Cuterebra Species 0.000 description 1
- 241000531134 Cuterebrinae Species 0.000 description 1
- LRNJHZNPJSPMGK-UHFFFAOYSA-N Cyanofenphos Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C(C#N)C=C1 LRNJHZNPJSPMGK-UHFFFAOYSA-N 0.000 description 1
- 239000005946 Cypermethrin Substances 0.000 description 1
- 239000005891 Cyromazine Substances 0.000 description 1
- 241001545440 D'Aguilar virus Species 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- 241000445733 Demodex caprae Species 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- 241000865080 Dermacentor albipictus Species 0.000 description 1
- 241001480819 Dermacentor andersoni Species 0.000 description 1
- 241001481702 Dermanyssidae Species 0.000 description 1
- 241001481694 Dermanyssus Species 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- WGOWCPGHOCIHBW-UHFFFAOYSA-N Dichlofenthion Chemical compound CCOP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl WGOWCPGHOCIHBW-UHFFFAOYSA-N 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical group C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
- 241001549210 Echidnophaga Species 0.000 description 1
- YUGWDVYLFSETPE-JLHYYAGUSA-N Empenthrin Chemical compound CC\C=C(/C)C(C#C)OC(=O)C1C(C=C(C)C)C1(C)C YUGWDVYLFSETPE-JLHYYAGUSA-N 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 241000713730 Equine infectious anemia virus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000005895 Esfenvalerate Substances 0.000 description 1
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 description 1
- 239000005896 Etofenprox Substances 0.000 description 1
- 239000005897 Etoxazole Substances 0.000 description 1
- FGIWFCGDPUIBEZ-UHFFFAOYSA-N Etrimfos Chemical compound CCOC1=CC(OP(=S)(OC)OC)=NC(CC)=N1 FGIWFCGDPUIBEZ-UHFFFAOYSA-N 0.000 description 1
- 241000371383 Fannia Species 0.000 description 1
- HMIBKHHNXANVHR-UHFFFAOYSA-N Fenothiocarb Chemical compound CN(C)C(=O)SCCCCOC1=CC=CC=C1 HMIBKHHNXANVHR-UHFFFAOYSA-N 0.000 description 1
- 239000005657 Fenpyroximate Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 201000006353 Filariasis Diseases 0.000 description 1
- 208000006004 Flea Infestations Diseases 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- KVKHBPGBGOVMBN-PWLVHAGJSA-N Flubenzimine Chemical compound C=1C=CC=CC=1N/1C(=N/C(F)(F)F)/S\C(=N/C(F)(F)F)\C\1=N/C1=CC=CC=C1 KVKHBPGBGOVMBN-PWLVHAGJSA-N 0.000 description 1
- 241000589602 Francisella tularensis Species 0.000 description 1
- 241000531136 Gasterophilinae Species 0.000 description 1
- 241000257324 Glossina <genus> Species 0.000 description 1
- 241000257321 Glossinidae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000060234 Gmelina philippensis Species 0.000 description 1
- 241001423309 Haemaphysalis campanulata Species 0.000 description 1
- 241001046324 Haemaphysalis concinna Species 0.000 description 1
- 241001423470 Haemaphysalis pentalagi Species 0.000 description 1
- 241000227776 Haemaphysalis punctata Species 0.000 description 1
- 241001423469 Haemaphysalis yeni Species 0.000 description 1
- 241001481667 Haematobia irritans exigua Species 0.000 description 1
- 241000790936 Haematopinidae Species 0.000 description 1
- 241000790933 Haematopinus Species 0.000 description 1
- 241000875835 Haematopinus asini Species 0.000 description 1
- 241000894055 Haematopinus eurysternus Species 0.000 description 1
- 241000024878 Hectopsyllidae Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 241000149124 Hepatozoon canis Species 0.000 description 1
- 241001608644 Hippoboscidae Species 0.000 description 1
- 101000641031 Homo sapiens Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000257176 Hypoderma <fly> Species 0.000 description 1
- 241000159699 Hypodermatinae Species 0.000 description 1
- 241000285721 Ibaraki virus Species 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 1
- 241001495069 Ischnocera Species 0.000 description 1
- 241000545319 Ixodes canisuga Species 0.000 description 1
- 241001480840 Ixodes hexagonus Species 0.000 description 1
- 241000179530 Ixodes pilosus Species 0.000 description 1
- 241001480843 Ixodes ricinus Species 0.000 description 1
- 241000472347 Ixodes rubicundus Species 0.000 description 1
- 241000238889 Ixodidae Species 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241001467800 Knemidokoptes Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001416115 Laelaps jettmari Species 0.000 description 1
- 241001397516 Leptopsylla Species 0.000 description 1
- 241001397515 Leptopsylla segnis Species 0.000 description 1
- 241001232872 Leptopsyllidae Species 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 241001113971 Linognathidae Species 0.000 description 1
- 241000670112 Linognathus ovillus Species 0.000 description 1
- 241001113946 Linognathus vituli Species 0.000 description 1
- 241000660280 Lipeurus caponis Species 0.000 description 1
- 241000131091 Lucanus cervus Species 0.000 description 1
- 239000005912 Lufenuron Substances 0.000 description 1
- 241000273338 Macronyssidae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 241000771995 Melophagus Species 0.000 description 1
- 241000771994 Melophagus ovinus Species 0.000 description 1
- 241000292447 Menacanthus cornutus Species 0.000 description 1
- 241000035435 Menopon gallinae Species 0.000 description 1
- 241000501409 Menoponidae Species 0.000 description 1
- 241001481698 Mesostigmata Species 0.000 description 1
- 239000005914 Metaflumizone Substances 0.000 description 1
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 description 1
- 239000002169 Metam Substances 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- LTMQQEMGRMBUSL-UHFFFAOYSA-N Metoxadiazone Chemical compound O=C1OC(OC)=NN1C1=CC=CC=C1OC LTMQQEMGRMBUSL-UHFFFAOYSA-N 0.000 description 1
- 241000403354 Microplus Species 0.000 description 1
- 239000005918 Milbemectin Substances 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000306622 Musca bezzii Species 0.000 description 1
- 241001023236 Musca conducens Species 0.000 description 1
- 241000581988 Muscina Species 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000963347 Mycoplasma haemocanis Species 0.000 description 1
- 208000006123 Myiasis Diseases 0.000 description 1
- RAOCRURYZCVHMG-UHFFFAOYSA-N N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCOC1=CC=C2N=C(NC(=O)OC)NC2=C1 RAOCRURYZCVHMG-UHFFFAOYSA-N 0.000 description 1
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 241000255932 Nematocera Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241001036422 Nosopsyllus fasciatus Species 0.000 description 1
- 241000562094 Notoedres cati Species 0.000 description 1
- 241000036147 Ochlerotatus taeniorhynchus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000257191 Oestridae Species 0.000 description 1
- 241000531125 Oestrinae Species 0.000 description 1
- 241000543819 Oestrus ovis Species 0.000 description 1
- 241000273340 Ornithonyssus Species 0.000 description 1
- 241000176318 Ornithonyssus bacoti Species 0.000 description 1
- 241000566163 Ornithonyssus bursa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- 229940087098 Oxidase inhibitor Drugs 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000919536 Panstrongylus Species 0.000 description 1
- 241000059531 Peaton virus Species 0.000 description 1
- 241000320508 Pentatomidae Species 0.000 description 1
- 241000150350 Peribunyaviridae Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000932963 Philopteridae Species 0.000 description 1
- 239000005921 Phosmet Substances 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- DTAPQAJKAFRNJB-UHFFFAOYSA-N Promecarb Chemical compound CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 DTAPQAJKAFRNJB-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000847064 Prosimulium yezoense Species 0.000 description 1
- 241000238705 Prostigmata Species 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- 241001649229 Psoroptes Species 0.000 description 1
- 241000620638 Psoroptes cuniculi Species 0.000 description 1
- 241001649230 Psoroptes ovis Species 0.000 description 1
- 241001675082 Pulex Species 0.000 description 1
- 241000718000 Pulex irritans Species 0.000 description 1
- 241000258921 Pulicidae Species 0.000 description 1
- 239000005925 Pymetrozine Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 239000005926 Pyridalyl Substances 0.000 description 1
- MWMQNVGAHVXSPE-UHFFFAOYSA-N Pyriprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SC(F)F)=C1NCC1=CC=CC=N1 MWMQNVGAHVXSPE-UHFFFAOYSA-N 0.000 description 1
- 239000005927 Pyriproxyfen Substances 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 206010037688 Q fever Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241001124072 Reduviidae Species 0.000 description 1
- 241001236639 Relictus Species 0.000 description 1
- 241000712907 Retroviridae Species 0.000 description 1
- 241001480837 Rhipicephalus annulatus Species 0.000 description 1
- 241000949016 Rhipicephalus bursa Species 0.000 description 1
- 241000864246 Rhipicephalus decoloratus Species 0.000 description 1
- 241000864202 Rhipicephalus evertsi Species 0.000 description 1
- 241001481697 Rhipicephalus turanicus Species 0.000 description 1
- 241000864200 Rhipicephalus zambeziensis Species 0.000 description 1
- 241000722251 Rhodnius Species 0.000 description 1
- 241000722249 Rhodnius prolixus Species 0.000 description 1
- 208000034712 Rickettsia Infections Diseases 0.000 description 1
- 241001495396 Rickettsia japonica Species 0.000 description 1
- 206010061495 Rickettsiosis Diseases 0.000 description 1
- OUNSASXJZHBGAI-UHFFFAOYSA-N Salithion Chemical compound C1=CC=C2OP(OC)(=S)OCC2=C1 OUNSASXJZHBGAI-UHFFFAOYSA-N 0.000 description 1
- 241000059503 Sathuperi orthobunyavirus Species 0.000 description 1
- 241000894243 Sericata Species 0.000 description 1
- 241000287219 Serinus canaria Species 0.000 description 1
- 241000059525 Shamonda orthobunyavirus Species 0.000 description 1
- 241000256108 Simulium <genus> Species 0.000 description 1
- 241000925083 Simulium ornatum Species 0.000 description 1
- 241000861933 Simulium reptans Species 0.000 description 1
- 241000255120 Simulium venustum Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000044136 Solenopotes Species 0.000 description 1
- 241000044147 Solenopotes capillatus Species 0.000 description 1
- 239000005930 Spinosad Substances 0.000 description 1
- 239000005664 Spirodiclofen Substances 0.000 description 1
- 239000005665 Spiromesifen Substances 0.000 description 1
- 239000005931 Spirotetramat Substances 0.000 description 1
- 241001494139 Stomoxys Species 0.000 description 1
- 241001494115 Stomoxys calcitrans Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000925066 Tabanus bromius Species 0.000 description 1
- 241000511648 Tabanus sudeticus Species 0.000 description 1
- 241001124066 Tachinidae Species 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005938 Teflubenzuron Substances 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- QUWSDLYBOVGOCW-UHFFFAOYSA-N Tetrasul Chemical compound C1=CC(Cl)=CC=C1SC1=CC(Cl)=C(Cl)C=C1Cl QUWSDLYBOVGOCW-UHFFFAOYSA-N 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- 241001414833 Triatoma Species 0.000 description 1
- 241001414831 Triatoma infestans Species 0.000 description 1
- 241001210412 Triatominae Species 0.000 description 1
- 241001259047 Trichodectes Species 0.000 description 1
- 241001495077 Trichodectidae Species 0.000 description 1
- 239000005942 Triflumuron Substances 0.000 description 1
- 241000331598 Trombiculidae Species 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 241001232874 Tunga Species 0.000 description 1
- 241001584775 Tunga penetrans Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241000353224 Xenopsylla Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 1
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 description 1
- KAATUXNTWXVJKI-QPIRBTGLSA-N [(s)-cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-QPIRBTGLSA-N 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 description 1
- KVIZNNVXXNFLMU-AIIUZBJTSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3r)-2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C\C KVIZNNVXXNFLMU-AIIUZBJTSA-N 0.000 description 1
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 1
- CFGPESLNPCIKIX-UHFFFAOYSA-N [2-[ethoxy(propylsulfanyl)phosphoryl]oxyphenyl] n-methylcarbamate Chemical compound CCCSP(=O)(OCC)OC1=CC=CC=C1OC(=O)NC CFGPESLNPCIKIX-UHFFFAOYSA-N 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- GDZNYEZGJAFIKA-UHFFFAOYSA-N acetoprole Chemical compound NC1=C(S(C)=O)C(C(=O)C)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl GDZNYEZGJAFIKA-UHFFFAOYSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229960002669 albendazole Drugs 0.000 description 1
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005136 alkenylsulfinyl group Chemical group 0.000 description 1
- 125000005137 alkenylsulfonyl group Chemical group 0.000 description 1
- 125000005108 alkenylthio group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000005134 alkynylsulfinyl group Chemical group 0.000 description 1
- 125000005109 alkynylthio group Chemical group 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- IMIDOCRTMDIQIJ-UHFFFAOYSA-N aminocarb Chemical compound CNC(=O)OC1=CC=C(N(C)C)C(C)=C1 IMIDOCRTMDIQIJ-UHFFFAOYSA-N 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124536 anticoccidial agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 description 1
- 125000001691 aryl alkyl amino group Chemical group 0.000 description 1
- 125000004659 aryl alkyl thio group Chemical group 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 1
- VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 125000004266 aziridin-1-yl group Chemical group [H]C1([H])N(*)C1([H])[H] 0.000 description 1
- 125000004267 aziridin-2-yl group Chemical group [H]N1C([H])([H])C1([H])* 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 description 1
- YFXPPSKYMBTNAV-UHFFFAOYSA-N bensultap Chemical compound C=1C=CC=CC=1S(=O)(=O)SCC(N(C)C)CSS(=O)(=O)C1=CC=CC=C1 YFXPPSKYMBTNAV-UHFFFAOYSA-N 0.000 description 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 1
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229950002373 bioresmethrin Drugs 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- IRUJZVNXZWPBMU-UHFFFAOYSA-N cartap Chemical compound NC(=O)SCC(N(C)C)CSC(N)=O IRUJZVNXZWPBMU-UHFFFAOYSA-N 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- BIWJNBZANLAXMG-YQELWRJZSA-N chloordaan Chemical compound ClC1=C(Cl)[C@@]2(Cl)C3CC(Cl)C(Cl)C3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-YQELWRJZSA-N 0.000 description 1
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 1
- 125000004651 chloromethoxy group Chemical group ClCO* 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950004178 closantel Drugs 0.000 description 1
- 239000003224 coccidiostatic agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 1
- 125000001651 cyanato group Chemical group [*]OC#N 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
- 125000000062 cyclohexylmethoxy group Chemical group [H]C([H])(O*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 description 1
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 description 1
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
- 229960005424 cypermethrin Drugs 0.000 description 1
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 1
- 229950000775 cyromazine Drugs 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- 125000004783 dichloromethoxy group Chemical group ClC(O*)Cl 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- QQQYTWIFVNKMRW-UHFFFAOYSA-N diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- SPCNPOWOBZQWJK-UHFFFAOYSA-N dimethoxy-(2-propan-2-ylsulfanylethylsulfanyl)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)SCCSC(C)C SPCNPOWOBZQWJK-UHFFFAOYSA-N 0.000 description 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 1
- 229960003997 doramectin Drugs 0.000 description 1
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 description 1
- 108010056417 emodepside Proteins 0.000 description 1
- ZMQMTKVVAMWKNY-YSXLEBCMSA-N emodepside Chemical compound C([C@@H]1C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@H](C(O[C@H](CC=2C=CC(=CC=2)N2CCOCC2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O1)=O)CC(C)C)C(C=C1)=CC=C1N1CCOCC1 ZMQMTKVVAMWKNY-YSXLEBCMSA-N 0.000 description 1
- 229960001575 emodepside Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 208000009724 equine infectious anemia Diseases 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 1
- 125000006627 ethoxycarbonylamino group Chemical group 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 1
- 229950005085 etofenprox Drugs 0.000 description 1
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 1
- IRHZVMHXVHSMKB-UHFFFAOYSA-N fenbendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 IRHZVMHXVHSMKB-UHFFFAOYSA-N 0.000 description 1
- 229960005473 fenbendazole Drugs 0.000 description 1
- 229950006668 fenfluthrin Drugs 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940118764 francisella tularensis Drugs 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 description 1
- 125000004993 haloalkoxycarbonyl group Chemical group 0.000 description 1
- 125000006809 haloalkylaminocarbonyl group Chemical group 0.000 description 1
- 125000000232 haloalkynyl group Chemical group 0.000 description 1
- 125000005292 haloalkynyloxy group Chemical group 0.000 description 1
- 125000003106 haloaryl group Chemical group 0.000 description 1
- 125000004996 haloaryloxy group Chemical group 0.000 description 1
- CNKHSLKYRMDDNQ-UHFFFAOYSA-N halofenozide Chemical compound C=1C=CC=CC=1C(=O)N(C(C)(C)C)NC(=O)C1=CC=C(Cl)C=C1 CNKHSLKYRMDDNQ-UHFFFAOYSA-N 0.000 description 1
- 125000005150 heteroarylsulfinyl group Chemical group 0.000 description 1
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 1
- 125000005368 heteroarylthio group Chemical group 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 description 1
- 229930000073 hydroprene Natural products 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- HICUREFSAIZXFQ-JOWPUVSESA-N i9z29i000j Chemical compound C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\[C@H](OC(=O)C(=N/OC)\C=1C=CC=CC=1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 HICUREFSAIZXFQ-JOWPUVSESA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 1
- VPRAQYXPZIFIOH-UHFFFAOYSA-N imiprothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCN1C(=O)N(CC#C)CC1=O VPRAQYXPZIFIOH-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical group C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 description 1
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- 125000001793 isothiazol-3-yl group Chemical group [H]C1=C([H])C(*)=NS1 0.000 description 1
- 125000004500 isothiazol-4-yl group Chemical group S1N=CC(=C1)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000001810 isothiocyanato group Chemical group *N=C=S 0.000 description 1
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 description 1
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 1
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000005910 lambda-Cyhalothrin Substances 0.000 description 1
- 102000035110 latrophilin Human genes 0.000 description 1
- 108091005543 latrophilin Proteins 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 229960000521 lufenuron Drugs 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- AFCCDDWKHLHPDF-UHFFFAOYSA-M metam-sodium Chemical compound [Na+].CNC([S-])=S AFCCDDWKHLHPDF-UHFFFAOYSA-M 0.000 description 1
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- 229930002897 methoprene Natural products 0.000 description 1
- 229950003442 methoprene Drugs 0.000 description 1
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 1
- 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 1
- 229960004816 moxidectin Drugs 0.000 description 1
- YNKFZRGTXAPYFD-UHFFFAOYSA-N n-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 description 1
- 125000004708 n-butylthio group Chemical group C(CCC)S* 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003935 n-pentoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004706 n-propylthio group Chemical group C(CC)S* 0.000 description 1
- BUYMVQAILCEWRR-UHFFFAOYSA-N naled Chemical compound COP(=O)(OC)OC(Br)C(Cl)(Cl)Br BUYMVQAILCEWRR-UHFFFAOYSA-N 0.000 description 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 description 1
- 125000005029 naphthylthio group Chemical group C1(=CC=CC2=CC=CC=C12)S* 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- SGKGVABHDAQAJO-UHFFFAOYSA-N nitroxynil Chemical group OC1=C(I)C=C(C#N)C=C1[N+]([O-])=O SGKGVABHDAQAJO-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 1
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- JYWIYHUXVMAGLG-UHFFFAOYSA-N oxyclozanide Chemical compound OC1=C(Cl)C=C(Cl)C=C1NC(=O)C1=C(O)C(Cl)=CC(Cl)=C1Cl JYWIYHUXVMAGLG-UHFFFAOYSA-N 0.000 description 1
- 229950003126 oxyclozanide Drugs 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000005005 perfluorohexyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960003536 phenothrin Drugs 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- 125000003395 phenylethylamino group Chemical group [H]N(*)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 description 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229940096992 potassium oleate Drugs 0.000 description 1
- MLICVSDCCDDWMD-KVVVOXFISA-M potassium;(z)-octadec-9-enoate Chemical compound [K+].CCCCCCCC\C=C/CCCCCCCC([O-])=O MLICVSDCCDDWMD-KVVVOXFISA-M 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 229960002957 praziquantel Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- HHFOOWPWAXNJNY-UHFFFAOYSA-N promoxolane Chemical compound CC(C)C1(C(C)C)OCC(CO)O1 HHFOOWPWAXNJNY-UHFFFAOYSA-N 0.000 description 1
- 229950008352 promoxolane Drugs 0.000 description 1
- PWYIUEFFPNVCMW-UHFFFAOYSA-N propaphos Chemical compound CCCOP(=O)(OCCC)OC1=CC=C(SC)C=C1 PWYIUEFFPNVCMW-UHFFFAOYSA-N 0.000 description 1
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 1
- 125000000177 propargylthio group Chemical group [H]C#CC([H])([H])S* 0.000 description 1
- BZNDWPRGXNILMS-VQHVLOKHSA-N propetamphos Chemical compound CCNP(=S)(OC)O\C(C)=C\C(=O)OC(C)C BZNDWPRGXNILMS-VQHVLOKHSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- QHMTXANCGGJZRX-WUXMJOGZSA-N pymetrozine Chemical compound C1C(C)=NNC(=O)N1\N=C\C1=CC=CN=C1 QHMTXANCGGJZRX-WUXMJOGZSA-N 0.000 description 1
- DDIQWGKUSJOETH-UHFFFAOYSA-N pyrafluprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SCF)=C1NCC1=CN=CC=N1 DDIQWGKUSJOETH-UHFFFAOYSA-N 0.000 description 1
- 229960005134 pyrantel Drugs 0.000 description 1
- YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000004944 pyrazin-3-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 description 1
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 1
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 description 1
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 description 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 125000005030 pyridylthio group Chemical group N1=C(C=CC=C1)S* 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229940108410 resmethrin Drugs 0.000 description 1
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- JJSYXNQGLHBRRK-UHFFFAOYSA-N ryanodine Chemical compound OC12C(C3(CCC(C)C4O)O)(C)CC5(O)OC34C1(O)C5(C)C(C(C)C)(O)C2OC(=O)C1=CC=CN1 JJSYXNQGLHBRRK-UHFFFAOYSA-N 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical class OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- AFJYYKSVHJGXSN-KAJWKRCWSA-N selamectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(O[C@@H]([C@@H](C)CC2)C2CCCCC2)C2)C[C@@H]2OC(=O)[C@@H]([C@]23O)C=C(C)C(=N\O)/[C@H]3OC\C2=C/C=C/[C@@H]1C AFJYYKSVHJGXSN-KAJWKRCWSA-N 0.000 description 1
- 229960002245 selamectin Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940125794 sodium channel blocker Drugs 0.000 description 1
- 239000003195 sodium channel blocking agent Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940014213 spinosad Drugs 0.000 description 1
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 description 1
- 239000004544 spot-on Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 1
- UOORRWUZONOOLO-UHFFFAOYSA-N telone II Natural products ClCC=CCl UOORRWUZONOOLO-UHFFFAOYSA-N 0.000 description 1
- 229950004921 temefos Drugs 0.000 description 1
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 229960005199 tetramethrin Drugs 0.000 description 1
- 125000004523 tetrazol-1-yl group Chemical group N1(N=NN=C1)* 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000000858 thiocyanato group Chemical group *SC#N 0.000 description 1
- DNVLJEWNNDHELH-UHFFFAOYSA-N thiocyclam Chemical compound CN(C)C1CSSSC1 DNVLJEWNNDHELH-UHFFFAOYSA-N 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- PYNKFIVDSJSNGL-UHFFFAOYSA-N thiosultap Chemical compound OS(=O)(=O)SCC(N(C)C)CSS(O)(=O)=O PYNKFIVDSJSNGL-UHFFFAOYSA-N 0.000 description 1
- 201000001064 tick infestation Diseases 0.000 description 1
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- DDVNRFNDOPPVQJ-HQJQHLMTSA-N transfluthrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=CC(F)=C1F DDVNRFNDOPPVQJ-HQJQHLMTSA-N 0.000 description 1
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- 125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 229960000323 triclabendazole Drugs 0.000 description 1
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 201000002311 trypanosomiasis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 1
- 239000005943 zeta-Cypermethrin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Description
本発明は、動物用外部寄生虫防除剤、外部寄生虫由来の感染症に罹患した動物の治療方法ならびに外部寄生虫由来の感染症に動物が罹患するのを防止する方法に関する。 The present invention relates to an animal ectoparasite control agent, a method for treating an animal suffering from an ectoparasite-derived infection, and a method for preventing an animal from suffering from an ectoparasite-derived infection.
家畜、家禽、ペットなどの動物の皮膚や被毛などの体外部に寄生し、血液やフケなどを栄養源とする寄生虫が知られている。当該寄生虫の代表例としては、ノミ、シラミ、ハジラミ、マダニ、アカラス、耳疥癬(耳ダニ)、疥癬(ヒゼンダニ)、ツメダニ、肺ダニ、ニキビダニ(毛包虫)などが挙げられる。また、動物の体外部に取り付いて、血液、表皮、フケなどを栄養源とする害虫が知られている。当該害虫の代表例としては、ハエ、アブ、カなどの双翅目害虫などが挙げられる。なお、本願明細書においては、上述のような、動物の血液やフケなどを栄養源とする寄生虫および害虫を外部寄生虫と呼ぶ。このような外部寄生虫が動物に寄生すると、それに由来して動物が皮膚病などの感染症に罹患することがある。また、該感染症はヒトに感染することもある。
外部寄生虫の防除剤として、様々な化合物を有効成分とするものが開発されている。例えば、ピレスロイド系化合物、ピリジン系化合物、アリールピラゾール化合物、イソオキサゾリン化合物などを有効成分とするものが特許文献1、特許文献2、特許文献7において提案されている。
Parasites that parasitize outside the body of animal skin such as livestock, poultry, and pets, and hair, and that use blood and dandruff as nutrients are known. Representative examples of the parasites include fleas, lice, lice, ticks, acaras, ear scabies (ear mites), scabies (hymenids), claw mites, lung ticks, and acne mites (hair follicles). Also known are pests that attach outside the body of animals and have blood, epidermis, dandruff, etc. as nutrients. Representative examples of the pest include diptera pests such as flies, abs and mosquitoes. In the present specification, parasites and pests that use animal blood, dandruff and the like as nutrients as described above are referred to as ectoparasites. When such ectoparasites infest animals, the animals may be affected by infections such as skin diseases. The infection may also infect humans.
As ectoparasite control agents, various compounds containing various compounds as active ingredients have been developed. For example, Patent Document 1, Patent Document 2, and Patent Document 7 have proposed a pyrethroid compound, a pyridine compound, an arylpyrazole compound, an isoxazoline compound, and the like as active ingredients.
しかしながら、従来の外部寄生虫の防除剤のいくつかは、外部寄生虫に対する防除活性が低い、活性の持続時間が短い、作用スペクトルが狭い、毒性が高い、他の化合物との混用に制限があるなどの課題があった。また、従来の防除剤に対して耐性を持つようになった外部寄生虫が出現するなどの新たな課題が生じている。
そのため、これらの課題が解決された新たな動物用外部寄生虫防除剤の開発が要望されている。
本発明は、外部寄生虫に対して優れた防除効果を有する動物用外部寄生虫防除剤ならびに外部寄生虫由来感染症の予防若しくは治療方法を提供することを目的とする。
However, some conventional ectoparasite control agents have low ectoparasite control activity, short duration of activity, narrow action spectrum, high toxicity, and limited use with other compounds There were issues such as. In addition, new problems such as the appearance of ectoparasites that have become resistant to conventional control agents have arisen.
Therefore, there is a demand for the development of a new animal ectoparasite control agent that solves these problems.
It is an object of the present invention to provide an animal ectoparasite control agent having an excellent control effect against ectoparasites and a method for preventing or treating ectoparasite-derived infectious diseases.
本発明者は、上記課題を解決するために鋭意探索を行った。そして、本発明者は、農作物の生育を助けるための薬剤の有効成分として特許文献3などで知られているヘテロ環化合物またはその塩に着目し、検討を重ねた。その結果、特定のヘテロ環化合物を有効成分として含有する防除剤に特に優れた外部寄生虫防除効果があることを見出した。本発明は、これらの知見に基づいて完成するに至ったものである。 The present inventor has eagerly searched to solve the above problems. And this inventor paid attention to the heterocyclic compound or its salt known by patent document 3 etc. as an active ingredient of the chemical | medical agent for assisting growth of agricultural products, and repeated examination. As a result, the present inventors have found that a control agent containing a specific heterocyclic compound as an active ingredient has a particularly excellent ectoparasite control effect. The present invention has been completed based on these findings.
すなわち、本発明は、以下のものを含む。
〔1〕 式(I)で表されるヘテロ環化合物およびそれらの塩から選ばれる少なくとも1種の化合物を有効成分として含有する動物用外部寄生虫防除剤。
That is, the present invention includes the following.
[1] An ectoparasite control agent for animals comprising as an active ingredient at least one compound selected from the heterocyclic compounds represented by formula (I) and salts thereof.
(式(I)中、Xは、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
nは、Xの置換数を示し且つ0〜5のいずれかの整数である。nが2以上のとき、X同士は互いに同一でも異なっていてもよい。
A1およびA2はそれぞれ独立に、炭素原子または窒素原子を示す。
B1およびB2はそれぞれ独立に、炭素原子または窒素原子を示す。
B1が炭素原子で且つB2が窒素原子である場合、B1とB2との間の結合は、二重結合となってもよい。
B3は、炭素原子または酸素原子を示す。
R1は、水素原子、ハロゲン原子、または無置換のもしくは置換基を有するC1〜6アルキル基を示す。
X0は、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
m1は、X0の置換数を示し且つ0〜3のいずれかの整数である。m1が2以上のとき、X0同士は互いに同一でも異なっていてもよい。
R11は、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するアミノ基、または無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基を示す。
R12は、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、またはハロゲン原子を示す。
また、R11とR12とが繋がって、それらが結合する炭素原子と一緒になって、置換基R20を有する5〜8員環の炭化水素環または置換基R20を有する5〜8員環のヘテロ環を形成してもよい。
R20は、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、シアノ基、無置換のもしくは置換基を有するC1〜7アシル基、無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基、アミノ基、または−N(R2)COR3で表される置換基を示す。
R2は、水素原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC1〜7アシル基、または無置換のもしくは置換基を有するC1〜6アルコキシカルボニル基を示す。
R3は、水素原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、無置換のもしくは置換基を有するC3〜8シクロアルキル基、無置換のもしくは置換基を有するC1〜6アルコキシ基、無置換のもしくは置換基を有するC2〜6アルケニルオキシ基、無置換の若しくは置換基を有するC2〜6アルキニルオキシ基、無置換のもしくは置換基を有するC6〜10アリール基、または無置換のもしくは置換基を有するヘテロ環基を示す。
Eは、炭素原子または窒素原子を示す。)
(In the formula (I), X is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2 -6 alkynyl group, a hydroxyl group, an unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
n shows the substitution number of X and is an integer in any one of 0-5. When n is 2 or more, Xs may be the same as or different from each other.
A 1 and A 2 each independently represent a carbon atom or a nitrogen atom.
B 1 and B 2 each independently represent a carbon atom or a nitrogen atom.
When B 1 is a carbon atom and B 2 is a nitrogen atom, the bond between B 1 and B 2 may be a double bond.
B 3 represents a carbon atom or an oxygen atom.
R 1 represents a hydrogen atom, a halogen atom, or an unsubstituted or substituted C 1-6 alkyl group.
X 0 is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, a hydroxyl group , An unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
m1 represents the number of substitutions of X 0 and is an integer from 0 to 3. When m1 is 2 or more, X 0 may be the same or different from each other.
R 11 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted amino group, or an unsubstituted or substituted group A C1-6 alkylaminocarbonyl group having
R 12 represents an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, or a halogen atom.
Further, connected is R 11 and R 12, together with the carbon atoms to which they are attached 5-8 membered having a hydrocarbon ring or a substituent R 20 5-8 membered ring having a substituent R 20 A ring heterocycle may be formed.
R 20 is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, a hydroxyl group An unsubstituted or substituted C1-6 alkoxy group, a nitro group, a cyano group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted C1-6 alkylaminocarbonyl group , An amino group, or a substituent represented by —N (R 2 ) COR 3 .
R 2 represents a hydrogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-7 acyl group, or an unsubstituted or substituted C1-6 alkoxycarbonyl group. Indicates.
R 3 represents a hydrogen atom, an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, an unsubstituted or substituted C 2-6 alkynyl group, A substituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C2-6 alkenyloxy group, an unsubstituted or substituted group; A C2-6 alkynyloxy group having an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted heterocyclic group;
E represents a carbon atom or a nitrogen atom. )
〔2〕 式(II)で表されるヘテロ環化合物およびそれらの塩から選ばれる少なくとも1種の化合物を有効成分として含有する動物用外部寄生虫防除剤。 [2] An ectoparasite control agent for animals comprising as an active ingredient at least one compound selected from the heterocyclic compounds represented by formula (II) and salts thereof.
(式(II)中、Dは、5〜8員環の炭化水素環または5〜8員環のヘテロ環を示す。
R21は、Dに結合する置換基であり且つ無置換のもしくは置換基を有するC1〜7アシル基、無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基、アミノ基、または−N(R2)COR3で表される置換基を示す。
X1は、Dを含む縮合環に結合する置換基であり且つハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
mは、X1の置換数を示し且つ0〜6のいずれかの整数である。mが2以上のとき、X1同士は互いに同一でも異なっていてもよい。X1は、Dを含む縮合環上に置換されてもよい。
X、n、A1、A2、R1、E、R2およびR3は、式(I)におけるそれらと同じ意味を示す。)
(In formula (II), D represents a 5- to 8-membered hydrocarbon ring or a 5- to 8-membered heterocyclic ring.
R 21 is a substituent bonded to D and is an unsubstituted or substituted C 1-7 acyl group, an unsubstituted or substituted C 1-6 alkylaminocarbonyl group, an amino group, or —N ( R 2 ) represents a substituent represented by COR 3 .
X 1 is a substituent bonded to the condensed ring containing D and is a halogen atom, an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, unsubstituted Or a substituted C2-6 alkynyl group, a hydroxyl group, an unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
m represents the number of substitutions of X 1 and is an integer of 0 to 6. When m is 2 or more, X 1 may be the same as or different from each other. X 1 may be substituted on the condensed ring containing D.
X, n, A 1 , A 2 , R 1 , E, R 2 and R 3 have the same meaning as in formula (I). )
〔3〕 式(III)で表されるヘテロ環化合物およびそれらの塩から選ばれる少なくとも1種の化合物を有効成分として含有する動物用外部寄生虫防除剤。 [3] An ectoparasite control agent for animals comprising as an active ingredient at least one compound selected from the heterocyclic compounds represented by formula (III) and salts thereof.
(式(III)中、pは括弧内のメチレン基の繰り返し数を示し且つ1または2のいずれかである。
X、n、A1、A2、R1、X1、m、R2、R3およびEは、式(II)におけるそれらと同じ意味を示す。)
(In formula (III), p represents the number of repeating methylene groups in parentheses and is either 1 or 2.
X, n, A 1 , A 2 , R 1 , X 1 , m, R 2 , R 3 and E have the same meaning as in formula (II). )
〔4〕 式(IV)で表されるヘテロ環化合物およびそれらの塩から選ばれる少なくとも1種の化合物を有効成分として含有する動物用外部寄生虫防除剤。 [4] An ectoparasite control agent for animals comprising as an active ingredient at least one compound selected from the heterocyclic compounds represented by formula (IV) and salts thereof.
(式(IV)中、X、n、R1、X1、m、E、R2、R3およびpは、式(III)におけるそれらと同じ意味を示す。)
(In the formula (IV), X, n, R 1 , X 1 , m, E, R 2 , R 3 and p have the same meaning as in formula (III).)
〔5〕 獣医学上許容しうる量の前記〔1〕〜〔4〕のいずれかひとつに記載の外部寄生虫防除剤を投与することを含む外部寄生虫由来の感染症に罹患した動物の治療方法。
〔6〕 獣医学上許容しうる量の前記〔1〕〜〔4〕のいずれかひとつに記載の外部寄生虫防除剤を投与することを含む外部寄生虫由来の感染症に動物が罹患するのを防止する方法。
[5] Treatment of an animal suffering from an ectoparasite-derived infection comprising administering a veterinary-acceptable amount of the ectoparasite control agent according to any one of [1] to [4] Method.
[6] An animal suffers from an ectoparasite-derived infection comprising administration of a veterinary-acceptable amount of the ectoparasite control agent according to any one of [1] to [4]. How to prevent.
本発明の動物用外部寄生虫防除剤は、ダニ類などの外部寄生虫を高い効果で動物から防除でき、効果の持続時間が長く、作用スペクトルが広く、且つ低毒性であり、他の薬剤との混用の制限が少ない。
本発明の動物用外部寄生虫防除剤を動物に投与することによって、外部寄生虫由来の感染症に動物が罹患するのを防止することができる。
本発明の動物用外部寄生虫防除剤を外部寄生虫由来の感染症に罹患した動物に投与することによって、感染症を治療することができる。
The ectoparasite control agent for animals of the present invention can control ectoparasites such as ticks from animals with high effects, has a long duration of effect, has a wide action spectrum, and is low in toxicity. There are few restrictions on mixed use.
By administering the animal ectoparasite control agent of the present invention to an animal, it is possible to prevent the animal from suffering from an ectoparasite-derived infection.
An infectious disease can be treated by administering the animal ectoparasite control agent of the present invention to an animal suffering from an ectoparasite-derived infection.
本発明の動物用外部寄生虫防除剤は、式(I)、式(II)、式(III)または式(IV)で表されるヘテロ環化合物およびそれらの塩から選ばれる少なくとも1種の化合物を有効成分として含有するものである。 The animal ectoparasite control agent of the present invention is at least one compound selected from heterocyclic compounds represented by the formula (I), formula (II), formula (III) or formula (IV) and salts thereof Is contained as an active ingredient.
〔有効成分〕
本発明の動物用外部寄生虫防除剤に使用される有効成分は、式(I)で表されるヘテロ環化合物またはその塩から選ばれる少なくとも1種の化合物、好ましくは式(II)で表されるヘテロ環化合物またはその塩から選ばれる少なくとも1種の化合物、より好ましくは式(III)で表されるヘテロ環化合物またはその塩から選ばれる少なくとも1種の化合物、さらに好ましくは式(IV)で表されるヘテロ環化合物またはその塩から選ばれる少なくとも1種の化合物である。
[Active ingredients]
The active ingredient used in the animal ectoparasite control agent of the present invention is at least one compound selected from a heterocyclic compound represented by the formula (I) or a salt thereof, preferably represented by the formula (II). At least one compound selected from heterocyclic compounds or salts thereof, more preferably at least one compound selected from heterocyclic compounds represented by formula (III) or salts thereof, and more preferably in formula (IV) It is at least one compound selected from the heterocyclic compounds represented or salts thereof.
まず、式(I)〜(IV)にて使用されている記号、用語などの意味を説明する。
「無置換の」の用語は、母核となる基のみであることを意味する。「置換基を有する」との記載がなく母核となる基の名称のみで記載しているときは、別段の断りがない限り「無置換の」意味である。
一方、「置換基を有する」の用語は、母核となる基のいずれかの水素原子が、母核と同一または異なる構造の基で置換されていることを意味する。従って、「置換基」は、母核となる基に結合した他の基である。置換基は1つであってもよいし、2つ以上であってもよい。2つ以上の置換基は同一であってもよいし、異なるものであってもよい。
「C1〜6」などの用語は、母核となる基の炭素原子数が1〜6個などであることを表している。この炭素原子数には、置換基の中に在る炭素原子の数を含まない。例えば、置換基としてエトキシ基を有するブチル基は、C2アルコキシC4アルキル基に分類する。
First, the meanings of symbols and terms used in formulas (I) to (IV) will be described.
The term “unsubstituted” means only the group that is the mother nucleus. When there is no description of “having a substituent” and only the name of the group serving as a mother nucleus is used, it means “unsubstituted” unless otherwise specified.
On the other hand, the term “having a substituent” means that any hydrogen atom of a group serving as a mother nucleus is substituted with a group having the same or different structure from the mother nucleus. Accordingly, the “substituent” is another group bonded to a group serving as a mother nucleus. The number of substituents may be one, or two or more. Two or more substituents may be the same or different.
Terms such as “C1-6” indicate that the number of carbon atoms of the group serving as the mother nucleus is 1-6. This number of carbon atoms does not include the number of carbon atoms present in the substituent. For example, a butyl group having an ethoxy group as a substituent is classified as a C2 alkoxy C4 alkyl group.
「置換基」は化学的に許容され、本発明の効果を有する限りにおいて特に制限されない。
「置換基」となり得る基としては、 フッ素原子、塩素原子、臭素原子、ヨウ素原子などのハロゲン原子; メチル基、エチル基、n−プロピル基、i−プロピル基、n−ブチル基、s−ブチル基、i−ブチル基、t−ブチル基、n−ペンチル基、n−ヘキシル基などのC1〜6アルキル基; シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基などのC3〜8シクロアルキル基; ビニル基、1−プロペニル基、2−プロペニル基、1−ブテニル基、2−ブテニル基、3−ブテニル基、1−メチル−2−プロペニル基、2−メチル−2−プロペニル基、1−ペンテニル基、2−ペンテニル基、3−ペンテニル基、4−ペンテニル基、1−メチル−2−ブテニル基、2−メチル−2−ブテニル基、1−ヘキセニル基、2−ヘキセニル基、3−ヘキセニル基、4−ヘキセニル基、5−ヘキセニル基などのC2〜6アルケニル基; 2−シクロプロペニル基、2−シクロペンテニル基、3−シクロヘキセニル基、4−シクロオクテニル基などのC3〜8シクロアルケニル基; エチニル基、1−プロピニル基、2−プロピニル基、1−ブチニル基、2−ブチニル基、3−ブチニル基、1−メチル−2−プロピニル基、2−メチル−3−ブチニル基、1−ペンチニル基、2−ペンチニル基、3−ペンチニル基、4−ペンチニル基、1−メチル−2−ブチニル基、2−メチル−3−ペンチニル基、1−ヘキシニル基、1,1−ジメチル−2−ブチニル基などのC2〜6アルキニル基;
The “substituent” is not particularly limited as long as it is chemically acceptable and has the effects of the present invention.
Examples of groups that can be “substituents” include halogen atoms such as fluorine atom, chlorine atom, bromine atom, iodine atom; methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl C1-6 alkyl group such as a group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group; C3-8 such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cycloheptyl group A cycloalkyl group; a vinyl group, a 1-propenyl group, a 2-propenyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a 1-methyl-2-propenyl group, a 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hetenyl group C2-6 alkenyl groups such as xenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group; 2-cyclopropenyl group, 2-cyclopentenyl group, 3-cyclohexenyl group, 4- C3-8 cycloalkenyl groups such as cyclooctenyl group; ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2- Methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, A C2-6 alkynyl group such as a 1,1-dimethyl-2-butynyl group;
メトキシ基、エトキシ基、n−プロポキシ基、i−プロポキシ基、n−ブトキシ基、s−ブトキシ基、i−ブトキシ基、t−ブトキシ基などのC1〜6アルコキシ基; ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などのC2〜6アルケニルオキシ基; エチニルオキシ基、プロパルギルオキシ基などのC2〜6アルキニルオキシ基; フェニル基、ナフチル基などのC6〜10アリール基; フェノキシ基、1−ナフトキシ基などのC6〜10アリールオキシ基; ベンジル基、フェネチル基などのC7〜11アラルキル基; ベンジルオキシ基、フェネチルオキシ基などのC7〜11アラルキルオキシ基; ホルミル基、アセチル基、プロピオニル基、ベンゾイル基、シクロヘキシルカルボニル基などのC1〜7アシル基; ホルミルオキシ基、アセチルオキシ基、プロピオニルオキシ基、ベンゾイルオキシ基、シクロヘキシルカルボニルオキシ基などのC1〜7アシルオキシ基; メトキシカルボニル基、エトキシカルボニル基、n−プロポキシカルボニル基、i−プロポキシカルボニル基、n−ブトキシカルボニル基、t−ブトキシカルボニル基などのC1〜6アルコキシカルボニル基; カルボキシル基; C1-6 alkoxy groups such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group; vinyloxy group, allyloxy group, propenyl C2-6 alkenyloxy groups such as oxy group and butenyloxy group; C2-6 alkynyloxy groups such as ethynyloxy group and propargyloxy group; C6-10 aryl groups such as phenyl group and naphthyl group; phenoxy group and 1-naphthoxy group A C7-10 aralkyl group such as a benzyl group or a phenethyl group; a C7-11 aralkyloxy group such as a benzyloxy group or a phenethyloxy group; a formyl group, an acetyl group, a propionyl group, a benzoyl group, C1- such as a cyclohexylcarbonyl group Acyl group; C1-7 acyloxy group such as formyloxy group, acetyloxy group, propionyloxy group, benzoyloxy group, cyclohexylcarbonyloxy group; methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group A C1-6 alkoxycarbonyl group such as n-butoxycarbonyl group and t-butoxycarbonyl group; carboxyl group;
水酸基; オキソ基; クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2−ジクロロ−n−プロピル基、1−フルオロ−n−ブチル基、パーフルオロ−n−ペンチル基などのC1〜6ハロアルキル基; 2−クロロ−1−プロペニル基、2−フルオロ−1−ブテニル基などのC2〜6ハロアルケニル基; 4,4−ジクロロ−1−ブチニル基、4−フルオロ−1−ペンチニル基、5−ブロモ−2−ペンチニル基などのC2〜6ハロアルキニル基; 2−クロロ−n−プロポキシ基、2,3−ジクロロブトキシ基などのC1〜6ハロアルコキシ基; 2−クロロプロペニルオキシ基、3−ブロモブテニルオキシ基などのC2〜6ハロアルケニルオキシ基; 4−クロロフェニル基、4−フルオロフェニル基、2,4−ジクロロフェニル基などのC6〜10ハロアリール基; 4−フルオロフェニルオキシ基、4−クロロ−1−ナフトキシ基などのC6〜10ハロアリールオキシ基; クロロアセチル基、トリフルオロアセチル基、トリクロロアセチル基、4−クロロベンゾイル基などのハロゲン置換C1〜7アシル基; Hydroxyl group; oxo group; C1-6 haloalkyl such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group Group; C2-6 haloalkenyl group such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group; 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5- C2-6 haloalkynyl group such as bromo-2-pentynyl group; C1-6 haloalkoxy group such as 2-chloro-n-propoxy group and 2,3-dichlorobutoxy group; 2-chloropropenyloxy group, 3-bromo C2-6 haloalkenyloxy groups such as butenyloxy group; 4-chlorophenyl group, 4-fluorophenyl group, 2,4-dichlorophen C6-10 haloaryl group such as 4-fluorophenyloxy group, C6-10 haloaryloxy group such as 4-fluorophenyloxy group, 4-chloro-1-naphthoxy group; chloroacetyl group, trifluoroacetyl group, trichloroacetyl group, 4- Halogen-substituted C1-7 acyl groups such as chlorobenzoyl groups;
シアノ基;イソシアノ基;ニトロ基;イソシアナト基;シアナト基;アミノ基; メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基などのC1〜6アルキルアミノ基; アニリノ基、ナフチルアミノ基などのC6〜10アリールアミノ基; ベンジルアミノ基、フェニルエチルアミノ基などのC7〜11アラルキルアミノ基; ホルミルアミノ基、アセチルアミノ基、プロパノイルアミノ基、ブチリルアミノ基、i−プロピルカルボニルアミノ基、ベンゾイルアミノ基などのC1〜7アシルアミノ基; メトキシカルボニルアミノ基、エトキシカルボニルアミノ基、n−プロポキシカルボニルアミノ基、i−プロポキシカルボニルアミノ基などのC1〜6アルコキシカルボニルアミノ基; アミノカルボニル基、ジメチルアミノカルボニル基、フェニルアミノカルボニル基、N−フェニル−N−メチルアミノカルボニル基などの無置換の若しくは置換基を有するアミノカルボニル基; イミノメチル基、(1−イミノ)エチル基、(1−イミノ)−n−プロピル基などのイミノ基で置換されたC1〜6アルキル基; ヒドロキシイミノメチル基、(1−ヒドロキシイミノ)エチル基、(1−ヒドロキシイミノ)プロピル基、メトキシイミノメチル基、(1−メトキシイミノ)エチル基などのヒドロキシイミノ基で置換されたC1〜6アルキル基; Cyano group; isocyano group; nitro group; isocyanato group; cyanato group; amino group; C1-6 alkylamino group such as methylamino group, dimethylamino group and diethylamino group; C6-10 arylamino group such as anilino group and naphthylamino group Group: C7-11 aralkylamino group such as benzylamino group, phenylethylamino group; C1-7 such as formylamino group, acetylamino group, propanoylamino group, butyrylamino group, i-propylcarbonylamino group, benzoylamino group Acylamino group; C1-6 alkoxycarbonylamino group such as methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group; aminocarbonyl group, dimethylaminocarbonyl An unsubstituted or substituted aminocarbonyl group such as phenylaminocarbonyl group, N-phenyl-N-methylaminocarbonyl group; iminomethyl group, (1-imino) ethyl group, (1-imino) -n-propyl A C1-6 alkyl group substituted with an imino group such as a group; hydroxyiminomethyl group, (1-hydroxyimino) ethyl group, (1-hydroxyimino) propyl group, methoxyiminomethyl group, (1-methoxyimino) ethyl A C1-6 alkyl group substituted with a hydroxyimino group such as a group;
メルカプト基;イソチオシアナト基;チオシアナト基; メチルチオ基、エチルチオ基、n−プロピルチオ基、i−プロピルチオ基、n−ブチルチオ基、i−ブチルチオ基、s−ブチルチオ基、t−ブチルチオ基などのC1〜6アルキルチオ基; ビニルチオ基、アリルチオ基などのC2〜6アルケニルチオ基; エチニルチオ基、プロパルギルチオ基などのC2〜6アルキニルチオ基; フェニルチオ基、ナフチルチオ基などのC6〜10アリールチオ基; チアゾリルチオ基、ピリジルチオ基などのヘテロアリールチオ基; ベンジルチオ基、フェネチルチオ基などのC7〜11アラルキルチオ基; (メチルチオ)カルボニル基、(エチルチオ)カルボニル基、(n−プロピルチオ)カルボニル基、(i−プロピルチオ)カルボニル基、(n−ブチルチオ)カルボニル基、(i−ブチルチオ)カルボニル基、(s−ブチルチオ)カルボニル基、(t−ブチルチオ)カルボニル基などの(C1〜6アルキルチオ)カルボニル基; Mercapto group; isothiocyanato group; thiocyanato group; C1-6 alkylthio such as methylthio group, ethylthio group, n-propylthio group, i-propylthio group, n-butylthio group, i-butylthio group, s-butylthio group, t-butylthio group C2-6 alkenylthio groups such as vinylthio groups and allylthio groups; C2-6 alkynylthio groups such as ethynylthio groups and propargylthio groups; C6-10 arylthio groups such as phenylthio groups and naphthylthio groups; thiazolylthio groups and pyridylthio groups A heteroarylthio group of C7-11 aralkylthio group such as benzylthio group and phenethylthio group; (methylthio) carbonyl group, (ethylthio) carbonyl group, (n-propylthio) carbonyl group, (i-propylthio) carbonyl group, ( - butylthio) carbonyl group, (i-butylthio) carbonyl group, (s-butylthio) carbonyl group, (t-butylthio) (Cl to 6 alkylthio, such as carbonyl groups) carbonyl group;
メチルスルフィニル基、エチルスルフィニル基、t−ブチルスルフィニル基などのC1〜6アルキルスルフィニル基; アリルスルフィニル基などのC2〜6アルケニルスルフィニル基; プロパルギルスルフィニル基などのC2〜6アルキニルスルフィニル基; フェニルスルフィニル基などのC6〜10アリールスルフィニル基; チアゾリルスルフィニル基、ピリジルスルフィニル基などのヘテロアリールスルフィニル基; ベンジルスルフィニル基、フェネチルスルフィニル基などのC7〜11アラルキルスルフィニル基; メチルスルホニル基、エチルスルホニル基、t−ブチルスルホニル基などのC1〜6アルキルスルホニル基; アリルスルホニル基などのC2〜6アルケニルスルホニル基; プロパルギルスルホニル基などのC2〜6アルキニルスルホニル基; フェニルスルホニル基などのC6〜10アリールスルホニル基; チアゾリルスルホニル基、ピリジルスルホニル基などのヘテロアリールスルホニル基; ベンジルスルホニル基、フェネチルスルホニル基などのC7〜11アラルキルスルホニル基; C1-6 alkylsulfinyl groups such as methylsulfinyl group, ethylsulfinyl group, t-butylsulfinyl group; C2-6 alkenylsulfinyl groups such as allylsulfinyl group; C2-6 alkynylsulfinyl groups such as propargylsulfinyl group; phenylsulfinyl group and the like A heteroarylsulfinyl group such as thiazolylsulfinyl group and pyridylsulfinyl group; a C7-11 aralkylsulfinyl group such as benzylsulfinyl group and phenethylsulfinyl group; a methylsulfonyl group, an ethylsulfonyl group, t- C1-6 alkylsulfonyl group such as butylsulfonyl group; C2-6 alkenylsulfonyl group such as allylsulfonyl group; C2 such as propargylsulfonyl group A C6-10 arylsulfonyl group such as a phenylsulfonyl group; a heteroarylsulfonyl group such as a thiazolylsulfonyl group or a pyridylsulfonyl group; a C7-11 aralkylsulfonyl group such as a benzylsulfonyl group or a phenethylsulfonyl group;
ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員ヘテロアリール基; ピリジル基、ピラジニル基、ピリミジニル基、ピリダニジル基、トリアジニル基などの6員ヘテロアリール基; アジリジニル基、エポキシ基、ピロリジニル基、テトラヒドロフラニル基、ピペリジル基、ピペラジニル基、モルホリニル基などの飽和ヘテロ環基; トリメチルシリル基、トリエチルシリル基、t−ブチルジメチルシリル基などのトリC1〜6アルキル置換シリル基; トリフェニルシリル基; などを挙げることができる。 5-membered heteroaryl groups such as pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl; pyridyl, pyrazinyl Groups, 6-membered heteroaryl groups such as pyrimidinyl group, pyridinyl group, triazinyl group; saturated heterocyclic groups such as aziridinyl group, epoxy group, pyrrolidinyl group, tetrahydrofuranyl group, piperidyl group, piperazinyl group, morpholinyl group; trimethylsilyl group, triethyl And a tri-C1-6 alkyl-substituted silyl group such as a silyl group or a t-butyldimethylsilyl group; a triphenylsilyl group;
また、これらの「置換基」は、当該基の中のいずれかの水素原子がさらに別の「置換基」で置換されたものであってもよい。 These “substituents” may be those in which any hydrogen atom in the group is further substituted with another “substituent”.
(X)
Xは、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。nは、Xの置換数を示し且つ0〜5のいずれかの整数である。nが2以上のとき、X同士は互いに同一でも異なっていてもよい。
(X)
X is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, a hydroxyl group, An unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group is shown. n shows the substitution number of X and is an integer in any one of 0-5. When n is 2 or more, Xs may be the same as or different from each other.
Xにおける「C1〜6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。アルキル基としては、メチル基、エチル基、n−プロピル基、n−ブチル基、n−ペンチル基、n−ヘキシル基、i−プロピル基、i−ブチル基、s−ブチル基、t−ブチル基、i−ペンチル基、ネオペンチル基、2−メチルブチル基、2,2−ジメチルプロピル基、i−ヘキシル基などが挙げられる。 The “C1-6 alkyl group” in X may be a straight chain or a branched chain. As the alkyl group, methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s-butyl group, t-butyl group I-pentyl group, neopentyl group, 2-methylbutyl group, 2,2-dimethylpropyl group, i-hexyl group and the like.
Xにおける「置換基を有するC1〜6アルキル基」としては、 シクロプロピルメチル基、2−シクロプロピルエチル基、シクロペンチルメチル基、2−シクロヘキシルエチル基、2−シクロオクチルエチル基などのC3〜8シクロアルキルC1〜6アルキル基; フルオロメチル基、クロロメチル基、ブロモメチル基、ジフルオロメチル基、ジクロロメチル基、ジブロモメチル基、トリフルオロメチル基、トリクロロメチル基、トリブロモメチル基、2,2,2−トルフルオロエチル基、2,2,2−トリクロロエチル基、ペンタフルオロエチル基、4−フルオロブチル基、4−クロロブチル基、3,3,3−トリフルオロプロピル基、2,2,2−トリフルオロ−1−トリフルオロメチルエチル基、パーフルオロヘキシル基、パークロロヘキシル基、2,4,6−トリクロロヘキシル基などのC1〜6ハロアルキル基; The “C 1-6 alkyl group having a substituent” in X is a C 3-8 cyclo group such as cyclopropylmethyl group, 2-cyclopropylethyl group, cyclopentylmethyl group, 2-cyclohexylethyl group, 2-cyclooctylethyl group, etc. Alkyl C1-6 alkyl group; fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, dichloromethyl group, dibromomethyl group, trifluoromethyl group, trichloromethyl group, tribromomethyl group, 2,2,2- Trifluoroethyl group, 2,2,2-trichloroethyl group, pentafluoroethyl group, 4-fluorobutyl group, 4-chlorobutyl group, 3,3,3-trifluoropropyl group, 2,2,2-trifluoro -1-trifluoromethylethyl group, perfluorohexyl group, perchlorohexene A C1-6 haloalkyl group such as a xyl group or a 2,4,6-trichlorohexyl group;
ヒドロキシメチル基、2−ヒドロキシエチル基などのヒドロキシC1〜6アルキル基; メトキシメチル基、エトキシメチル基、メトキシエチル基、エトキシエチル基、メトキシ−n−プロピル基、n−プロポキシメチル基、i−プロポキシエチル基、s−ブトキシメチル基、t−ブトキシエチル基などのC1〜6アルコキシC1〜6アルキル基; メトキシメトキシメチル基、1−メトキシエトキシメチル基、2−メトキシエトキシメチル基、2−(1−メトキシエトキシ)エチル基、2−(2−メトキシエトキシ)エチル基などのC1〜6アルコキシC1〜6アルコキシC1〜6アルキル基; ジメトキシメチル基、ジエトキシメチル基、2,2−ジメトキシエチル基、1,2−ジメトキシエチル基、3,3−ジメトキシn−プロピル基、2,2−ジエトキシエチル基などのジC1〜6アルコキシC1〜6アルキル基; ホルミルオキシメチル基、アセトキシメチル基、2−アセトキシエチル基、プロピオニルオキシメチル基、プロピオニルオキシエチル基などのC1〜7アシルオキシC1〜6アルキル基; イミノメチル基、(1−イミノ)エチル基、(1−イミノ)プロピル基などのイミノ基で置換されたC1〜6アルキル基; ヒドロキシイミノメチル基、(1−ヒドロキシイミノ)エチル基、(1−ヒドロキシイミノ)−n−プロピル基、メトキシイミノメチル基、(1−メトキシイミノ)エチル基などのヒドロキシイミノ基で置換されたC1〜6アルキル基; 無置換の若しくは置換基を有するベンジル基、無置換の若しくは置換基を有するフェネチル基などの無置換の若しくは置換基を有するC7〜11アラルキル基; などが挙げられる。 Hydroxy C1-6 alkyl groups such as hydroxymethyl group and 2-hydroxyethyl group; methoxymethyl group, ethoxymethyl group, methoxyethyl group, ethoxyethyl group, methoxy-n-propyl group, n-propoxymethyl group, i-propoxy group C1-6 alkoxy C1-6 alkyl groups such as ethyl group, s-butoxymethyl group, t-butoxyethyl group; methoxymethoxymethyl group, 1-methoxyethoxymethyl group, 2-methoxyethoxymethyl group, 2- (1- C1-6 alkoxy C1-6 alkoxy C1-6 alkyl groups such as methoxyethoxy) ethyl group, 2- (2-methoxyethoxy) ethyl group; dimethoxymethyl group, diethoxymethyl group, 2,2-dimethoxyethyl group, 1 , 2-dimethoxyethyl group, 3,3-dimethoxy n-propyl group, Di-C1-6 alkoxy C1-6 alkyl group such as 2-diethoxyethyl group; C1-7 acyloxy such as formyloxymethyl group, acetoxymethyl group, 2-acetoxyethyl group, propionyloxymethyl group, propionyloxyethyl group A C1-6 alkyl group; a C1-6 alkyl group substituted with an imino group such as an iminomethyl group, a (1-imino) ethyl group, or a (1-imino) propyl group; a hydroxyiminomethyl group, (1-hydroxyimino) ethyl A C1-6 alkyl group substituted with a hydroxyimino group such as a group, (1-hydroxyimino) -n-propyl group, methoxyiminomethyl group, (1-methoxyimino) ethyl group; unsubstituted or substituted An unsubstituted or unsubstituted benzyl group, an unsubstituted or substituted phenethyl group, etc. Or a C7-11 aralkyl group having a substituent;
Xにおける「C2〜6アルケニル基」としては、ビニル基、1−プロペニル基、2−プロペニル基、1−ブテニル基、2−ブテニル基、3−ブテニル基、1−メチル−2−プロペニル基、2−メチル−2−プロペニル基、1−ペンテニル基、2−ペンテニル基、3−ペンテニル基、4−ペンテニル基、1−メチル−2−ブテニル基、2−メチル−2−ブテニル基、1−ヘキセニル基、2−ヘキセニル基、3−ヘキセニル基、4−ヘキセニル基、5−ヘキセニル基などが挙げられる。
Xにおける「置換基を有するC2〜6アルケニル基」としては、2−クロロ−1−プロペニル基、2−フルオロ−1−ブテニル基などのC2〜6ハロアルケニル基; などが挙げられる。
Examples of the “C2-6 alkenyl group” in X include a vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2 -Methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
Examples of the “C2-6 alkenyl group having a substituent” in X include C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group;
Xにおける「C2〜6アルキニル基」としては、エチニル基、1−プロピニル基、2−プロピニル基、1−ブチニル基、2−ブチニル基、3−ブチニル基、1−メチル−2−プロピニル基、2−メチル−3−ブチニル基、1−ペンチニル基、2−ペンチニル基、3−ペンチニル基、4−ペンチニル基、1−メチル−2−ブチニル基、2−メチル−3−ペンチニル基、1−ヘキシニル基、1,1−ジメチル−2−ブチニル基などが挙げられる。
Xにおける「置換基を有するC2〜6アルキニル基」としては、4,4−ジクロロ−1−ブチニル基、4−フルオロ−1−ペンチニル基、5−ブロモ−2−ペンチニル基などのC2〜6ハロアルキニル基; などが挙げられる。
Examples of the “C2-6 alkynyl group” in X include ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2 -Methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group 1,1-dimethyl-2-butynyl group and the like.
Examples of the “C2-6 alkynyl group having a substituent” in X include C2-6 halo such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group and the like. Alkynyl group; and the like.
Xにおける「C1〜6アルコキシ基」としては、メトキシ基、エトキシ基、i−プロポキシ基、n−ブトキシ基、i−ブトキシ基、s−ブトキシ基、t−ブトキシ基、n−ペンチルオキシ基、i−ペンチルオキシ基、n−ヘキシルオキシ基などが挙げられる。
Xにおける「置換基を有するC1〜6アルコキシ基」としては、 フルオロメトキシ基、クロロメトキシ基、ブロモメトキシ基、ジフルオロメトキシ基、ジクロロメトキシ基、ジブロモメトキシ基、トリフルオロメトキシ基、トリクロロメトキシ基、トリブロモメトキシ基、2,2,2−トリフルオロエトキシ基、2,2,2−トリクロロエトキシ基、ペンタフルオロエトキシ基、4−フルオロブトキシ基、3,3,3−トリフルオロプロポキシ基、2,2,2−トリフルオロ−1−トリフルオロメチルエトキシ基、パーフルオロヘキシルオキシ基などのC1〜6ハロアルコキシ基; メトキシメトキシ基、1−メトキシエトキシ基、2−メトキシエトキシ基、エトキシメトキシ基、1−エトキシエトキシ基、2−エトキシエトキシ基、1−メトキシ−n−プロポキシ基、2−メトキシ−n−プロポキシ基、3−メトキシ−n−プロポキシ基などのC1〜6アルコキシC1〜6アルコキシ基; シクロプロピルメトキシ基、シクロブチルメトキシ基、シクロペンチルメトキシ基、シクロヘキシルメトキシ基、2−メチルシクロプロピルメトキシ基、2,3−ジメチルシクロプロピルメトキシ基、2−シクロプロピルエトキシ基などのC3〜8シクロアルキルC1〜6アルコキシ基; ベンジルオキシ基、フェネチルオキシ基などのC7〜11アラルキルオキシ基; などが挙げられる。
As the “C 1-6 alkoxy group” in X, a methoxy group, an ethoxy group, an i-propoxy group, an n-butoxy group, an i-butoxy group, an s-butoxy group, a t-butoxy group, an n-pentyloxy group, i -A pentyloxy group, n-hexyloxy group, etc. are mentioned.
Examples of the “C1-6 alkoxy group having a substituent” in X include a fluoromethoxy group, a chloromethoxy group, a bromomethoxy group, a difluoromethoxy group, a dichloromethoxy group, a dibromomethoxy group, a trifluoromethoxy group, a trichloromethoxy group, Bromomethoxy group, 2,2,2-trifluoroethoxy group, 2,2,2-trichloroethoxy group, pentafluoroethoxy group, 4-fluorobutoxy group, 3,3,3-trifluoropropoxy group, 2,2 , 2-trifluoro-1-trifluoromethylethoxy group, perfluorohexyloxy group and other C1-6 haloalkoxy groups; methoxymethoxy group, 1-methoxyethoxy group, 2-methoxyethoxy group, ethoxymethoxy group, 1- Ethoxyethoxy group, 2-ethoxyethoxy group, 1-methyl A C1-6 alkoxy C1-6 alkoxy group such as a xy-n-propoxy group, a 2-methoxy-n-propoxy group, a 3-methoxy-n-propoxy group; a cyclopropylmethoxy group, a cyclobutylmethoxy group, a cyclopentylmethoxy group, C3-8 cycloalkyl C1-6 alkoxy groups such as cyclohexylmethoxy group, 2-methylcyclopropylmethoxy group, 2,3-dimethylcyclopropylmethoxy group, 2-cyclopropylethoxy group; benzyloxy group, phenethyloxy group, etc. C7-11 aralkyloxy group;
これらのうち、Xは、ハロゲン原子、またはC1〜6ハロアルキル基であることが好ましい。 Among these, X is preferably a halogen atom or a C1-6 haloalkyl group.
(A1、A2)
A1およびA2はそれぞれ独立に、炭素原子または窒素原子を示す。
A1およびA2がいずれも炭素原子である場合は、これを含む芳香環はベンゼン環を表す。A1およびA2がいずれも窒素原子である場合は、これを含む芳香環はピリミジン環を表す。A1またはA2のいずれかが、窒素原子であって、他方が炭素原子である場合は、これを含む芳香環はピリジン環を表す。本発明においては、A1およびA2がいずれも炭素原子であることが好ましい。
(A 1, A 2)
A 1 and A 2 each independently represent a carbon atom or a nitrogen atom.
When both A 1 and A 2 are carbon atoms, the aromatic ring containing them represents a benzene ring. When both A 1 and A 2 are nitrogen atoms, the aromatic ring containing them represents a pyrimidine ring. When either A 1 or A 2 is a nitrogen atom and the other is a carbon atom, the aromatic ring containing it represents a pyridine ring. In the present invention, both A 1 and A 2 are preferably carbon atoms.
(B1、B2、B3)
B1およびB2はそれぞれ独立に、炭素原子または窒素原子を示す。B1またはB2のいずれかひとつは窒素原子であることが好ましい。
B3は、炭素原子または酸素原子を示す。
B1が炭素原子であって、B2が窒素原子である場合、B1とB2との間の結合は、二重結合となっていてもよい。
B1が窒素原子であって、B2およびB3がいずれも炭素原子である場合は、これを含むヘテロ環は、ピロリジン環を示す。
B2が窒素原子であって、B1およびB3がいずれも炭素原子である場合は、これを含むヘテロ環は、ピロリン環(別名:3,4-ジヒドロ−2H−ピロール環)を示す。
B1が炭素原子、B2が窒素原子であって、B3が酸素原子である場合は、これを含むヘテロ環は、イソオキサゾリン環(別名:4,5−ジヒドロイソオキサゾール環)を示す。
(B 1, B 2, B 3)
B 1 and B 2 each independently represent a carbon atom or a nitrogen atom. Any one of B 1 and B 2 is preferably a nitrogen atom.
B 3 represents a carbon atom or an oxygen atom.
When B 1 is a carbon atom and B 2 is a nitrogen atom, the bond between B 1 and B 2 may be a double bond.
When B 1 is a nitrogen atom and B 2 and B 3 are both carbon atoms, the heterocycle containing the same represents a pyrrolidine ring.
When B 2 is a nitrogen atom and both B 1 and B 3 are carbon atoms, the heterocycle containing the same represents a pyrroline ring (also known as 3,4-dihydro-2H-pyrrole ring).
When B 1 is a carbon atom, B 2 is a nitrogen atom, and B 3 is an oxygen atom, the heterocycle containing this represents an isoxazoline ring (also known as a 4,5-dihydroisoxazole ring).
(R1)
R1は、水素原子、ハロゲン原子、または無置換のもしくは置換基を有するC1〜6アルキル基を示す。
R1における「C1〜6アルキル基」としては、前記Xにおいて例示したそれと同じものを挙げることができる。
これらのうち、R1は、C1〜6ハロアルキル基であることが好ましい。
(R 1 )
R 1 represents a hydrogen atom, a halogen atom, or an unsubstituted or substituted C 1-6 alkyl group.
Examples of the “C 1-6 alkyl group” for R 1 include the same as those exemplified for X above.
Of these, R 1 is preferably a C 1-6 haloalkyl group.
(X0)
X0は、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
m1は、X0の置換数を示し且つ0〜3のいずれかの整数である。m1が2以上のとき、X0同士は互いに同一でも異なっていてもよい。
X0における「C1〜6アルキル基」、「C2〜6アルケニル基」、「C2〜6アルキニル基」、および「C1〜6アルコキシ基」としては、前記Xにおいて例示したそれらと同じものを挙げることができる。
(X 0 )
X 0 is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, a hydroxyl group , An unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
m1 represents the number of substitutions of X 0 and is an integer from 0 to 3. When m1 is 2 or more, X 0 may be the same or different from each other.
Examples of the “C1-6 alkyl group”, “C2-6 alkenyl group”, “C2-6 alkynyl group”, and “C1-6 alkoxy group” in X 0 are the same as those exemplified in the above X. Can do.
(R11、R12)
R11は、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するアミノ基、または無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基を示す。
R11における「C1〜6アルキル基」、「C2〜6アルケニル基」としては、前記Xにおいて例示したそれらと同じものを挙げることができる。
(R 11, R 12)
R 11 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted amino group, or an unsubstituted or substituted group A C1-6 alkylaminocarbonyl group having
Examples of the “C 1-6 alkyl group” and “C 2-6 alkenyl group” in R 11 include the same groups as those exemplified in the above X.
R11における「置換基を有するC1〜6アルキル基」としては、前記Xにおいて例示したものの他に、ホルミルアミノメチル基、アセチルアミノメチル基、2−アセチルアミノエチル基、プロピオニルアミノメチル基、プロピオニルアミノメチル基などのC1〜7アシルアミノC1〜6アルキル基; などが挙げられる。 As the “C1-6 alkyl group having a substituent” in R 11, in addition to those exemplified in the above X, formylaminomethyl group, acetylaminomethyl group, 2-acetylaminoethyl group, propionylaminomethyl group, propionylamino A C1-7 acylamino C1-6 alkyl group such as a methyl group;
R11における「置換基を有するアミノ基」としては、メチルアミノ基、エチルアミノ基、ジメチルアミノ基などのC1〜6アルキルアミノ基、; ビニルアミノ基、アリルアミノ基などのC2〜6アルケニルアミノ基; ヒドラジノ基、N’,N’−ジメチルヒドラジノ基、N’−メチレンヒドラジノ基などのN’−置換ヒドラジノ基; などが挙げられる。 As the “amino group having a substituent” in R 11, a C1-6 alkylamino group such as a methylamino group, an ethylamino group or a dimethylamino group; a C2-6 alkenylamino group such as a vinylamino group or an allylamino group; And N′-substituted hydrazino groups such as hydrazino group, N ′, N′-dimethylhydrazino group, N′-methylenehydrazino group;
R11における「C1〜6アルキルアミノカルボニル基」としては、メチルアミノカルボニル基、エチルアミノカルボニル、n−プロピルアミノカルボニル基などが挙げられる。
R11における「置換基を有するC1〜6アルキルアミノカルボニル基」としては、トリフルオロメチルアミノカルボニル基、2,2,2−トリフルオロエチルアミノカルボニル基などのC1〜6ハロアルキルアミノカルボニル基; メトキシメチルアミノカルボニル基、メトキシエチルアミノカルボニル基などのC1〜6アルコキシC1〜6アルキルアミノカルボニル基; ピリジルメチルアミノカルボニル基、ピリジルエチルアミノカルボニル、ピリミジルメチルアミノカルボニル基などのヘテロアリール基置換C1〜6アルキルアミノカルボニル基; などが挙げられる。
Examples of the “C 1-6 alkylaminocarbonyl group” for R 11 include a methylaminocarbonyl group, an ethylaminocarbonyl group, and an n-propylaminocarbonyl group.
As the “C1-6 alkylaminocarbonyl group having a substituent” for R 11, a C1-6 haloalkylaminocarbonyl group such as a trifluoromethylaminocarbonyl group or a 2,2,2-trifluoroethylaminocarbonyl group; C1-6 alkoxy C1-6 alkylaminocarbonyl groups such as aminocarbonyl group and methoxyethylaminocarbonyl group; heteroaryl group substitution C1-6 such as pyridylmethylaminocarbonyl group, pyridylethylaminocarbonyl, pyrimidylmethylaminocarbonyl group Alkylaminocarbonyl group; and the like.
R12は、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC1〜6アルコキシ基、またはハロゲン原子を示す。
R12における「C1〜6アルキル基」、「C2〜6アルケニル基」、「C1〜6アルコキシ基」としては、前記Xにおいて例示したそれらと同じものを挙げることができる。
R 12 represents an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C1-6 alkoxy group, or a halogen atom. Show.
Examples of the “C1-6 alkyl group”, “C2-6 alkenyl group”, and “C1-6 alkoxy group” in R 12 include the same as those exemplified in the above X.
また、R11とR12は、それらが繋がって、それらが結合する炭素原子と一緒になって、置換基R20を有する5〜8員環の炭化水素環または置換基R20を有する5〜8員環のヘテロ環を形成してもよい。
R20は、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、シアノ基; 無置換のもしくは置換基を有するC1〜7アシル基、無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基、アミノ基、または−N(R2)COR3で表される置換基を示す。
Also, R 11 and R 12, they are connected, together with the carbon atoms to which they are attached 5 with a hydrocarbon ring or a substituent R 20 5-8 membered ring having a substituent R 20 An 8-membered heterocycle may be formed.
R 20 is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, a hydroxyl group An unsubstituted or substituted C1-6 alkoxy group, a nitro group, a cyano group; an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted C1-6 alkylaminocarbonyl group , An amino group, or a substituent represented by —N (R 2 ) COR 3 .
「5〜8員環の炭化水素環」または「5〜8員環のヘテロ環」としては、シクロペンテン環、シクロヘプタン環などのC5〜8シクロアルケン環; ベンゼン環などのC6〜8アリール環; ジヒドロフラン環、ピロール環、ピラゾール環、3,4−ジヒドロ−2H−ピラン環などのヘテロ環; などが挙げられる。 As the “5- to 8-membered hydrocarbon ring” or “5- to 8-membered heterocycle”, a C5-8 cycloalkene ring such as a cyclopentene ring or a cycloheptane ring; a C6-8 aryl ring such as a benzene ring; And heterocyclic rings such as a dihydrofuran ring, a pyrrole ring, a pyrazole ring, and a 3,4-dihydro-2H-pyran ring;
R20における「C1〜6アルキル基」、「C2〜6アルケニル基」、「C2〜6アルキニル基」、「C1〜6アルコキシ基」としては、前記Xにおいて例示したそれらと同じものを挙げることができる。R20における「C1〜6アルキルアミノカルボニル基」としては、前記R11において例示したそれらと同じものを挙げることができる。
R20における「C1〜7アシル基」としては、ホルミル基、アセチル基、プロピオニル基、ベンゾイル基などを例示することができる。
R20における「置換基を有するC1〜7アシル基」としては、クロロアセチル基、トリフルオロアセチル基、トリクロロアセチル基、4−クロロベンゾイル基などのハロゲン置換C1〜7アシル基を例示することができる。
Examples of the “C1-6 alkyl group”, “C2-6 alkenyl group”, “C2-6 alkynyl group”, and “C1-6 alkoxy group” in R 20 include the same as those exemplified in the above X. it can. As the “C 1-6 alkylaminocarbonyl group” for R 20, the same groups as those exemplified for R 11 can be mentioned.
Examples of the “C1-7 acyl group” in R 20 include formyl group, acetyl group, propionyl group, benzoyl group and the like.
Examples of the “C1-7 acyl group having a substituent” in R 20 include halogen-substituted C1-7 acyl groups such as a chloroacetyl group, a trifluoroacetyl group, a trichloroacetyl group, and a 4-chlorobenzoyl group. .
(R2)
R2は、水素原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC1〜7アシル基、または無置換のもしくは置換基を有するC1〜6アルコキシカルボニル基を示す。
(R 2 )
R 2 represents a hydrogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-7 acyl group, or an unsubstituted or substituted C1-6 alkoxycarbonyl group. Indicates.
R2における「C1〜6アルキル基」としては、前記Xにおいて例示したそれと同じものを挙げることができる。
R2における「C1〜7アシル基」としては、前記R20において例示したそれと同じものを挙げることができる。
Examples of the “C1-6 alkyl group” for R 2 include the same as those exemplified for X above.
Examples of the “C1-7 acyl group” for R 2 include the same as those exemplified for R 20 above.
R2における「C1〜6アルコキシカルボニル基」としては、メトキシカルボニル基、エトキシカルボニル基、n−プロポキシカルボニル基、i−プロポキシカルボニル基などを例示することができる。
R2における「置換基を有するC1〜6アルコキシカルボニル基」としては、 シクロプロピルメトキシカルボニル基、シクロブチルメトキシカルボニル基、シクロペンチルメトキシカルボニル基、シクロヘキシルメトキシカルボニル基、2−メチルシクロプロピルメトキシカルボニル基、2,3−ジメチルシクロプロピルメトキシカルボニル基、2−クロロシクロプロピルメトキシカルボニル基、2−シクロプロピルエトキシカルボニル基などのC3〜8シクロアルキルC1〜6アルコキシカルボニル基; フルオロメトキシカルボニル基、クロロメトキシカルボニル基、ブロモメトキシカルボニル基、ジフルオロメトキシカルボニル基、ジクロロメトキシカルボニル基、ジブロモメトキシカルボニル基、トリフルオロメトキシカルボニル基、トリクロロメトキシカルボニル基、トリブロモメトキシカルボニル基、2,2,2−トリフルオロエトキシカルボニル基、2,2,2−トリクロロエトキシカルボニル基、ペンタフルオロエトキシカルボニル基、4−フルオロブトキシカルボニル基、3,3,3−トリフルオロプロポキシカルボニル基、2,2,2−トリフルオロ−1−トリフルオロメチルエトキシカルボニル基、パーフロロヘキシルオキシカルボニル基などのC1〜6ハロアルコキシカルボニル基;などを例示することができる。
Examples of the “C1-6 alkoxycarbonyl group” for R 2 include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, and the like.
Examples of the “substituted C1-6 alkoxycarbonyl group” for R 2 include cyclopropylmethoxycarbonyl group, cyclobutylmethoxycarbonyl group, cyclopentylmethoxycarbonyl group, cyclohexylmethoxycarbonyl group, 2-methylcyclopropylmethoxycarbonyl group, 2 , 3-dimethylcyclopropylmethoxycarbonyl group, 2-chlorocyclopropylmethoxycarbonyl group, C3-8 cycloalkyl C1-6 alkoxycarbonyl group such as 2-cyclopropylethoxycarbonyl group; fluoromethoxycarbonyl group, chloromethoxycarbonyl group, Bromomethoxycarbonyl group, difluoromethoxycarbonyl group, dichloromethoxycarbonyl group, dibromomethoxycarbonyl group, trifluoromethoxycarbonyl group, Trichloromethoxycarbonyl group, tribromomethoxycarbonyl group, 2,2,2-trifluoroethoxycarbonyl group, 2,2,2-trichloroethoxycarbonyl group, pentafluoroethoxycarbonyl group, 4-fluorobutoxycarbonyl group, 3,3 , 3-trifluoropropoxycarbonyl groups, 2,2,2-trifluoro-1-trifluoromethylethoxycarbonyl groups, C1-6 haloalkoxycarbonyl groups such as perfluorohexyloxycarbonyl groups; .
(R3)
R3は、水素原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、無置換のもしくは置換基を有するC3〜8シクロアルキル基、無置換のもしくは置換基を有するC1〜6アルコキシ基、無置換のもしくは置換基を有するC2〜6アルケニルオキシ基、無置換の若しくは置換基を有するC2〜6アルキニルオキシ基、無置換のもしくは置換基を有するC6〜10アリール基、または無置換のもしくは置換基を有するヘテロ環基を示す。
(R 3 )
R 3 represents a hydrogen atom, an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, an unsubstituted or substituted C 2-6 alkynyl group, A substituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C2-6 alkenyloxy group, an unsubstituted or substituted group; A C2-6 alkynyloxy group having an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted heterocyclic group;
R3における「C1〜6アルキル基」、「C2〜6アルケニル基」、「C2〜6アルキニル基」、および「C1〜6アルコキシ基」としては、前記Xにおいて例示したそれらと同じものを挙げることができる。 Examples of the “C1-6 alkyl group”, “C2-6 alkenyl group”, “C2-6 alkynyl group”, and “C1-6 alkoxy group” in R 3 are the same as those exemplified in the above X. Can do.
R3における「C3〜8シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基などが挙げられる。
R3における「置換基を有するシクロアルキル基」としては、クロロシクロヘキシル基、ブロモシクロヘキシル基、2−メチルシクロプロピル基、2,3−ジメチルシクロプロピル基などが挙げられる。
Examples of the “C3-8 cycloalkyl group” for R 3 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and the like.
Examples of the “cycloalkyl group having a substituent” for R 3 include a chlorocyclohexyl group, a bromocyclohexyl group, a 2-methylcyclopropyl group, and a 2,3-dimethylcyclopropyl group.
R3における「C2〜6アルケニルオキシ基」としては、ビニルオキシ基、1−プロペニルオキシ基、2−プロペニルオキシ基、1−ブテニルオキシ基、2−ブテニルオキシ基、3−ブテニルオキシ基、1−メチル−2−プロペニルオキシ基、2−メチル−2−プロペニルオキシ基、1−ペンテニルオキシ基、2−ペンテニルオキシ基、1−メチル−2−ブテニルオキシ基、2−メチル−2−ブテニルオキシ基、1−ヘキセニルオキシ基、2−ヘキセニルオキシ基などが挙げられる。
R3における「置換基を有するC2〜6アルケニルオキシ基」としては、2−クロロ−1−プロペニルオキシ基、2−フルオロ−1−ブテニルオキシ基などのC2〜6ハロアルケニルオキシ基; などが挙げられる。
Examples of the “C2-6 alkenyloxy group” in R 3 include a vinyloxy group, 1-propenyloxy group, 2-propenyloxy group, 1-butenyloxy group, 2-butenyloxy group, 3-butenyloxy group, 1-methyl-2- Propenyloxy group, 2-methyl-2-propenyloxy group, 1-pentenyloxy group, 2-pentenyloxy group, 1-methyl-2-butenyloxy group, 2-methyl-2-butenyloxy group, 1-hexenyloxy group, Examples include 2-hexenyloxy group.
Examples of the “substituted C2-6 alkenyloxy group” for R 3 include C2-6 haloalkenyloxy groups such as 2-chloro-1-propenyloxy group and 2-fluoro-1-butenyloxy group; .
R3における「C2〜6アルキニルオキシ基」としては、エチニルオキシ基、1−プロピニルオキシ基、2−プロピニルオキシ基、1−ブチニルオキシ基、2−ブチニルオキシ基、3−ブチニルオキシ基、1−メチル−2−プロピニルオキシ基、2−メチル−3−ブチニルオキシ基、1−ペンチニルオキシ基、2−ペンチニルオキシ基、1−メチル−2−ブチニルオキシ基、2−メチル−3−ペンチニルオキシ基、1−ヘキシニルオキシ基などが挙げられる。
R3における「置換基を有するC2〜6アルキニルオキシ基」としては、4,4−ジクロロ−1−ブチニルオキシ基、4−フルオロ−1−ペンチニルオキシ基、5−ブロモ−2−ペンチニルオキシ基などのC2〜6ハロアルキニルオキシ基; などが挙げられる。
Examples of the “C2-6 alkynyloxy group” in R 3 include ethynyloxy group, 1-propynyloxy group, 2-propynyloxy group, 1-butynyloxy group, 2-butynyloxy group, 3-butynyloxy group, 1-methyl-2 -Propynyloxy group, 2-methyl-3-butynyloxy group, 1-pentynyloxy group, 2-pentynyloxy group, 1-methyl-2-butynyloxy group, 2-methyl-3-pentynyloxy group, 1- Examples include hexynyloxy group.
The “C2-6 alkynyloxy group having a substituent” for R 3 includes a 4,4-dichloro-1-butynyloxy group, a 4-fluoro-1-pentynyloxy group, and a 5-bromo-2-pentynyloxy group. C2-6 haloalkynyloxy groups such as; and the like.
R3における「C6〜10アリール基」は、単環であってもよいし、多環であってもよい。多環アリール基は、少なくとも一つの環が芳香環であれば、残りの環が飽和脂環、不飽和脂環または芳香環のいずれであってもよい。C6〜10アリール基としては、フェニル基、ナフチル基、アズレニル基、インデニル基、インダニル基、テトラリニル基などが挙げられる。 The “C6-10 aryl group” in R 3 may be monocyclic or polycyclic. In the polycyclic aryl group, if at least one ring is an aromatic ring, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the C6-10 aryl group include a phenyl group, a naphthyl group, an azulenyl group, an indenyl group, an indanyl group, and a tetralinyl group.
R3における「ヘテロ環基」は、窒素原子、酸素原子及び硫黄原子から選ばれる1〜4個のヘテロ原子が環を構成する原子として含むものである。ヘテロ環基は、単環であってもよいし、多環であってもよい。
ヘテロ環基としては、5員ヘテロアリール基、6員ヘテロアリール基、縮合ヘテロアリール基、飽和ヘテロ環基、部分不飽和ヘテロ環基などが挙げられる。
The “heterocyclic group” in R 3 includes 1 to 4 heteroatoms selected from a nitrogen atom, an oxygen atom and a sulfur atom as atoms constituting the ring. The heterocyclic group may be monocyclic or polycyclic.
Examples of the heterocyclic group include a 5-membered heteroaryl group, a 6-membered heteroaryl group, a condensed heteroaryl group, a saturated heterocyclic group, and a partially unsaturated heterocyclic group.
5員ヘテロアリール基としては、 ピロール−1−イル基、ピロール−2−イル基、ピロール−3−イル基などのピロリル基; フラン−2−イル基、フラン−3−イル基などのフリル基; チオフェン−2−イル基、チオフェン−3−イル基などのチエニル基; イミダゾール−1−イル基、イミダゾール−2−イル基、イミダゾール−4−イル基、イミダゾール−5−イル基などのイミダゾリル基; ピラゾール−1−イル基、ピラゾール−3−イル基、ピラゾール−4−イル基、ピラゾール−5−イル基などのピラゾリル基;オキサゾール−2−イル基、オキサゾール−4−イル基、オキサゾール−5−イル基などのオキサゾリル基; イソオキサゾール−3−イル基、イソオキサゾール−4−イル基、イソオキサゾール−5−イル基などのイソオキサゾリル基; チアゾール−2−イル基、チアゾール−4−イル基、チアゾール−5−イル基などのチアゾリル基; イソチアゾール−3−イル基、イソチアゾール−4−イル基、イソチアゾール−5−イル基などのイソチアゾリル基; 1,2,3−トリアゾール−1−イル基、1,2,3−トリアゾール−4−イル基、1,2,3−トリアゾール−5−イル基、1,2,4−トリアゾール−1−イル基、1,2,4−トリアゾール−3−イル基、1,2,4−トリアゾール−5−イル基などのトリアゾリル基; 1,2,4−オキサジアゾール−3−イル基、1,2,4−オキサジアゾール−5−イル基、1,3,4−オキサジアゾール−2−イル基などのオキサジアゾリル基; 1,2,4−チアジアゾール−3−イル基、1,2,4−チアジアゾール−5−イル基、1,3,4−チアジアゾール−2−イル基などのチアジアゾリル基; テトラゾール−1−イル基、テトラゾール−2−イル基などのテトラゾリル基; などが挙げられる。 Examples of the 5-membered heteroaryl group include pyrrolyl groups such as pyrrol-1-yl group, pyrrol-2-yl group and pyrrol-3-yl group; furyl groups such as furan-2-yl group and furan-3-yl group. A thienyl group such as a thiophen-2-yl group and a thiophen-3-yl group; an imidazolyl group such as an imidazol-1-yl group, an imidazol-2-yl group, an imidazol-4-yl group, and an imidazol-5-yl group; A pyrazolyl group such as a pyrazol-1-yl group, a pyrazol-3-yl group, a pyrazol-4-yl group, and a pyrazol-5-yl group; an oxazol-2-yl group, an oxazol-4-yl group, and an oxazole-5 -Oxazolyl groups such as yl groups; isoxazol-3-yl groups, isoxazol-4-yl groups, isoxazol-5-yl groups and the like Isoxazolyl group; thiazolyl group such as thiazol-2-yl group, thiazol-4-yl group, thiazol-5-yl group; isothiazol-3-yl group, isothiazol-4-yl group, isothiazol-5-yl 1,2,3-triazol-1-yl group, 1,2,3-triazol-4-yl group, 1,2,3-triazol-5-yl group, 1,2,4 -Triazolyl groups such as triazol-1-yl group, 1,2,4-triazol-3-yl group, 1,2,4-triazol-5-yl group; 1,2,4-oxadiazole-3- Oxadiazolyl group such as yl group, 1,2,4-oxadiazol-5-yl group, 1,3,4-oxadiazol-2-yl group; 1,2,4-thiadiazol-3-yl group, 1, , 4-thiadiazol-5-yl group, 1,3,4-thiadiazol-2-yl-thiadiazolyl group such as a group; and the like; tetrazol-1-yl group, tetrazolyl group, such as tetrazol-2-yl group.
6員ヘテロアリール基としては、 ピリジン−2−イル基、ピリジン−3−イル基、ピリジン−4−イル基などのピリジル基; ピラジン−2−イル基、ピラジン−3−イル基などのピラジニル基; ピリミジン−2−イル基、ピリミジン−4−イル基、ピリミジン−5−イル基などのピリミジニル基; ピリダジン−3−イル基、ピリダジン−4−イル基などのピリダジニル基;トリアジニル基;などが挙げられる。 Examples of the 6-membered heteroaryl group include pyridyl groups such as pyridin-2-yl group, pyridin-3-yl group and pyridin-4-yl group; pyrazinyl groups such as pyrazin-2-yl group and pyrazin-3-yl group A pyrimidinyl group such as a pyrimidin-2-yl group, a pyrimidin-4-yl group and a pyrimidin-5-yl group; a pyridazinyl group such as a pyridazin-3-yl group and a pyridazin-4-yl group; a triazinyl group; It is done.
その他のヘテロ環基としては、 アジリジン−1−イル基、アジリジン−2−イル基、エポキシ基; ピロリジン−1−イル基、ピロリジン−2−イル基、ピロリジン−3−イル基、テトラヒドロフラン−2−イル基、テトラヒドロフラン−3−イル基; ピペリジン−1−イル基、ピペリジン−2−イル基、ピペリジン−3−イル基、ピペリジン−4−イル基、ピペラジン−1−イル基、ピペラジン−2−イル基、モルホリン−2−イル基、モルホリン−3−イル基、モルホリン−4−イル基; 1,3−ベンゾジオキソール−4−イル基、1,3−ベンゾジオキソール−5−イル基、1,4−ベンゾジオキサン−5−イル基、1,4−ベンゾジオキサン−6−イル基、3,4−ジヒドロ−2H−1,5−ベンゾジオキセピン−6−イル基、3,4−ジヒドロ−2H−1,5−ベンゾジオキセピン−7−イル基、2,3−ジヒドロベンゾフラン−4−イル基、2,3−ジヒドロベンゾフラン−5−イル基、2,3−ジヒドロベンゾフラン−6−イル基、2,3−ジヒドロベンゾフラン−7−イル基; などが挙げられる。 Other heterocyclic groups include: aziridin-1-yl group, aziridin-2-yl group, epoxy group; pyrrolidin-1-yl group, pyrrolidin-2-yl group, pyrrolidin-3-yl group, tetrahydrofuran-2- Yl group, tetrahydrofuran-3-yl group; piperidin-1-yl group, piperidin-2-yl group, piperidin-3-yl group, piperidin-4-yl group, piperazin-1-yl group, piperazin-2-yl Group, morpholin-2-yl group, morpholin-3-yl group, morpholin-4-yl group; 1,3-benzodioxol-4-yl group, 1,3-benzodioxol-5-yl group 1,4-benzodioxan-5-yl group, 1,4-benzodioxan-6-yl group, 3,4-dihydro-2H-1,5-benzodioxepin-6-yl group, , 4-Dihydro-2H-1,5-benzodioxepin-7-yl group, 2,3-dihydrobenzofuran-4-yl group, 2,3-dihydrobenzofuran-5-yl group, 2,3-dihydro A benzofuran-6-yl group, a 2,3-dihydrobenzofuran-7-yl group;
これらのうち、R3は、C1〜6アルキル基、C1〜6アルコキシC1〜6アルキル基、またはC1〜6アルコキシC1〜6アルコキシC1〜6アルキル基であることが好ましい。 Among these, R 3 is preferably a C 1-6 alkyl group, a C 1-6 alkoxy C 1-6 alkyl group, or a C 1-6 alkoxy C 1-6 alkoxy C 1-6 alkyl group.
(E)
Eは、炭素原子または窒素原子を示す。これらのうち、Eは、炭素原子であることが好ましい。
(E)
E represents a carbon atom or a nitrogen atom. Of these, E is preferably a carbon atom.
(式(II)で表されるヘテロ環化合物)
式(II)で表されるヘテロ環化合物は、式(I)中の、B1が炭素原子、B2が窒素原子、B3が酸素原子、B1とB2との間が二重結合になっているものである。すなわち、式(II)で表されるヘテロ環化合物は、イソオキサゾリン環(4,5−ジヒドロイソオキサゾール環)を有する。
さらに、式(II)で表されるヘテロ環化合物は、式(I)中の、R11とR12とが繋がって、それらが結合する炭素原子と一緒になって、置換基R21を有する5〜8員環の炭化水素環または置換基R21を有する5〜8員環のヘテロ環を形成しているものである。
式(II)中のDは5〜8員の炭化水素環または5〜8員のヘテロ環を示す。
R21は、Dに結合する置換基であり且つ無置換のもしくは置換基を有するC1〜7アシル基、無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基、アミノ基、または−N(R2)COR3で表される置換基を示す。
(Heterocyclic compound represented by formula (II))
In the heterocyclic compound represented by the formula (II), in the formula (I), B 1 is a carbon atom, B 2 is a nitrogen atom, B 3 is an oxygen atom, and B 1 and B 2 are double bonds. It is what has become. That is, the heterocyclic compound represented by the formula (II) has an isoxazoline ring (4,5-dihydroisoxazole ring).
Furthermore, the heterocyclic compound represented by the formula (II) has a substituent R 21 in which R 11 and R 12 in the formula (I) are linked together with the carbon atom to which they are bonded. those that form a heterocyclic ring of 5- to 8-membered ring having a 5- to 8-membered hydrocarbon ring or a substituent R 21 rings.
D in Formula (II) represents a 5- to 8-membered hydrocarbon ring or a 5- to 8-membered heterocycle.
R 21 is a substituent bonded to D and is an unsubstituted or substituted C 1-7 acyl group, an unsubstituted or substituted C 1-6 alkylaminocarbonyl group, an amino group, or —N ( R 2 ) represents a substituent represented by COR 3 .
(X1)
X1は、Dを含む縮合環に結合する置換基であり且つハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
mは、X1の置換数を示し且つ0〜6のいずれかの整数である。mが2以上のとき、X1同士は互いに同一でも異なっていてもよい。
X1における「アルキル基」、「C2〜6アルケニル基」、「C2〜6アルキニル基」、および「C1〜6アルコキシ基」としては、前記Xにおいて例示したそれらと同じものを挙げることができる。
式(II)中のX、n、A1、A2、R1、E、R2およびR3は、式(I)におけるそれらと同じ意味を示す。
(X 1 )
X 1 is a substituent bonded to the condensed ring containing D and is a halogen atom, an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, unsubstituted Or a substituted C2-6 alkynyl group, a hydroxyl group, an unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
m represents the number of substitutions of X 1 and is an integer of 0 to 6. When m is 2 or more, X 1 may be the same as or different from each other.
"Alkyl group" in X 1, the "C2~6 alkenyl group", "C2~6 alkynyl group", and "C1~6 alkoxy group" may include the same ones as those exemplified in the X.
X, n, A 1 , A 2 , R 1 , E, R 2 and R 3 in formula (II) have the same meaning as in formula (I).
(式(III)で表されるヘテロ環化合物)
式(III)で表されるヘテロ環化合物は、式(II)中の、Dが5員または6員の炭化水素環、R21が−N(R2)COR3で表される置換基になっているものである。すなわち、pは括弧内のメチレン基の繰り返し数を示し且つ1または2のいずれかである。pは好ましくは1である。すなわち、式(III)で表されるヘテロ環化合物はインダン環(別名:2,3−ジヒドロインデン環)を有するものが好ましい。式(III)中のX、n、A1、A2、R1、X1、m、R2、R3およびEは、式(II)におけるそれらと同じ意味を示す。
(Heterocyclic compound represented by formula (III))
In the heterocyclic compound represented by the formula (III), D is a 5- or 6-membered hydrocarbon ring in the formula (II), and R 21 is a substituent represented by —N (R 2 ) COR 3. It is what has become. That is, p represents the number of repeating methylene groups in parentheses and is either 1 or 2. p is preferably 1. That is, the heterocyclic compound represented by the formula (III) preferably has an indane ring (also known as a 2,3-dihydroindene ring). X, n, A 1 , A 2 , R 1 , X 1 , m, R 2 , R 3 and E in formula (III) have the same meaning as in formula (II).
(式(IV)で表されるヘテロ環化合物)
式(IV)で表されるヘテロ環化合物は、式(III)中の、A1およびA2の両方が炭素原子になっているものである。式(IV)中のX、n、R1、X1、m、E、R2、R3およびpは、式(III)におけるそれらと同じ意味を示す。
(Heterocyclic compound represented by formula (IV))
The heterocyclic compound represented by the formula (IV) is one in which both A 1 and A 2 in the formula (III) are carbon atoms. X, n, R 1 , X 1 , m, E, R 2 , R 3 and p in formula (IV) have the same meaning as in formula (III).
式(I)〜式(IV)で表されるヘテロ環化合物の塩としては、塩酸塩、硝酸塩、硫酸塩、リン酸塩などの無機酸の塩;酢酸塩、乳酸塩、プロピオン酸塩、安息香酸塩などの有機酸の塩;が挙げられる。 Examples of the salt of the heterocyclic compound represented by formula (I) to formula (IV) include salts of inorganic acids such as hydrochloride, nitrate, sulfate, and phosphate; acetate, lactate, propionate, benzoate And salts of organic acids such as acid salts.
式(I)〜式(IV)で表されるヘテロ環化合物またはその塩の具体例および製造方法は、特許文献3、特許文献4、特許文献5、特許文献6などに記載されている。よって、それらを参酌することによって、本発明に使用される式(I)〜式(IV)で表されるヘテロ環化合物またはその塩を容易に製造または入手することができる。 Specific examples and production methods of the heterocyclic compounds represented by the formulas (I) to (IV) or salts thereof are described in Patent Document 3, Patent Document 4, Patent Document 5, Patent Document 6, and the like. Therefore, by taking them into consideration, the heterocyclic compounds represented by the formulas (I) to (IV) or salts thereof used in the present invention can be easily produced or obtained.
〔他の成分〕
本発明の動物用外部寄生虫防除剤には、上記有効成分以外の成分を含んでいてもよい。例えば、各種ビタミン類、ミネラル類、ホルモン剤、アミノ酸類、酵素製剤、解熱剤、鎮静剤、消炎剤、抗ガン剤、抗生物質、内部寄生虫駆除剤、抗菌剤、殺菌剤、着色剤、芳香剤、保存剤、ワクチンなどが挙げられる。また、殺虫、殺ダニ、駆虫、殺真菌、殺線虫、抗原虫、殺菌、抗ウイルスなどの生物学的活性を有する化合物を含んでいてもよい。
[Other ingredients]
The animal ectoparasite control agent of the present invention may contain components other than the above-mentioned active ingredients. For example, various vitamins, minerals, hormones, amino acids, enzyme preparations, antipyretics, sedatives, anti-inflammatory agents, anticancer agents, antibiotics, endoparasite control agents, antibacterial agents, bactericides, coloring agents, fragrances , Preservatives, vaccines and the like. Further, it may contain a compound having biological activity such as insecticidal, acaricidal, anthelmintic, fungicidal, nematicidal, antigenic, insecticidal or antiviral.
〔剤形〕
本発明の動物用外部寄生虫防除剤は、剤形によって特に制限されない。剤形としては、粉剤、粒剤、錠剤、散剤、カプセル剤、プレミックス剤、液剤、乳剤、ウエハース、ビスケット、ミンチ肉などが挙げられる。
本発明の動物用外部寄生虫防除剤は、剤形に応じて、担体、界面活性剤、固体希釈材、液体希釈材などを含んでいてもよい。例えば、乳糖、蔗糖、ブドウ糖、澱粉、麦粉、コーン粉、大豆油粕、脱脂米糠、炭酸カルシウム、その他市販の飼料原料などが挙げられる。
(Dosage form)
The animal ectoparasite control agent of the present invention is not particularly limited by the dosage form. Examples of the dosage form include powders, granules, tablets, powders, capsules, premixes, liquids, emulsions, wafers, biscuits, minced meat and the like.
The animal ectoparasite control agent of the present invention may contain a carrier, a surfactant, a solid diluent, a liquid diluent and the like depending on the dosage form. Examples thereof include lactose, sucrose, glucose, starch, wheat flour, corn flour, soybean oil cake, defatted rice bran, calcium carbonate, and other commercially available feed materials.
〔投与方法など〕
本発明の動物用外部寄生虫防除剤は、単独で、動物に投与することができる。また、必要に応じて他の動物薬、例えば抗菌剤、栄養剤、駆虫剤、殺菌剤、抗コクシジウム剤、殺虫剤、殺ダニ剤、殺真菌剤、殺線虫剤、抗原虫薬、抗ウイルス剤、ワクチン、ホルモン剤、抗がん剤、抗生物質、解熱剤、鎮静剤、消炎剤、内部寄生虫駆除剤などとともに投与することができる。
[Method of administration, etc.]
The animal ectoparasite control agent of the present invention can be administered to an animal alone. Also, if necessary, other animal drugs such as antibacterial agents, nutrients, anthelmintics, fungicides, anticoccidial agents, insecticides, acaricides, fungicides, nematicides, antiprotozoal agents, antiviral agents It can be administered together with vaccines, hormonal agents, anticancer agents, antibiotics, antipyretics, sedatives, anti-inflammatory agents, endoparasite control agents, and the like.
本発明の動物用外部寄生虫防除剤と混用若しくは併用できる他の動物薬などは特に制限されない。例えば、以下のものが挙げられる。 Other veterinary drugs that can be mixed or used in combination with the animal ectoparasite control agent of the present invention are not particularly limited. For example, the following are mentioned.
1)有機(チオ)ホスフェート系: アセフェート、アザメチホス、アジンホス・メチル、アジンホス・エチル、ブロモホス・エチル、ブロムフェンビンホス、BRP、クロルピリホス、クロルピリホス・メチル、クロルピリホス・エチル、クロルフェンビンホス、カズサホス、カルボフェノチオン、クロルエトキシホス、クロルメホス、クマホス、シアノフェンホス、シアノホス、CYAP、ダイアジノン、ジクロルボス、ジクロトホス、ジメトエート、ジスルホトン、ジメトン-S-メチル、ジメチルビンホス、ジメトン−S−メチルスルホン、ジアリホス、ダイアジノン、ジクロフェンチオン、ジオキサベンゾホス、ジスルホトン、エチオン、エトプロホス、エトリムホス、EPN、フェナミホス、フェニトロチオン、フェンチオン、フェンスルホチオン、フルピラゾホス、ホノホス、ホルモチオン、ホスメチラン、ヘプテノホス、イサゾホス、ヨードフェンホス、イソフェンホス、イソキサチオン、イプロベンホス、マラチオン、メビンホス、メタミドホス、メチダチオン、モノクロトホス、メカルバム、メタクリホス、ナレッド、オメトエート、オキシジメトン・メチル、パラオクソン、パラチオン、パラチオン・メチル、フェントエート、ホサロン、ホスメット、ホスファミドン、ホレート、ホキシム、ピリミホス・メチル、ピリミホス・エチル、プロフェノホス、プロチオホス、ホスチアゼート、ホスホカルブ、プロパホス、プロペタムホス、プロトエート、ピリダフェンチオン、ピラクロホス、キナルホス、サリチオン、スルプロホス、スルホテップ、テトラクロルビンホス、テルブホス、トリアゾホス、トリクロルホン、テブピリムホス、テメホス、チオメトン、バミドチオン; 1) Organic (thio) phosphates: acephate, azamethiphos, azinephos methyl, azinephos ethyl, bromophos ethyl, bromfenbinphos, BRP, chlorpyrifos, chlorpyrifos methyl, chlorpyrifos ethyl, chlorfenvinphos, kazusafos, carbo Phenothion, chloroethoxyphos, chlormefos, coumaphos, cyanophenphos, cyanophos, CYAP, diazinon, dichlorvos, dicrotophos, dimethoate, disulfotone, dimeton-S-methyl, dimethylvinphos, dimeton-S-methylsulfone, diariphos, diazinon, Diclofenthion, Dioxabenzophos, Disulfoton, Ethion, Etoprofos, Etrimfos, EPN, Phenamifos, Fenitrothion, Fenthion, Fensulfothio , Flupyrazophos, phonophos, formothione, phosmethylan, heptenophos, isazophos, iodofenphos, isofenphos, isoxathione, iprobenphos, malathion, mevinphos, methamidophos, methidathion, monocrotophos, mecarbam, methalyphos, nared, ometoate, oxydimethone parathione , Parathion methyl, phentoate, hosalon, phosmet, phosphamidone, folate, phoxime, pyrimifos methyl, pyrimifos ethyl, propenophos, prothiophos, phosthiazate, phosphocarb, propaphos, propetamphos, protoate, pyridafenthion, pyracrophos, quinalphos, sulthiote, sulfophos , Tetrachlorbinphos, terb Phos, triazophos, trichlorfone, tebupyrimfos, temefos, thiometone, bamidithione;
2)カルバメート系: アラニカルブ、アルジカルブ、ベンダイオカルブ、ベンフラカルブ、カルバリル、カルボフラン、カルボスルファン、フェノキシカルブ、フェノチオカルブ、メチオカルブ、メソミル、オキサミル、ピリミカーブ、プロポキスル、チオジカルブ、トリアザメート、エチオフェンカルブ、フェノブカルブ、MIPC、MPMC、MTMC、ピリダフェンチオン、フラチオカルブ、XMC、アルドキシカルブ、アリキシカルブ、アミノカルブ、ベンダイオカルブ、ブフェンカルブ、ブタカルブ、ブトカルボキシム、ブトキシカルボキシム、クロエトカルブ、ジメチラン、ホルメタネート、イソプロカルブ、メタム・ナトリウム、メトルカルブ、プロメカルブ、チオファノックス、トリメタカルブ、キシリルカルブ; 2) Carbamate series: Alanicarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, phenoxycarb, phenothiocarb, methiocarb, mesomil, oxamyl, pirimicurve, propoxyl, thiodicarb, triazamate, etiofencarb, MIPC, MPC MTMC, pyridafenthion, furthiocarb, XMC, aldoxicarb, arixicarb, aminocarb, bendiocarb, bufencarb, butacarb, butcarboxyme, butoxycarboxyme, chloetocarb, dimethylane, formethanate, isoprocarb, metam sodium, metolcarb, promecarb, thiofa Knox, Trimetacarb, Xylylcarb;
3)ピレトロイド系: アレトリン、ビフェントリン、シフルトリン、ベータ・シフルトリン、シハロトリン、ラムダ・シハロトリン、シフェノトリン、シペルメトリン、アルファ・シペルメトリン、ベータ・シペルメトリン、ゼタ・シペルメトリン、デルタメトリン、エスフェンバレレート、エトフェンプロックス、フェンプロパトリン、フェンバレレート、イミプロトリン、ペルメトリン、プラレトリン、ピレトリン、ピレトリンI、ピレトリンII、レスメトリン、シラフルオフェン、フルバリネート、テフルトリン、テトラメトリン、トラロメトリン、トランスフルトリン、プロフルトリン、ジメフルトリン、アクリナトリン、シクロプロトリン、ハルフェンプロックス、フルシトリネート、ビオアレスリン、ビオエタノメトリン、ビオペルメトリン、ビオレスメトリン、トランスペルメトリン、エンペントリン、フェンフルトリン、フェンピリトリン、フルブロシトリネート、フルフェンプロックス、フルメトリン、メトフルトリン、フェノトリン、プロトリフェンブト、ピレスメトリン、テラレトリン; 3) Pyrethroids: alletrin, bifenthrin, cyfluthrin, beta cyfluthrin, cyhalothrin, lambda cyhalothrin, ciphenothrin, cypermethrin, alpha cypermethrin, beta cypermethrin, zeta cypermethrin, deltamethrin, esfenvalerate, etofen Prox, Fenpropatrin, Fenvalerate, Imiprothrin, Permethrin, Praretrin, Pyretrin, Pyretrin I, Pyretrin II, Resmethrin, Silafluophene, Fluverate, Tefluthrin, Tetramethrin, Tralomethrin, Transfluthrin, Profluthrin, Cymetritoline, Acrinathrin Halfenprox, flucitrinate, bioareslin, bioethanomethrin, bio Rumetorin, Bioresmethrin, trans permethrin, empenthrin, fenfluthrin Trinh, Fen pyridinium Trinh, full Bro shea tri sulphonate, full Fen flufenprox, flumethrin, metofluthrin, phenothrin, protrifenbute, pyresmethrin, terallethrin;
4)成長調節物質: a)キチン合成阻害剤: クロルフルアズロン、ジフルベンズロン、フルシクロクスロン、フルフェノクスロン、ヘキサフルムロン、ルフェヌロン、ノバルロン、テフルベンズロン、トリフルムロン、ビストリフルロン、ノビフルムロン、ブプロフェジン、ヘキシチアゾクス、エトキサゾール、クロフェンテジン、フルアズロン、ペンフルロン; b)エクジソンアンタゴニスト: ハロフェノジド、メトキシフェノジド、テブフェノジド、クロマフェノジド、アザジラクチン; c)幼若ホルモン様物質: ピリプロキシフェン、メトプレン、ジオフェノラン、エポフェノナン、ハイドロプレン、キノプレン、トリプレン; d)脂質生合成阻害剤: スピロジクロフェン、スピロメシフェン、スピロテトラマト、フロニカミド; 4) Growth regulator: a) Chitin synthesis inhibitor: chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novallon, teflubenzuron, triflumuron, bistrifluron, nobiflumuron, buprofezin, hexithiazox B) ecdysone antagonists: halofenozide, methoxyphenozide, tebufenozide, chromafenozide, azadirachtin; c) juvenile hormone-like substances: pyriproxyfen, methoprene, diophenolan, epofenonan, hydroprene, quinoprene, quinoprene, quinoprene, quinoprene, quinoprene D) lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat, flonicamid;
5)ニコチン受容体アゴニスト/アンタゴニスト化合物: アセタミプリド、クロチアニジン、ジノテフラン、イミダクロプリド、ニテンピラム、チアクロプリド、チアメトキサム、ニチアジン、ニコチン、ベンスルタップ、カルタップ;
6)GABAアンタゴニスト化合物: a)アセトプロール、エチプロール、フィプロニル、バニリプロール、ピラフルプロール、ピリプロール; b)有機塩素系: カンフェクロル、クロルデン、エンドスルファン、HCH、γ−HCH、ヘプタクロル、メトキシクロル;
5) Nicotine receptor agonist / antagonist compounds: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, nithiazine, nicotine, bensultap, cartap;
6) GABA antagonist compounds: a) acetoprole, ethiprole, fipronil, vanilliprol, pyrafluprole, pyriprole; b) organochlorine: camfechlor, chlordane, endosulfan, HCH, γ-HCH, heptachlor, methoxychlor;
7)大環状ラクトン殺虫剤: アバメクチン、エマメクチン安息香酸塩、ミルベメクチン、レピメクチン、スピノサド、イベルメクチン、セラメクチン、ドラメクチン、エピノメクチン、モキシデクチン、
8)METI I化合物: フェナザキン、ピリダベン、テブフェンピラド、トルフェンピラド、フルフェネリム、ヒドラメチルノン、フェンピロキシメート、ピリミジフェン、ジコホル;
9)METI IIおよびIII化合物: アセキノシル、フルアクリピリム、ロテノン;
7) Macrocyclic lactone insecticide: abamectin, emamectin benzoate, milbemectin, lepimectin, spinosad, ivermectin, selamectin, doramectin, epinomectin, moxidectin,
8) METI I compounds: phenazaquin, pyridaben, tebufenpyrad, tolfenpyrad, fluphenelim, hydramethylnon, fenpyroximate, pyrimidifen, dicophor;
9) METI II and III compounds: acequinosyl, fluacrylpyrim, rotenone;
10)脱共役剤化合物: クロルフェナピル、ビナパクリル、ジノブトン、ジノカップ、DNOC;
11)酸化的リン酸化阻害剤化合物: シヘキサチン、ジアフェンチウロン、フェンブタチン・オキシド、プロパルギット、アゾシクロチン;
12)脱皮かく乱化合物: シロマジン;
13)混合機能オキシダーゼ阻害剤化合物: ピペロニルブトキシド;
14)ナトリウムチャネル遮断剤化合物: インドキサカルブ、メタフルミゾン;
15)微生物農薬: BT剤、昆虫病原ウイルス剤、昆虫病原糸状菌剤、線虫病原糸状菌剤;バチルス属種、白きょう病菌、黒きょう病菌、ペキロマイセス属種、チューリンギエンシン、バーティシリウム属種;
16)ラトロフィリン受容体作用薬: デプシペプチド、環状デプシペプチド、24員環状デプシペプチド、エモデプシド;
10) Uncoupler compounds: chlorfenapyr, binapacryl, dinobutone, dinocup, DNOC;
11) Oxidative phosphorylation inhibitor compounds: cyhexatin, diafenthiuron, phenbutatin oxide, propargite, azocyclotin;
12) molting disrupting compounds: cyromazine;
13) Mixed function oxidase inhibitor compound: piperonyl butoxide;
14) Sodium channel blocker compounds: indoxacarb, metaflumizone;
15) Microbial pesticides: BT agent, entomopathogenic virus agent, entomopathogenic fungus agent, nematode pathogenic fungus agent; Bacillus spp., White scab fungus, black scab fungus, Pekir Myces sp., Thuringiensins, Verticillium Genus species;
16) Latrophilin receptor agonist: depsipeptide, cyclic depsipeptide, 24-membered cyclic depsipeptide, emodepside;
17)オクトパミン性作用薬: アミトラズ;
18)リアノジン誘導体作用薬: フルベンジアミド、クロラントラニリプロール、シアントラリニプロール
19)マグネシウム刺激性ATPアーゼの阻害薬: チオシクラム、チオスルタップ、ネライストキシン;
20)摂食阻害薬: ピメトロジン;
21)ダニ成長阻害薬: クロフェンテジン、エトキサゾール;
22)その他のもの: ベンクロチアズ、ビフェナゼート、ピリダリル、硫黄、シエノピラフェン、シフルメトフェン、アミドフルメット、テトラジホン、クロルジメホルム、1,3−ジクロロプロペン、DCIP、フェニソブロモレート、ベンゾメート、メタアルデヒド、スピネトラム、ピリフルキナゾン、ベンゾキシメート、ブロモプロピレート、キノメチオネート、クロルベンジレート、クロルピクリン、クロチアゾベン、ジシクラニル、フェノキサクリム、フェントリファニル、フルベンジミン、フルフェンジン、ゴシップルア、ジャポニルア、メトキサジアゾン、石油、オレイン酸カリウム、スルフルラミド、テトラスル、トリアラセン;
17) Octopaminergic agents: Amitraz;
18) Ryanodine derivative agonists: fulbenzamide, chlorantraniliprole, cyantraliniprol 19) Inhibitors of magnesium-stimulated ATPase: thiocyclam, thiosultap, nereistoxin;
20) Antifeedant: Pymetrozine;
21) Tick growth inhibitors: clofentezin, etoxazole;
22) Others: Benclothiaz, Bifenazate, Pyridalyl, Sulfur, Sienopyrafen, Ciflumethofene, Amidoflumet, Tetradiphone, Chlordimeform, 1,3-Dichloropropene, DCIP, Phenisobromolate, Benzate, Metaaldehyde, Spinetram, Pyrifluquinazone, Benzoxy Mate, bromopropyrate, quinomethionate, chlorbenzilate, chloropicrin, clothiazoben, dicyclanyl, phenoxacrime, fentriphanyl, flubenzimine, flufenzine, gossip lure, japonyla, metoxadiazone, petroleum, potassium oleate, sulfluramide, tetrasul, trialacene;
23)駆虫剤: a)ベンズイミダゾール系: フェンベンダゾール、アルベンダゾール、トリクラベンダゾール、オキシベンダゾール; b)サリチルアニリド系: クロサンテル、オキシクロザニド; c)置換フェノール系: ニトロキシニル; d)ピリミジン系: ピランテル; e)イミダゾチアゾール系: レバミソール; f)テトラヒドロピリミジン: プラジカンテル; g)その他の駆虫薬: シクロジエン、リアニア、クロルスロン、メトロニダゾール; 23) Anthelmintic: a) benzimidazole series: fenbendazole, albendazole, triclabendazole, oxybendazole; b) salicylanilide series: closantel, oxyclozanide; c) substituted phenol series: nitroxinyl; d) pyrimidine series: pyrantel E) imidazothiazole series: levamisole; f) tetrahydropyrimidine: praziquantel; g) other anthelmintic drugs: cyclodiene, riania, chlorthrone, metronidazole;
本発明の動物用外部寄生虫防除剤と他の動物薬との使用比率は、特に制限されないが、通常、100:0〜1:99(重量比)である。 The ratio of use of the animal ectoparasite control agent of the present invention and other animal drugs is not particularly limited, but is usually 100: 0 to 1:99 (weight ratio).
本発明の防除剤が有効な宿主動物としては、イヌ、ネコ、マウス、ラット、ハムスター、モルモット、リス、ウサギ、フェレット、鳥(例えば、ハト、オウム、九官鳥、文鳥、インコ、ジュウシマツ、カナリア);ウシ、ウマ、ブタ、ヒツジ、ヤギ;アヒル、ニワトリ、七面鳥、カモなどが挙げられる。 Examples of host animals in which the control agent of the present invention is effective include dogs, cats, mice, rats, hamsters, guinea pigs, squirrels, rabbits, ferrets, birds (for example, pigeons, parrots, nine-birds, wild birds, parakeets, juvenile pine, canary); Examples include cattle, horses, pigs, sheep, goats; ducks, chickens, turkeys and ducks.
本発明の動物用外部寄生虫防除剤の対象となる外部寄生虫は、宿主動物の背、腋下、下腹部、内股部などに寄生して動物から血液やフケなどの栄養源を得て生息するもの、および宿主動物の背、臀部などに飛来して動物から血液やフケなどの栄養源を得て生息するものを包含する。外部寄生虫としては、ダニ類、シラミ類、ノミ類などが挙げられる。 The ectoparasites targeted by the animal ectoparasite control agent according to the present invention inhabit the host animal's back, armpit, lower abdomen, inner thigh, etc., and obtain nutrients such as blood and dandruff from the animals. And those that fly to the back, buttocks, etc. of the host animal and inhabit by obtaining nutrients such as blood and dandruff from the animal. Examples of ectoparasites include ticks, lice and fleas.
ダニ類(Acari)としては以下の害虫が挙げられる。
(1)中気門目(Mesostigmata)のダニ類(mite)
(a) ワクモ科(Dermanyssidae)のダニ:
ワクモ(Dermanyssus gallinae)などのワクモ属種(Dermanyssus spp.);など、
(b) オオサシダニ科(Macronyssidae)のダニ:
トリサシダニ(Ornithonyssus sylviarum)、ネッタイトリサシダニ(Ornithonyssus bursa)、イエダニ(Ornithonyssus bacoti)などのイエダニ属種(Ornithonyssus spp.);など、
(c) トゲダニ科(Laelapidae)のダニ:
ネズミトゲダニ(Laelaps echidninus)、ホクマントゲダニ(Laelaps jettmari)などのトゲダニ属種(Laelaps spp.);など。
Examples of mites (Acari) include the following pests.
(1) Mesostigmata mites (mite)
(a) Dermanyssidae mites:
Species of the genus (Dermanyssus spp.) Such as vaccinia (Dermanyssus gallinae);
(b) Mite of the family Macronyssidae:
House dust mite species (Ornithonyssus spp.) Such as avian tick mite (Ornithonyssus sylviarum), netty bird mite (Ornithonyssus bursa), house dust mite (Ornithonyssus bacoti);
(c) Laticidae mites:
Species of the genus genus (Laelaps spp.), Such as the mouse spider mite (Laelaps echidninus), the stag beetle (Laelaps jettmari);
(2)後気門目(Metastigmata)のマダニ類(tick)
(a) ヒメダニ科(Argasidae)のダニ:
ナガヒメダニ(Argas persicus)、アルガス・リフレクサス(Argas reflexus)などのナガヒメダニ属種(Argas spp.); オルニトドラス・モウバータ(Ornithodorus moubata)などのヒメダニ属種(Ornithodoros spp.);など、
(b) マダニ科(Ixodidae)のダニ:
ヘマフィサリス・コンシナ(Haemaphysalis concinna)、ヘマフィサリス・パンクタータ(Haemaphysalis punctata)、ヘマフィサリス・シンアバリナ(Haemaphysalis cinnabarina)、ヘマフィサリス・オトフィラ(Haemaphysalis otophila)、ヘマフィサリス・レアチ(Haemaphysalis leachi)、フタトゲチマダニ(Haemaphysalis longicornis)、マゲシマチマダニ(Haemaphysalis mageshimaensis)、イエンチマダニ(Haemaphysalis yeni)、ツリガネチマダニ(Haemaphysalis campanulata)、クロウサギチマダニ(Haemaphysalis pentalagi)、キチマダニ(Haemaphysalis flava)、オオトゲチマダニ(Haemaphysalis megaspinosa)、ヤマトチマダニ(Haemaphysalis japonica)、ダグラスチマダニ(Haemaphysalis douglasi)などのチマダニ属種(Haemaphysalis spp.); アンブリオマ・アメリカナム(Amblyomma americanum)、アンブリオマ・バリエガタム(Amblyomma variegatum)、アンブリオマ・マキュラタム(Amblyomma maculatum)、アンブリオマ・ヘブラエウム(Amblyomma hebraeum)、アンブリオマ・カジェネンス(Amblyomma cajennense)、タカサゴキララマダニ(Amblyomma testudinarium)などのキララマダニ属種(Amblyomma spp.); マダニ(Ixodes ricinus)、イクソデス・ヘキサゴナス(Ixodes hexagonus)、イクソデス・キャニスガ(Ixodes canisuga)、イクソデス・ピロサス(Ixodes pilosus)、イクソデス・ルビキュンダス(Ixodes rubicundus)、イクソデス・スキャプラリス(Ixodes scapularis)、イクソデス・ホロシクラス(Ixodes holocyclus)、ヤマトマダニ(Ixodes ovatus)、シュルツェマダニ(Ixodes persulcatus)、タネガタマダニ(Ixodes nipponensis)などのマダニ属種(Ixodes spp.); オウシマダニ(Rhipicephalus(Boophilus)microplus)、リピセファラス(ブーフィラス)・デコロラタス(Rhipicephalus(Boophilus)decoloratus)、リピセファラス(ブーフィラス)・アニュラタス(Rhipicephalus(Boophilus)annulatus)、リピセファラス(ブーフィラス)・カルセラタス(Rhipicephalus(Boophilus)calceratus)などのウシマダニ亜属種(Boophilus spp.); リピセファラス・エベルトシ(Rhipicephalus evertsi)、クリイロコイタマダニ(Rhipicephalus sanguineus)、リピセファラス・ブルサ(Rhipicephalus bursa)、リピセファラス・アッペンディキュラタス(Rhipicephalus appendiculatus)、リピセファラス・キャペンシス(Rhipicephalus capensis)、リピセファラス・ツラニカス(Rhipicephalus turanicus)、リピセファラス・ザンベジエンシス(Rhipicephalus zambeziensis)などのコイタマダニ属種(Rhipicephalus spp.); デルマセントール・マルギナタス(Dermacentor marginatus)、デルマセントール・レティキュラタス(Dermacentor reticulatus)、デルマセントール・ピクタス(Dermacentor pictus)、デルマセントール・アルビピクタス(Dermacentor albipictus)、デルマセントール・アンデルソニ(Dermacentor andersoni)、デルマセントール・バリアビリス(Dermacentor variabilis)などのカクマダニ属種(Dermacentor spp.);など。
(2) Metastigmata tick (tick)
(a) Mite from Argasidae:
Argas spp., Such as Argas persicus, Argas reflexus; Ornithodoros spp., Such as Ornithodorus moubata;
(b) Ixodidae ticks:
Haemaphysalis concinna, Haemaphysalis punctata, Haemaphysalis cinnabarina, physic physics, Haemaphysalis cinophila, physic physics ), Tick ticks (Haemaphysalis yeni), black ticks (Haemaphysalis campanulata), blue tick ticks (Haemaphysalis pentalagi), tick ticks (Haemaphysalis flava), large ticks (Haemaphysalis megaspinosa), ema physalis tick (Haemaphysalis megaspinosa) Haemaphysalis spp .; Amblyomma americanum, Ambrioma variegatum Amblyomma variegatum, Amblyomma maculatum, Amblyomma hebraeum, Amblyomma cajennense, Amblyomma testudinlyly tick (Amblyomma testudinlyly) ), Ixodes hexagonus, Ixodes canisuga, Ixodes pilosus, Ixodes rubicundus, Ixodes scapularis, Ixodes scapularis, Ixodes socularis Tick species (Ixodes spp.) Such as Ixodes ovatus, Ixodes persulcatus, Ixodes nipponensis; Rickicephalus (Boophilus) microplus, Lipisepha Bovine tick subspecies (Rhipicephalus (Boophilus) decoloratus), Ripeicephalus (Boophilus) annulatus (Rhipicephalus (Boophilus) annulatus), Ripeicephalus (Buophilus) Calcertas (Rhipicephalus (Boophilus) calceratus), etc. .); Rhipicephalus evertsi, Rhipicephalus sanguineus, Rhipicephalus bursa, Rhipicephalus appendiculatus, Rhipicephalus appendiculatus, Rhipicephalus appendiculatus cap Rhipicephalus turanicus, Rhipicephalus zambeziensis and other species of the genus Rhipicephalus spp .; Dermacentor Marginatas (De rmacentor marginatus, Dermacentor reticulatus, Dermacentor pictus, Dermacentor albipictus, Dermacentor andersoni, vari vari D ) And other species (Dermacentor spp.);
(3)無気門目(Astigmata)のコナダニ類(Acaridida)
(a) キュウセンダニ科(Psoroptidae)のダニ:
プソロプテス・オービス(Psoroptes ovis)、プソロプテス・キュニキュリ(Psoroptes cuniculi)、プソロプテス・エクイ(Psoroptes equi)などのキュウセンダニ属種(Psoroptidae spp.); コリオプテス・ボビス(Chorioptes bovis)などのショクヒヒゼンダニ属種(Chorioptes spp.);など、
(b) ヒゼンダニ科(Sarcoptidae)のダニ:
サルコプテス・スカビエイ(Sarcoptes scabiei)、サルコプテス・カニス(Sarcoptes canis)、サルコプテス・ボビス(Sarcoptes bovis)、サルコプテス・オービス(Sarcoptes ovis)、サルコプテス・ルピカプラエ(Sarcoptes rupicaprae)、サルコプテス・エクイ(Sarcoptes equi)、サルコプティス・スイス(Sarcoptes suis)などのヒゼンダニ属種(Sarcoptes spp.);など。
(3) Astigmata (Acaridida)
(a) Psoroptidae mites:
Psoroptes ovis, Psoroptes cuniculi, Psoroptes equi, and other tick species such as Chorioptes bovis Chorioptes spp.);
(b) Scaroptidae mites:
Sarcoptes scabiei, Sarcoptes canis, Sarcoptes bovis, Sarcoptes ovis, Sarcoptes rupicaprae, Sarcoptes rupicaprae, Sarcoptes rupicaprae Scaroptes spp., Such as Switzerland (Sarcoptes suis);
(4)前気門目(Prostigmata)のケダニ類(Actinedida)
(a) ニキビダニ科(Demodixidae)のダニ:
イヌニキビダニ(Demodex canis)、デモデックス・ボービス(Demodex bovis)、デモデックス・オービス(Demodex ovis)、デモデックス・カプラエ(Demodex caprae)、デモデックス・エクイ(Demodex equi)、デモデックス・カバリ(Demodex caballi)、デモデックス・スイス(Demodex suis)、ネコニキビダニ(Demodex cati)などのニキビダニ属種(Demodex spp.);など、
(b) ツツガムシ科(Trombiculidae)のダニ:
トロンビクラ・アルフレズゲシ(Trombicula alfreddugesi)、トロンビキュラ・アカムシ(Trombicula akamushi)などのツツガムシ属種(Trombiculidae spp.);など。
(4) Prostigmata mites (Actinedida)
(a) Tick from the Demodixidae family:
Demodex canis, Demodex bovis, Demodex ovis, Demodex caprae, Demodex equi, Demodex caballi ), Demodex swiss (Demodex suis), wilt mite species (Demodex spp.);
(b) Mite from the family Troombiculidae:
Trombiculidae spp., Such as Trombicula alfreddugesi and Trombicula akamushi;
シラミ類(Phthiraptera)としては以下の害虫が挙げられる。
(1)シラミ亜目(Anoplura)のシラミ類(louse)
(a) ケモノジラミ科(Haematopinidae)のシラミ:
ウマジラミ(Haematopinus asini)、ウシジラミ(Haematopinus eurysternus)、ブタジラミ(Haematopinus suis)などのブタジラミ属種(Haematopinus spp.);など、
(b) ケモノホソジラミ科(Linognathidae)のシラミ:
イヌジラミ(Linognathus setosus)、ウシホソジラミ(Linognathus vituli)、リノグナサス・オビラス(Linognathus ovillus)、リノグナサス・オビフォルミス(Linognathus oviformis)、リノグナサス・ペダリス(Linognathus pedalis)、ヤギホソジラミ(Linognathus stenopsis)などのリノグナツス属種(Linognathus spp.); ケブカウシジラミ(Solenopotes capillatus)などのソレノポテス属種(Solenopotes spp.);など。
Examples of lice (Phthiraptera) include the following pests.
(1) Louse of Anoplura
(a) Lice from the Haematopinidae family:
Haematopinus asini, bovine lice (Haematopinus eurysternus), porcine louse species (Haematopinus spp.) Such as pig lice (Haematopinus suis);
(b) Linognathidae lice:
Dog lice (Linognathus setosus), Cow horned lice (Linognathus vituli), Linognathus ovillus, Linognathus oviformis, Linognathus oviformis, Linognathus psoris ); Solenopotes spp., Such as Solenopotes capillatus;
(2)タンカクハジラミ亜目 (Amblycera)のハジラミ類(biting louse)
(a) タンカクハジラミ科(Menoponidae)のハジラミ:
ニワトリオオハジラミ(Menacanthus stramineus)、ニワトリツノハジラミ(Menacanthus cornutus)、ウスイロニワトリハジラミ(Menacanthus pallidulus)などのメナカンツス属種(Menacanthus spp.); ニワトリハジラミ(Menopon gallinae)などのメノポン属種(Menopon spp.);など。
(2) Amblycera subs (biting louse)
(a) White-headed lice (Menoponidae):
Menacanthus spp., Such as Chicken Acneus stramineus, Menacanthus cornutus, Menacanthus pallidulus; );Such.
(3)チョウカクハジラミ亜目(Ischnocera)のハジラミ類(biting louse)
(a) チョウカクハジラミ科(Philopteridae)のハジラミ:
ハトナガハジラミ(Columbicola columbae)などのコランビコーラ属種(Columbicola spp.); ハバビロナガハジラミ(Cuclotogaster heterographus)などのクルクロトガステル属種(Cuclotogaster spp.); カクアゴハジラミ(Goniodes dissimilis)、マルハジラミ(Goniodes gigas)、ヒメニワトリハジラミ(Goniodes gallinae)などのゴニオデス属種(Goniodes spp.); ニワトリナガハジラミ(Lipeurus caponis)などのリペウルス属種(Lipeurus spp.);など、
(b) ケモノハジラミ科(Trichodectidae)のハジラミ:
ウシハジラミ(Bovicola bovis)、ヒツジハジラミ(Bovicola ovis)、ボビコラ・リンバータ(Bovicola limbata)、ヤギハジラミ(Bovicola caprae)、ウマハジラミ(Bovicola equi)などのボビコーラ属種(Bovicola spp.); イヌハジラミ(Trichodectes canis)などのケモノハジラミ属種(Trichodectes spp.); ネコハジラミ(Felicola subrostrata)などのフェリコラ属種(Felicola spp.);など。
(3) Ischnocera subs (biting louse)
(a) Philopteridae lice:
Columbicola spp. Such as Columbicola columbae; Cuclotogaster spp. Such as Cuclotogaster heterographus; Goniodes dissimilis gas, Goniodes dissimilis Goniodes spp., Such as Goniodes gallinae; Lipiperus spp., Such as Lipeurus caponis;
(b) Trichodectidae lice:
Bovidola spp., Such as Bovicola bovis, Bovicola ovis, Bovicola limbata, Bovicola caprae, Bovicola equip, etc .; Trichodectes spp .; Felicola spp., Such as Felicola subrostrata;
(4)ノミ類(Siphonaptera)としては以下の害虫が挙げられる。
(a) スナノミ科(Tungidae)のノミ:
スナノミ(Tunga penetrans)などのスナノミ属種(Tunga spp.);など、
(b) ヒトノミ科(Pulicidae)のノミ:
イヌノミ(Ctenocephalides canis)、ネコノミ(Ctenocephalides felis)などのイヌノミ属種(Ctenocephalides spp.); ハリネズミノミ(Archaeopsylla erinacei)などのアルカエオプシラ属種(Archaeopsylla spp.); 東洋ネズミノミ(Xenopsylla cheopis)などのネズミノミ属種(Xenopsylla spp.); ヒトノミ(Pulex irritans)などのヒトノミ属種(Pulex spp.); ニワトリフトノミ(Echidnophaga gallinacea)などのエチドノファガ属種(Echidnophaga spp.);など、
(c) ナガノミ科(Ceratophyllidae)のノミ:
トリノミ(Ceratophyllus gallinae)、ヤマトネズミノミ(Ceratophyllus anisus)などのナガノミ属種(Ceratophyllus spp.); ヨーロッパネズミノミ(Nosopsyllus fasciatus)などのノソプスルラス属種(Nosopsyllus spp.);など、
(d) ホソノミ科(Leptopsyllidae)のノミ:
メクラネズミノミ(Leptopsylla segnis)などのホソノミ属種(Leptopsylla spp.);など。
(4) The fleas (Siphonaptera) include the following pests.
(a) Fleas from the Tungidae family:
Species of the genus (Tunga spp.) Such as Sunungomi (Tunga penetrans);
(b) Fleas from the family Flea Family (Pulicidae):
Cunnocephalides (Ctenocephalides canis), Catfish (Ctenocephalides felis) and other species of genus (Ctenocephalides spp.); Hedgehog (Archaeopsylla erinacei); (Xenopsylla spp.); Human flea species (Pulex spp.); Etchidnophaga gallinacea and other species (Echidnophaga spp.);
(c) Ceratophyllidae chisel:
Tortoise (Ceratophyllus gallinae), Yamato mouse (Ceratophyllus anisus) and other species (Ceratophyllus spp.); European mouse (Nosopsyllus fasciatus),
(d) Fleas from the family Leptopsyllidae:
Leptopsylla segnis and other species such as Leptopsylla spp.
本発明の動物用外部寄生虫防除剤の対象となるその他の外部寄生虫としては、カメムシ目の害虫が挙げられる。
カメムシ目(Hemiptera)の害虫としては以下の害虫が挙げられる。
(a) トコジラミ科(Cimicidae)の昆虫:
トコジラミ(Cimex lectularius)などのシメックス属種(Cimex spp.);など、
(b) サシガメ科(Reduviidae)の昆虫:
(b-1) オオサシガメ亜科(Triatominae)の昆虫:
パンストロンギラス属種(Panstrongylus spp.); ベネズエラサシガメ(Rhodnius prolixus)などのロドニウス属種(Rhodnius spp.); サシガメ(Triatoma infestans)などのサシガメ属種(Triatoma spp.);など。
Other ectoparasites that are targets of the animal ectoparasite control agent of the present invention include stink bugs.
Examples of the insects of the order of the Hemiptera include the following pests.
(a) Insects of Cimicidae:
Cymex spp., Such as Cimex lectularius;
(b) Reduviidae insects:
(b-1) Insects of the Triatominae family:
Panstrongylus spp .; Rhodnius spp. Such as Rhodnius prolixus; Triatoma spp. Such as Triatoma infestans;
本発明の動物用外部寄生虫防除剤は、刺咬性昆虫(咀嚼性ハエ、吸血成虫ハエ、移動性双翅類の幼虫、寄生バエのウジ)であるハエ目(Diptera)害虫にも有効である。
ハエ類(Diptera)の害虫としては以下の害虫が挙げられる。
(1)長角亜目(Nematocera)
(a) カ科(Culicidae)のカ:
ネッタイイエカ(Culex quinquefasciatus)、アカイエカ(Culex pipiens pallens)、キュレックス・タルサリス(Culex tarsalis)、チカイエカ(Culex pipiens molestus)、ネッタイイエカ(Culex pipiens fatigans)、コガタアカイエカ(Culex tritaeniorhynchus summorosus)などのイエカ属種(Culex spp.); オオクロヤブカ(Armigeres subalbatus)などのアルミゲレス属種(Armigeres spp.); ガンビアハマダラカ(Anopheles gambiae)、アノフェレス・マキュリペニス(Anopheles maculipennis)、シナハマダラカ(Anopheles sinensis)、オオツルハマダラカ(Anopheles lesteri)などのハマダラカ属種(Anopheles spp.); ネッタイシマカ(Aedes aegypti)、ヒトスジシマカ(Aedes albopictus)、イーデス・タエニオリンクス(Aedes taeniorhynchus)、トウゴウヤブカ(Aedes togoi)、キンイロヤブカ(Aedes vexans nipponii)などのヤブカ属種(Aedes spp.);など、
(b) ブユ科(Simuliidae)のブユ:
シムリウム・レプタンス(Simulium reptans)、ツメトゲブユ(Simulium ornatum)、ヒメアシマダラブユ(Simulium venustum)、ウマブユ(Simulium salopiense)などのブユ属種(Simulium spp.); キアシオオブユ(Prosimulium yezoense)などのプロシムリウム属種(Prosimulium spp.);
The animal ectoparasite control agent of the present invention is also effective against insect pests (Diptera) that are biting insects (chewing flies, adult sucking flies, migratory dipterous larvae, maggots of parasitic flies) .
The following pests can be mentioned as pests of flies (Diptera).
(1) Nematocera
(a) Culicidae mosquitoes:
Culex quinquefasciatus, Culex pipiens pallens, Culex tarsalis, Culex pipiens molestus, Culex pipiens fatigans, Culex tritamoros spp. .); Almigeres spp., Such as Armigeres subalbatus; Gambia anopheles gambiae, Anopheles maculipennis, Anopheles sinensis, l Genus (Anopheles spp.); Aedes aegypti, Aedes albopictus, Aedes taeniorhynchus, Aedes togoi, Apones vexans nip, etc. Buka species (Aedes spp.); Such as,
(b) Buyers of Simuliidae:
Promululium species such as Simulium reptans, Simulium ornatum, Simulium venustum, Simulium salopiense; Prosimulium yezoense Prosimulium spp.);
(2)短角亜目
(a) アブ科(Tabanidae)のアブ:
タバヌス・ブロミウス(Tabanus bromius)、タバヌス・スポドプテルス(Tabanus spodopterus)、タバヌス・アトラタス(Tabanus atratus)、タバヌス・スデチカス(Tabanus sudeticus)、ウシアブ(Tabanus trigonus)、アカウシアブ(Tabanus chrysurus)、シロフアブ(Tabanus trigeminus)、キスジアブ(Tabanus fulvimedioides)、イヨシロオビアブ(Tabanus iyoensis)などのアブ属種(Tabanus spp.); クリソプス・カエキュチエンス(Chrysops caecutiens)、クリソプス・レリクタス(Chrysops relictus)、キンメアブ(Chrysops suavis)、クロキンメアブ(Chrysops japonicus)などのメクラアブ属種(Chrysops spp.);など、
(b) イエバエ科(Muscidae)のハエ:
イエバエ(Musca domestica)、クロイエバエ(Musca bezzii)、ノイエバエ(Musca hervei)、ウスイロイエバエ(Musca conducens)、オオイエバエ(Musca stabulans)などのイエバエ属種(Muscina spp.); サシバエ(Stomoxys calcitrans)などのサシバエ属種(Stomoxys spp.); ノサシバエ(Haematobia irritans)、ヘマトビア・イリタンス・エクシグア(Haematobia irritans exigua)、ヘマトビア・スティミュランス(Haematobia stimulans)などのノサシバエ属種(Haematobia spp.);など、
(c) ツエツエバエ科(Glossinidae)のハエ:
シェシェバエ属種(Glossina spp.)など、
(d) シラミバエ科(Hippoboscidae)のハエ:
シラミバエ(Melophagus ovinus)などのメロファガス属種(Melophagus spp.);など
(e) クロバエ科(Calliphoridae)のハエ:
オオクロバエ(Calliphora lata)などのクロバエ属種(Calliphora); ヒツジキンバエ(Lucilia (Phaenicia) cuprina)、ヒロズキンバエ( Lucilia (Phaenicia) sericata)、ミドリキンバエ(Lucilia illustris)などのキンバエ属種(Lucilia spp.); ラセンウジバエ(Chrysomya hominivorax)、クリソミア・クロロピガ(Chrysomya chloropyga)、クリソミア・ベジアナ(Chrysomya bezziana)などのオビキンバエ属種(Chrysomyia. spp.);など、
(f) ヒツジバエ科(Oestridae)のハエ:
(f-1) カワモグリバエ亜科(Cuterebrinae)のハエ:
ウサギヒフバエ属種(Cuterebra spp.);など、
(f-2) ウシバエ亜科(Hypodermatinae)のハエ:
ウシバエ(Hypoderma bovis)、キスジウシバエ(Hypoderma lineatum)などのウシバエ属種(Hypoderma spp.);など、
(f-3) ウマバエ亜科(Gasterophilinae)のハエ:
ウマバエ(Gasterophilus intestinalis)、アトアカウマバエ(Gasterophilus haemorroidalis)、ガステロフィラス・イネルミス(Gasterophilus inermis)、ムネアカウマバエ(Gasterophilus nasalis)、ガステロフィラス・ニグリコルニス(Gasterophilus nigricornis)、アカウマバエ(Gasterophilus pecorum)などのウマバエ属種(Gasterophilus spp.);など、
(f-4) ヒツジバエ亜科(Oestrinae)のハエ:
ヒツジバエ(Oestrus ovis)などのヒツジバエ属種(Oestrus spp.);など。
これらのうち、本発明の動物用外部寄生虫防除剤の対象となる虫は、ノミ類およびダニ類が好ましい。
(2) Short angle
(a) Abs from Tabanidae:
Tabanus bromius, Tabanus spodopterus, Tabanus atratus, Tabanus sudeticus, Tabanus trigonus, Tabanus chrysurus, Tabanus chrysurus Abs species (Tabanus spp.), Such as Tabanus fulvimedioides and Tabanus iyoensis; Chrysops caecutiens, Chrysops relictus, Chrysop (ja), Chrysop (ja) Of the genus Mechrabu (Chrysops spp.);
(b) Muscidae flies:
Muscina spp., Such as Musca domestica, Musca bezzii, Musca hervei, Musca conducens, Musca stabulans, etc .; Stomoxys spp .; Haematobia irritans, Haematobia irritans exigua, Haematobia stimulans, and other species of Haematobia stimulans;
(c) Glossinidae flies:
Such as Glossina spp.
(d) Fly of the Hippoboscidae:
Melophagus spp., Such as lice fly (Melophagus ovinus); etc.
(e) Calliphoridae flies:
Calliphora, such as Calliphora lata; Lucilia spp., Lucilia (Phaenicia) cuprina, Lucilia (Phaenicia) sericata, Lucilia illustris; Chrysomya hominivorax, Chrysomya chloropyga, Chrysomya bezziana and other species of Chrysomya bezziana (Chrysomyia. Spp.);
(f) Oestridae flies:
(f-1) Flying from the Cuterebrinae family:
Rabbit Drosophila species (Cuterebra spp.);
(f-2) Hypodermatinae flies:
Hypoderma bovis, Hypoderma lineatum, and other species of the genus (Hypoderma spp.);
(f-3) Gasterophilinae flies:
Horseflies (Gasterophilus intestinalis), Ataster squirrels (Gasterophilus haemorroidalis), Gasterophilus inermis, Gasterophilus nasalis, Gasterophilus nigricornis (Gasterophilus nigricornis), Grumophilus pe Gasterophilus spp.);
(f-4) Oestrinae flies:
Oestrus spp., Such as Oestrus ovis;
Among these, fleas and ticks are preferred as the target insects for the animal ectoparasite control agent of the present invention.
本発明の動物用外部寄生虫防除剤を動物に投与すると、外部寄生虫を防除することができる。それによって、寄生虫を介して感染する疾患やその他の病的状態、または、寄生虫によって直接に引き起こされる傷害(以下寄生虫病ということがある)を予防することができる。
本発明の動物用外部寄生虫防除剤を動物に投与すると、外部寄生虫を抑制することができる。それによって、寄生虫病にかかりやすい動物の寄生虫病の発生を部分的または完全に阻害でき、寄生虫病の症状を軽減・除去でき、または寄生虫病を部分的または完全に治癒・治療することができる。
When the animal ectoparasite control agent of the present invention is administered to animals, ectoparasites can be controlled. Thereby, it is possible to prevent diseases or other pathological conditions that are transmitted through parasites, or injuries directly caused by parasites (hereinafter sometimes referred to as parasitic diseases).
When the animal ectoparasite control agent of the present invention is administered to animals, ectoparasites can be suppressed. It can partially or completely inhibit the occurrence of parasitic diseases in animals susceptible to parasitic diseases, reduce or eliminate the symptoms of parasitic diseases, or partially or completely cure or treat parasitic diseases be able to.
<1>疾患
外部寄生虫を介して伝染する疾患は、例えば、ウイルス性疾患、細菌性疾患、および原生動物媒介疾患である。ハエのように、病原菌を粘性のある脚に付着させてほかの場所に運搬するものと;衛生害虫の体内で病原体の発育や増殖が起こり、それが感染源となるものとがある。
以下にその具体例を挙げる。
<1> Diseases Diseases transmitted through ectoparasites are, for example, viral diseases, bacterial diseases, and protozoan-mediated diseases. Like flies, pathogens are attached to sticky legs and transported elsewhere; pathogens develop and multiply in the body of sanitary pests and become the source of infection.
Specific examples are given below.
(1)ウイルス性疾患
(a) ウシヌカカ(Culicoides oxystoma)が、ブニヤウイルス科(Bunyaviridae)のアカバネウイルス(Akabane virus)を介して感染させるアカバネ病;アイノウイルス(Aino virus)を介して感染させるアイノウイルス感染症;レオウイルス科(Reoviridae)のイバラキウイルスを介して感染させるイバラキ病;チュウザンウイルスを介して感染させるチュウザン病;レオウイルス科オルビウイルス属(Orbivirus)のブルータングウイルス(Bluetongue virus)を介して感染させるブルータング病;その他のアルボウイルスであるピートンウイルス(Peaton virus)、サシュペリウイルス(Sathuperi virus)、ディアギュラウイルス(D'Aguilar virus)およびシャモンダウイルス(Shamonda virus)を介して感染させるアルボウイルス病;
(b) ネッタイイエカ(Culex quinquefasciatus)が、フラビウイルス科(Flaviviridae)の豚コレラウイルスを介して感染させる豚コレラ;
(c) コガタアカイエカ(Culex tritaeniorhynchus summorosus)、アカイエカ(Culex pipiens pallens)が、フラビウイルス科(Flaviviridae)の日本脳炎ウイルスを介して感染させる日本脳炎;
(d) ヒメイエバエ(Fannia canisularis)が、ニューカッスル病ウイルス(Newcastle disease virus:NDV)を介して感染させる鳥類のニューカッスル病;
(e) アブ類(Tabanidae)などの吸血昆虫が、レトロウイルス科レンチウイルス属の馬伝染性貧血ウイルスを介して感染させる馬伝染性貧血;
(1) Viral diseases
(a) Akabane disease in which bovine midge (Culicoides oxystoma) is infected via Akabane virus of Bunyaviridae; Ainovirus infection which is infected via Aino virus; Reoviridae ( Reoviridae) Ibaraki disease infected via Ibaraki virus; Chuzan virus infected via Chuzan virus; Reoviridae Orbivirus bluetongue virus infected via Bluetongue virus; Arbovirus disease transmitted through other arboviruses such as Peaton virus, Sathuperi virus, D'Aguilar virus and Shamonda virus;
(b) Porcine cholera which Culex quinquefasciatus infects via swine cholera virus of Flaviviridae;
(c) Japanese encephalitis infected by Culex tritaeniorhynchus summorosus and Culex pipiens pallens via the Japanese encephalitis virus of Flaviviridae;
(d) Avian Newcastle disease that Fannia canisularis infects via Newcastle disease virus (NDV);
(e) equine infectious anemia infected by blood-sucking insects, such as Tabanidae, via equine infectious anemia virus of the genus Retroviridae;
(2)細菌性疾患
(a) フタトゲチマダニ(Haemaphysalis longicornis)が、リケッチア属(Rickettsia)の日本紅斑熱リケッチア(Richettsia japonica)を介して感染させるイヌの日本紅熱、リケッチア症など;
(b) キチマダニ(Haemaphysalis flava)が、野兎病菌(Francisella tularensis)を介して感染させる野兎病;
(c) ヤマトマダニ(Ixodes ovatus)が、Candidatus Mycoplasma haemominutumを介して感染させる猫伝染性貧血;
(2) Bacterial diseases
(a) Japanese red fever, rickettsiosis, etc. in dogs infected by Haemaphysalis longicornis via Rickettsia japonica
(b) Barbarian disease in which the tick tick (Haemaphysalis flava) is transmitted via the wild moss (Francisella tularensis);
(c) Cat infectious anemia which is transmitted by Candidatus Mycoplasma haemominutum by ticks (Ixodes ovatus);
(3)原生動物媒介疾患
(a) フタトゲチマダニ(Haemaphysalis longicornis)が、Babesia ovataを介して感染させるウシの大型ピロプラズマ病;Babesia gibsoniを介して感染させるイヌのピロプラズマ病;
(b) オウシマダニ(Rhipicephalus(Boophilus)microplus)が、Babesia bigemina、Babesia bovisを介して感染させるウシのQ熱などのバベジア症;Anaplasma marginaleを介して感染させるアナプラズマ症;
(c) クリイロコイタマダニ(Rhipicephalus sanguineus)が、Babesia canis、Babesia gibsoniを介して感染させるイヌのバベジア症;Anaplasma platysを介して感染させるイヌのアナプラズマ症;Hepatozoon canisを解して感染させるイヌのヘパトゾーン症;Haemobartonella canisを介して感染させるイヌのヘモバルトネラ症;
(d) ニワトリヌカカ(Culicoides arakawae)が、住血胞子虫(Leukocytozoon caulleryi)を介して感染させるニワトリのロイコチトゾーン病(leucocytozoonosis);
(e) アブ類(Tabanidae)などの吸血昆虫が、トリパノソーマ属種(Trypanosoma ssp.)を介して感染させる、慢性睡眠病、急性睡眠病などのトリパノソーマ症(trypanosomiasis);
(f) ネコノミ(Ctenocephalides felis)が、瓜実条虫(Diphylidium caninum)を介して感染させるイヌ、ネコの瓜実条虫症;
(g) トウゴウヤブカ(Aedes togoi)、ヒトスジシマカ(Aedes albopictus)、コガタアカイエカ(Culex tritaeniorhynchus summorosus)、およびアカイエカ(Culex pipiens pallens)が、犬糸状虫を介して感染させる犬糸状虫症;
(3) Protozoan-borne diseases
(a) Cattle large piroplasmosis infected by Babesia ovata by Haemaphysalis longicornis; Canine piroplasmosis infected by Babesia gibsoni;
(b) Babesiosis, such as Q fever in cattle infected by the tick (Rhipicephalus (Boophilus) microplus) via Babesia bigemina, Babesia bovis; Anaplasmosis infected via Anaplasma marginale;
(c) Rabicephalus sanguineus infected by Babesia canis and Babesia gibsoni in dogs with babesiosis; Canine anaplasmosis infected with Anaplasma platys; Hepatozoon canis with infection Hepatozone disease in dogs; Haemobartonella in dogs infected via Haemobartonella canis;
(d) Chicken leucocytozoonosis in which chickens (Culicoides arakawae) are infected via Leukocytozoon caulleryi;
(e) Trypanosomiasis such as chronic sleeping sickness, acute sleeping sickness, etc. infected by blood-sucking insects such as Tabanidae through Trypanosoma ssp .;
(f) Dogs cats (Ctenocephalides felis) are infected via Diphylidium caninum;
(g) Canine filariasis that Aedes togoi, Aedes albopictus, Culex tritaeniorhynchus summorosus, and Culex pipiens pallens infect through the dog filamentous worms;
<2>ウシバエ幼虫症・ウマバエ幼虫症
衛生害虫のなかで宿主に内部寄生するものがある。たとえばウシバエ幼虫はウシの皮下に、ウマバエ幼虫はウマの胃壁に、ヒツジバエ幼虫はヒツジの鼻腔に寄生する。また、ウシバエ幼虫はウシの背部皮下に寄生し、皮膚に孔を開けるため、皮革としての価値を大きく減じてしまう。
以下にその具体例を挙げる。
(a) ウシバエ(Hypoderma bovis)の幼虫、キスジウシバエ(Hypoderma lineatum)の幼虫が引き起こすウシバエ幼虫症;
(b) ウマバエ(Gasterophilus intestinalis)の幼虫、ムネアカウマバエ(Gasterophilus nasalis)の幼虫、アトアカウマバエ(Gasterophilus haemorroidalis)の幼虫が引き起こすウマバエ幼虫症;
(c) ミドリキンバエ(Lucilia illustris)の幼虫が引き起こすハエウジ症(myiasis);
<2> Bullfly larvae and fountain larvae Some hygienic pests are internally parasitic on the host. For example, cattle fly larvae infested with cows, horsefly larvae in the stomach wall of horses, and sheep fly larvae in the nasal cavity of sheep. In addition, cattle fly larvae parasitize the back of cattle and make holes in the skin, greatly reducing the value of leather.
Specific examples are given below.
(a) Caterpillar larvae caused by larvae of Hypoderma bovis and larvae of Hypoderma lineatum;
(b) fountain larvae caused by larvae of Gasterophilus intestinalis, larvae of Gasterophilus nasalis, larvae of Gasterophilus haemorroidalis;
(c) Myiasis caused by larvae of Lucilia illustris;
<3>寄生または刺咬による傷害
ヒゼンダニやツメダニなどのダニ類、カ、アブ、ハジラミなどの昆虫の刺咬を受けると、物理的傷害や毒物の注入により強い掻痒や痛みを生じ、宿主に大きなストレスを与える。さらに、動物が患部を掻きむしることにより二次感染を惹起する。このため、動物は不眠や食欲減退を起こして、家畜では泌乳量、増体量、産卵量が減退し、生産効率が落ちる、ときには死に至ることもある。
以下にその具体例を挙げる。
(a) サシバエ(Stomoxys calcitrans)、ノサシバエ(Haematobia irritans)がウシに引き起こす強い痒覚;
(b) ブタジラミ(Haematopinus suis)がブタに引き起こす強い痒覚;
(c) イヌノミ(Ctenocephalides canis)がイヌ・ネコに引き起こす痒覚;
(d) ニワトリヌカカ(Culicoides arakawae)が引き起こす痒覚;ニワトリハジラミ(Menopon gallinae)が引き起こす強い痒覚;
<3> Injuries caused by parasitism or bites When stabbed by ticks such as sword mites and claw mites, insects such as mosquitoes, flies, lice, etc., they cause severe pruritus and pain due to physical injury and injection of poisonous substances, resulting in significant damage to the host. Give stress. Furthermore, secondary infection is caused by the animal scratching the affected area. For this reason, animals suffer from insomnia and loss of appetite, and in livestock, milk production, body weight gain and egg production decline, production efficiency drops, and sometimes death.
Specific examples are given below.
(a) A strong sense of sensation caused by cattle flies (Stomoxys calcitrans) and flies (Haematobia irritans);
(b) Strong sensation caused by pig lice (Haematopinus suis) in pigs;
(c) The sensation caused by dog fleas (Ctenocephalides canis) in dogs and cats;
(d) The sensation caused by the chicken hawk (Culicoides arakawae); The strong sensation caused by the chicken lice (Menopon gallinae);
<4>吸血、貧血、出血などの傷害
衛生害虫のなかには、刺咬により宿主にストレスを与えると同時に吸血するものが多い。そのために宿主は貧血を起こし、衰弱や発育不良の原因となる。
以下にその具体例を挙げる。
(a) フタトゲチマダニ(Haemaphysalis longicornis)、オウシマダニ(Rhipicephalus(Boophilus)microplus)、ヤマトマダニ(Ixodes ovatus)、タネガタマダニ(Ixodes nipponensis)、シュルツェマダニ(Ixodes persulcatus)などのウシに対する吸血;
(b) フタトゲチマダニ(Haemaphysalis longicornis)、クリイロコイタマダニ(Rhipicephalus sanguineus)、キチマダニ(Haemaphysalis flava)、タネガタマダニ(Ixodes nipponensis)、シュルツェマダニ(Ixodes persulcatus)などのイヌに対する吸血;
(c) ワクモ(Dermanyssus gallinae)、トリサシダニ(Ornithonyssus sylviarum)のニワトリに対する吸血、ニワトリに引き起こす貧血;
(d) ブユ類(Simuliidae)が引き起こすウシの出血;
(e) アブ類(Tabanidae)が引き起こすウシの貧血;
(f) ネコノミ(Ctenocephalides felis)が引き起こすネコの長期に渡る貧血;
(g) ニワトリヌカカ(Culicoides arakawae)が引き起こすニワトリの貧血;
<4> Injuries such as blood sucking, anemia, bleeding, etc. Among the pests of hygiene, many of them absorb blood simultaneously with giving stress to the host by biting. As a result, the host is anemic, causing weakness and poor growth.
Specific examples are given below.
(a) blood sucking on cattle such as Haemaphysalis longicornis, red tick (Rhipicephalus (Boophilus) microplus), yellow tick (Ixodes ovatus), red tick (Ixodes nipponensis), shrze tick (Ixodes persulcatus);
(b) Blood absorption to dogs such as the tick tick (Haemaphysalis longicornis), the tick mite (Rhipicephalus sanguineus), the tick tick (Haemaphysalis flava), the tuna tick (Ixodes nipponensis), and the shruce tick (Ixodes persulcatus);
(c) blood sucking of chickens of Dermanyssus gallinae and Ornithonyssus sylviarum, anemia caused to chickens;
(d) Bovine hemorrhage caused by Simuliidae;
(e) Cattle anemia caused by Tabanidae;
(f) Long-term anemia of cats caused by cat fleas (Ctenocephalides felis);
(g) Chicken anemia caused by chicken hawk (Culicoides arakawae);
<5>皮膚障害
衛生害虫の寄生や刺咬により、掻痒、発赤、腫脹などのみならず、皮膚に重大な障害を与えるものがある。ヒゼンダニは強い掻痒とともに皮膚の脱毛、痂皮形成、糜爛などを起こし、ニキビダニは脱毛と2次感染による全身性の糜爛を生じさせる。また、吸血性の害虫は一般に吸血の際に多量の唾液を注入するので、それに対するアレルギー反応が生じ、強い痒みともに発赤、腫脹、丘疹、潰瘍などが発現する。
以下にその具体例を挙げる。
(a) ショクヒヒゼンダニ(Chorioptes bovis)、キュウセンヒゼンダニ属種(Psoroptidae spp.)が引き起こす、ウシ、ウマ、ヒツジの疥癬;ヒゼンダニ属種(Sarcoptes spp.)が引き起こす、ブタ、イヌの疥癬;ネコショウセンコウヒゼンダニ(Notoedres cati)が引き起こすネコの疥癬;ミミヒゼンダニ(Otodectes cynotis)が引き起こす、イヌ、ネコの耳疥癬;トリアシヒゼンダニ(Knemidokoptes mutans)が引き起こすニワトリの疥癬;
(b) ネコノミ(Ctenocephalides felis)が引き起こすノミアレルギー性皮膚炎;
(c) イヌニキビダニ(Demodex canis)が引き起こす毛包虫症;
(d) ブユ類(Simuliidae)が引き起こす丘疹、水泡、浮腫;
<5> Skin disorders Some sanitary pest parasites and bites not only cause pruritus, redness and swelling, but also seriously damage the skin. Scarlet mites cause hair loss, crust formation, wrinkles, etc. with strong pruritus, and acne mites cause systemic wrinkles due to hair loss and secondary infection. In addition, blood-sucking pests generally inject a large amount of saliva at the time of blood-sucking, causing an allergic reaction to it and causing redness, swelling, papules, ulcers, etc. with strong itching.
Specific examples are given below.
(a) Chorioptes bovis, Psoroptidae spp. causes cattle, horses, sheep scabies; Sarcoptes spp. causes swine, dogs scabies; Cat scabies caused by Notoedres cati; dogs, cat ear scabies caused by Otodectes cynotis; chicken scabies caused by Knemidokoptes mutans;
(b) Flea allergic dermatitis caused by cat fleas (Ctenocephalides felis);
(c) folliculosis caused by Demodex canis;
(d) Papules, blisters, edema caused by Simuliidae;
本発明の防除剤の投与量は、投与方法、投与目的、疾病症状などによって異なるが、通常、宿主動物の体重1kgに対して0.01mg以上100g以下、望ましくは0.1mg以上10g以下の割合である。 The dose of the control agent of the present invention varies depending on the administration method, administration purpose, disease symptoms, etc., but is usually 0.01 mg to 100 g, preferably 0.1 mg to 10 g, relative to 1 kg body weight of the host animal. It is.
宿主動物への投与は、口腔内投与、舌下投与などの経口投与、または静脈内投与、筋肉内投与、皮下投与、経皮投与、経鼻投与、経肺投与などの非経口投与によって行うことができる。
経口投与の具体例としては、錠剤、液剤、カプセル剤、ウエハース、ビスケット、ミンチ肉などの剤形にした本発明の防除剤を動物に食べさせる方法; 動物の飼料に本発明の防除剤を混入させておき、それを動物に食べさせる方法などが挙げられる。
Administration to the host animal is performed by oral administration such as buccal administration and sublingual administration, or parenteral administration such as intravenous administration, intramuscular administration, subcutaneous administration, transdermal administration, nasal administration, and pulmonary administration. Can do.
Specific examples of oral administration include a method for feeding an animal with the control agent of the present invention in the form of tablets, liquids, capsules, wafers, biscuits, minced meat, etc .; mixing the control agent of the present invention with animal feed Let me give it to the animal.
非経口投与の具体例としては、筋肉内、皮内、皮下などに注射または点滴する方法; スポットオン処理、ポワオン処理などによる方法; スプレー、シャンプーなどによる方法; 薬剤を首輪などの樹脂片などに浸み込ませておいて、それを動物に取り付ける方法などが挙げられる。 Specific examples of parenteral administration include intramuscular, intradermal, subcutaneous injection or infusion; spot-on, poon-on, etc .; spray, shampoo, etc .; For example, a method of attaching it to an animal by soaking it.
以下に実施例を示し、本発明をより具体的に説明するが、本発明はそれら実施例によって何ら制限されるものではない。
本実施例に係る動物用外部寄生虫防除剤の有効成分として使用したヘテロ環化合物を表1に示す。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the present invention is not limited to the examples.
Table 1 shows the heterocyclic compounds used as active ingredients of the animal ectoparasite control agent according to this example.
試験例1 フタトゲチマダニ(Haemaphysalis longicornis)に対する殺虫試験
20mL容のガラスバイアル瓶の内壁に、有効成分の濃度400ppmのアセトン溶液0.1175mlを塗布した。アセトンを揮発させてバイアル瓶内壁に薄膜を作製した。用いたバイアル瓶の内壁の表面積は47cm2なので、処理薬量は1μg/cm2になる。
このバイアル瓶の中に、フタトゲチマダニの幼ダニ20〜50頭を放し、蓋を閉じて恒温室(25℃、暗黒下)に収容した。
1日経過後および2日経過後に死虫数を計測し、以下の計算式から死虫率を算出した。なお、試験は二連制で行った。
また、同様の方法で、処理薬量を、0.1μg/cm2、0.01μg/cm2、0.001μg/cm2、および0.0001μg/cm2、に変更した試験も行った。
Test Example 1 Insecticidal test for Haemaphysalis longicornis 0.1175 ml of an acetone solution having an active ingredient concentration of 400 ppm was applied to the inner wall of a 20 mL glass vial. Acetone was volatilized to produce a thin film on the inner wall of the vial. Since the surface area of the inner wall of the used vial is 47 cm 2 , the treatment drug amount is 1 μg / cm 2 .
Twenty to fifty mite tick mites were released in this vial, and the lid was closed and housed in a thermostatic chamber (25 ° C., dark).
The number of dead insects was counted after 1 day and after 2 days, and the death rate was calculated from the following formula. Note that the test was conducted in a two-track system.
Further, in a similar manner, the application dose, 0.1μg / cm 2, 0.01μg / cm 2, 0.001μg / cm 2, and 0.0001 / cm 2, even test was changed to Been.
表1に示したヘテロ環化合物1−1および1−2並びに既存化合物のフィプロニルを有効成分としてそれぞれ用い、上記試験を行った。その結果を表2に示す。(表には二連で行った各試験結果の平均値を示す。) The above tests were conducted using the heterocyclic compounds 1-1 and 1-2 shown in Table 1 and the existing compound fipronil as active ingredients. The results are shown in Table 2. (The table shows the average value of each test result performed in duplicate.)
表1から、化合物1−1または化合物1−2などを有効成分として含有する本発明に係る動物用外部寄生虫防除剤は、既存化合物のフィプロニルを含有する防除剤よりも、外部寄生虫に対する即効性および低濃度活性において優れていることがわかる。 From Table 1, the animal ectoparasite control agent according to the present invention containing compound 1-1 or compound 1-2 as an active ingredient is more effective against ectoparasites than the control compound containing fipronil as an existing compound. It can be seen that the composition is excellent in performance and low concentration activity.
試験例2 オウシマダニ(Boophilus microplus)に対する殺虫試験(浸漬)
有効成分10mgをジメチルスルホキシド0.5mL中に溶解した。この溶液を水で希釈し、所定濃度に調整された水溶液を得た。
有孔プラスチックビーカーの中に、摂食状態のオウシマダニの成体雌8〜10匹を入れ、上記水溶液にビーカーを1分間浸した。プラスチックトレイに敷いたろ紙の上に、水溶液に浸されたダニを移した。一定期間経過後、ダニの死亡率を計算した。
死亡率100%はダニがすべて死亡したことを意味する。死亡率0%はすべてのダニが生存したことを意味する。
Test Example 2 Insecticidal test (immersion) on Boophilus microplus
10 mg of the active ingredient was dissolved in 0.5 mL of dimethyl sulfoxide. This solution was diluted with water to obtain an aqueous solution adjusted to a predetermined concentration.
In a perforated plastic beaker, 8 to 10 adult male ticks were fed and the beaker was immersed in the aqueous solution for 1 minute. The mites dipped in the aqueous solution were transferred onto the filter paper laid on the plastic tray. After a certain period, tick mortality was calculated.
A mortality rate of 100% means that all ticks have died. A mortality rate of 0% means that all mites have survived.
表1に示した化合物1−1、1−3〜1−10、1−12〜1−16、2−1〜2−3、3−5、3−7および4−1〜4−4を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、100ppmの適用割合で、死亡率80%以上の優れた活性を示した。 Compounds 1-1, 1-3 to 1-10, 112 to 1-16, 2-1 to 2-3, 3-5, 3-7 and 4-1 to 4-4 shown in Table 1 The above tests were performed using each as an active ingredient. All the compounds showed excellent activity with a mortality rate of 80% or more at an application rate of 100 ppm.
試験例3 オウシマダニ(Boophilus microplus)に対する殺虫試験(注射)
有効成分10mgをジメチルスルホキシド0.5mL中に溶解した。この溶液を水で希釈し、所定濃度に調整された水溶液を得た。
完全に摂食した15匹のオウシマダニの成体雌の腹部に上記水溶液を注入した。ダニを複製プレートに移し、一定の期間、人工気象室内で温置した。
一定期間経過後に、無精卵の産卵率を計測した。100%はすべての卵が無精卵であることを意味する。0%はすべての卵が受精卵であることを意味する。
Test Example 3 Insecticidal test for Boophilus microplus (injection)
10 mg of the active ingredient was dissolved in 0.5 mL of dimethyl sulfoxide. This solution was diluted with water to obtain an aqueous solution adjusted to a predetermined concentration.
The above aqueous solution was injected into the abdomen of 15 adult females of mites that were completely fed. Mites were transferred to replication plates and incubated for a period of time in a climate chamber.
After a certain period of time, the egg-laying rate of semen was measured. 100% means that all eggs are sterilized eggs. 0% means that all eggs are fertilized eggs.
表1に示した化合物1−1、1−3〜1−16、2−1〜2−3、3−1〜3−3、3−5、3−7および4−1〜4−4を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、20μg/動物の適用割合で、80%以上の優れた活性を示した。 Compounds 1-1, 1-3 to 1-16, 2-1 to 2-3, 3-1 to 3-3, 3-5, 3-7 and 4-1 to 4-4 shown in Table 1 The above tests were performed using each as an active ingredient. All the compounds showed an excellent activity of 80% or more at an application rate of 20 μg / animal.
試験例4 クリイロコイタマダニ(Rhipicephalus sanguineus)に対する殺虫試験(接触)
有効成分をアセトンに溶解して、濃度900ppmのアセトン溶液を調製した。
規定濃度まで希釈したアセトン溶液250μLをガラスバイアル瓶に注入し、該バイアル瓶をロック式のローラーに固定し、10rpmで回転させ、アセトンを2時間以上かけて揮発させた。このバイアル瓶の中に摂食を絶ったマダニの成体5匹を入れ、バイアル瓶を有孔カバーで覆った。
2日経過後、ダニの死亡率を計測した。死亡率100%はダニがすべて死亡したことを意味する。死亡率0%はすべてのダニが生存したことを意味する。
表1に示した化合物1−1、1−3〜1−10、1−12、1−13、1−15、2−2、2−3、3−3、3−5、3−7、4−2および4−4を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、5μg/cm2の適用割合で、死亡率80%以上の優れた活性を示した。
Test Example 4 Insecticidal test against Rhipicephalus sanguineus (contact)
The active ingredient was dissolved in acetone to prepare an acetone solution having a concentration of 900 ppm.
250 μL of an acetone solution diluted to a specified concentration was poured into a glass vial, the vial was fixed to a lock-type roller, rotated at 10 rpm, and acetone was volatilized over 2 hours. Five adult ticks that were cut off were placed in the vial, and the vial was covered with a perforated cover.
After 2 days, tick mortality was measured. A mortality rate of 100% means that all ticks have died. A mortality rate of 0% means that all mites have survived.
Compounds 1-1, 1-3 to 1-10, 1-12, 1-13, 1-15, 2-2, 2-3, 3-3, 3-5, 3-7, shown in Table 1 The above test was conducted using 4-2 and 4-4 as active ingredients. All the compounds showed excellent activity with a mortality rate of 80% or more at an application rate of 5 μg / cm 2 .
試験例5 ネコノミ(Ctenocephalides felis)に対する殺虫試験(接触)
有効成分をアセトンに溶解し、濃度900ppmのアセトン溶液を調製した。
規定濃度まで希釈したアセトン溶液250μLをガラスバイアル瓶に注入し、該バイアル瓶をロック式のローラーに固定し、10rpmで回転させ、アセトンを2時間以上かけて揮発させた。このバイアル瓶の中に摂食を絶ったネコノミの成体10匹を入れ、バイアル瓶を有孔カバーで覆った。
2日経過後、ノミの死亡率を計測した。死亡率100%はノミがすべて死亡したことを意味する。死亡率0%はすべてのノミが生存したことを意味する。
Test Example 5 Insecticidal test against cat flea (Ctenocephalides felis)
The active ingredient was dissolved in acetone to prepare an acetone solution having a concentration of 900 ppm.
250 μL of an acetone solution diluted to a specified concentration was poured into a glass vial, the vial was fixed to a lock-type roller, rotated at 10 rpm, and acetone was volatilized over 2 hours. Ten adult cat fleas that were cut off were placed in the vial, and the vial was covered with a perforated cover.
After 2 days, flea mortality was measured. A mortality rate of 100% means that all the fleas have died. A mortality rate of 0% means that all fleas have survived.
表1に示した化合物1−1、1−3〜1−10、1−12〜1−15、2−1〜2−3、3−1、3−2および4−1〜4−4を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、5μg/cm2の適用割合で、死亡率80%以上の優れた活性を示した。 Compounds 1-1, 1-3 to 1-10, 112 to 1-15, 2-1 to 2-3, 3-1, 3-2 and 4-1 to 4-4 shown in Table 1 The above tests were performed using each as an active ingredient. All the compounds showed excellent activity with a mortality rate of 80% or more at an application rate of 5 μg / cm 2 .
試験例6 ネコノミ(Ctenocephalides felis)に対する殺虫試験(経口)
有効成分10mgをジメチルスルホキシド0.5mL中に溶解した。この溶液を家畜の血で希釈して、規定濃度の化合物溶液を調製した。
絶食したネコノミの成体約10〜15匹をノミチャンバー内に配置した。血液チャンバーの底をパラフィルムで密封した。化合物溶液を血液チャンバーに充填した。ネコノミはパラフィンを通して血液を吸うことができるようになっている。血液チャンバーは37℃に保温し、ノミチャンバーは室温に保持した。
一定期間経過後、ネコノミの死亡率を計測した。死亡率100%はネコノミがすべて死亡したことを意味する。死亡率0%はすべてのネコノミが生存したことを意味する。
Test Example 6 Insecticidal test against cat flea (Ctenocephalides felis) (oral)
10 mg of the active ingredient was dissolved in 0.5 mL of dimethyl sulfoxide. This solution was diluted with livestock blood to prepare a compound solution with a specified concentration.
About 10-15 adult cat fleas were placed in a flea chamber. The bottom of the blood chamber was sealed with parafilm. The compound solution was filled into the blood chamber. Cat fleas can suck blood through paraffin. The blood chamber was kept at 37 ° C. and the flea chamber was kept at room temperature.
After a certain period of time, cat mortality was measured. A mortality rate of 100% means that all cat fleas have died. A mortality rate of 0% means that all cat fleas have survived.
表1に示した化合物1−1、1−3〜1−10、1−12〜1−16、2−1〜2−3、3−1〜3−5、3−7および4−1〜4−4を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、100ppmの適用割合で、死亡率80%以上の優れた活性を示した。 Compounds 1-1, 1-3 to 1-10, 112 to 1-16, 2-1 to 2-3, 3-1 to 3-5, 3-7 and 4-1 shown in Table 1 The above test was conducted using 4-4 as an active ingredient. All the compounds showed excellent activity with a mortality rate of 80% or more at an application rate of 100 ppm.
試験例7 ヒツジキンバエ(Lucillia cuprina)に対する試験
有効成分10mgをジメチルスルホキシド0.5mLに溶解した。この溶液を水で希釈して所定濃度の水溶液を得た。
試験管に馬のひき肉1cm3と上記水溶液0.5mLを入れた。これに約20から30匹のヒツジキンバエの幼虫を配置した。
一定期間経過後、ハエの死亡率を計測した。死亡率100%はハエがすべて死亡したことを意味する。死亡率0%はすべてのハエが生存したことを意味する。
Test Example 7 Test on sheep flies (Lucillia cuprina) 10 mg of active ingredient was dissolved in 0.5 mL of dimethyl sulfoxide. This solution was diluted with water to obtain an aqueous solution having a predetermined concentration.
A test tube was filled with 1 cm 3 of ground horse meat and 0.5 mL of the above aqueous solution. About 20-30 sheep larvae were placed on this.
After a certain period of time, fly mortality was measured. A mortality rate of 100% means that all flies have died. A mortality rate of 0% means that all flies have survived.
表1に示した化合物1−1、1−3〜1−14、1−16、2−1〜2−3、3−1〜3−3、3−5〜3−7および4−1〜4−4を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、100ppmの適用割合で、死亡率80%以上の優れた活性を示した。 Compounds 1-1, 1-3 to 1-14, 1-16, 2-1 to 2-3, 3-1 to 3-3, 3-5 to 3-7 and 4-1 shown in Table 1 The above test was conducted using 4-4 as an active ingredient. All the compounds showed excellent activity with a mortality rate of 80% or more at an application rate of 100 ppm.
試験例8 イエバエ(Musca domestica)に対する試験
有効成分10mgをジメチルスルホキシド0.5mLに溶解した。この溶液を水で希釈して所定濃度の水溶液を得た。
該水溶液に糖を %混ぜ合わせた。この混合液を、所定の大きさのスポンジに吸収させた。スポンジを試験容器内に配置した。イエバエの成体昆虫10匹を試験容器内に放ち、容器を有孔カバーで覆った。
一定期間経過後、ハエの死亡率を計測した。死亡率100%はハエがすべて死亡したことを意味する。死亡率0%はすべてのハエが生存したことを意味する。
Test Example 8 Test on Housefly (Musca domestica) 10 mg of the active ingredient was dissolved in 0.5 mL of dimethyl sulfoxide. This solution was diluted with water to obtain an aqueous solution having a predetermined concentration.
% Sugar was mixed with the aqueous solution. This mixed solution was absorbed into a sponge of a predetermined size. A sponge was placed in the test container. Ten adult house flies were released into the test container and the container was covered with a perforated cover.
After a certain period of time, fly mortality was measured. A mortality rate of 100% means that all flies have died. A mortality rate of 0% means that all flies have survived.
表1に示した化合物1−1、1−3〜1−10、1−12、1−14、1−16、2−1〜2−3、3−1〜3−3、3−5、3−7、4−3および4−4を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、100ppmの適用割合で、死亡率80%以上の優れた活性を示した。 Compounds 1-1, 1-3 to 1-10, 1-12, 1-14, 1-16, 2-1 to 2-3, 3-1 to 3-3, 3-5, shown in Table 1 The above test was conducted using 3-7, 4-3 and 4-4 as active ingredients. All the compounds showed excellent activity with a mortality rate of 80% or more at an application rate of 100 ppm.
試験例9 ネコにおけるネコノミ(Ctenocephalides felis)に対する試験
ネコの体重1kgあたり有効成分15mgとなるように調製した薬液をネコの首の後ろ(肩甲骨の間)の皮膚上に滴下した。当該ネコを6匹用意した。薬液処理した日から1日経過後に、ネコ1匹あたりに7匹の摂食状態でない成体ネコノミを、ネコの首周辺に寄生させた。寄生させた日から1日経過後に、生存しているネコノミの数を計測した。
薬液処理した日から6日経過後に、再び、ネコ1匹あたりに7匹の摂食状態でない成体ネコノミを、ネコの首周辺に寄生させた。寄生させた日から1日経過後に、生存しているネコノミの数を計測した。
同様に、ネコノミの寄生を、薬液処理した日から13日経過後、20日経過後、27日経過後、34日経過後、41日経過後、48日経過後にそれぞれ行い、いずれも寄生させた日から1日経過後に、生存しているネコノミの数を計測した。
Test Example 9 Test for Cat Fleas (Ctenocephalides felis) In cats, a drug solution prepared so as to have an active ingredient of 15 mg per kg body weight of the cat was dropped on the skin behind the neck of the cat (between the scapula). Six such cats were prepared. One day after the chemical treatment, 7 non-fed adult cat fleas per cat were infested around the neck of the cat. The number of surviving cat fleas was counted one day after the day of infestation.
Six days after the chemical treatment, 7 non-feeding adult cat fleas per cat were infested around the neck of the cat. The number of surviving cat fleas was counted one day after the day of infestation.
Similarly, cat flea infestation was performed after 13 days, 20 days, 27 days, 34 days, 41 days, and 48 days after the chemical treatment, and 1 day from the day of infestation. Later, the number of surviving cat fleas was counted.
この試験において、死亡率100%はネコノミがすべて死亡したことを意味する。死亡率0%はすべてのネコノミが生存したことを意味する。
表1に示した化合物1−1、1−4、1−5、1−8および1−9を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、薬液処理した日から42日経過後における計測で死亡率95%以上の優れた活性を示した。これらのうち、化合物1−1および1−5については、薬液処理した日から49日経過後における計測でも死亡率95%以上の特に優れた活性を示した。
In this test, 100% mortality means that all cat fleas have died. A mortality rate of 0% means that all cat fleas have survived.
The above test was conducted using compounds 1-1, 1-4, 1-5, 1-8 and 1-9 shown in Table 1 as active ingredients. All compounds showed excellent activity with a mortality rate of 95% or more as measured after 42 days from the day of chemical treatment. Of these, compounds 1-1 and 1-5 showed particularly excellent activity with a mortality rate of 95% or more even when measured after 49 days from the day of chemical treatment.
試験例10 ネコにおけるマダニ(Ixodes ricinus)に対する試験
ネコ1匹あたりに5匹の摂食状態でない成体マダニを、ネコの首周辺に寄生させた。当該ネコを6匹用意した。寄生させた日から2日経過後に、ネコの体重1kgあたり有効成分15mgとなるように調製した薬液を、ネコの首の後ろ(肩甲骨の間)の皮膚上に滴下した。薬液処理した日から2日経過後に、生存しているマダニの数を計測した。
薬液処理した日から5日経過後に、ネコ1匹あたり5匹の摂食状態でない成体マダニを、ネコの首周辺に寄生させた。寄生させた日から2日経過後に、生存しているマダニの数を計測した。
同様に、マダニの寄生を、薬液処理した日から12日経過後、19日経過後、26日経過後、33日経過後にそれぞれ行い、いずれも寄生させた日から2日経過後に、生存しているマダニの数を計測した。
Test Example 10 Test on Tick (Ixodes ricinus) in Cats Five non-feeding adult ticks per cat were infested around the neck of the cat. Six such cats were prepared. Two days after the day of infestation, a drug solution prepared so that the active ingredient was 15 mg per kg body weight of the cat was dropped on the skin behind the neck of the cat (between the scapula). The number of surviving ticks was counted two days after the chemical treatment.
Five days after the chemical treatment, 5 non-feeding adult ticks per cat were infested around the neck of the cat. The number of surviving ticks was counted after 2 days from the day of infestation.
Similarly, tick infestation was performed after 12 days, 19 days, 26 days, and 33 days from the day of chemical treatment, and after 2 days from the day of infestation, The number was measured.
この試験において、死亡率100%はマダニがすべて死亡したことを意味する。死亡率0%はすべてのマダニが生存したことを意味する。
表1に示した化合物1−1、1−4、1−5、1−8および1−9を有効成分としてそれぞれ用い、上記試験を行った。いずれの化合物も、薬液処理した日から14日経過後における計測で死亡率90%以上の優れた活性を示した。また、化合物1−8については薬液処理した日から21日経過後における計測で、化合物1−9については薬液処理した日から28日経過後における計測で、化合物1−1および1−5については薬液処理した日から35日経過後における計測でも、それぞれ死亡率90%以上の特に優れた活性を示した。
In this test, a mortality rate of 100% means that all ticks have died. A mortality rate of 0% means that all ticks have survived.
The above test was conducted using compounds 1-1, 1-4, 1-5, 1-8 and 1-9 shown in Table 1 as active ingredients. All the compounds showed excellent activity with a mortality rate of 90% or more as measured after 14 days from the day of chemical treatment. Compound 1-8 is measured after 21 days from the day of chemical treatment, compound 1-9 is measured after 28 days from the day of chemical treatment, and compounds 1-1 and 1-5 are treated with chemical solution. Even after 35 days from the date of measurement, the activity was particularly excellent with a mortality rate of 90% or more.
Claims (6)
(式(I)中、Xは、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
nは、Xの置換数を示し且つ0〜5のいずれかの整数である。nが2以上のとき、X同士は互いに同一でも異なっていてもよい。
A1およびA2はそれぞれ独立に、炭素原子または窒素原子を示す。
B1およびB2はそれぞれ独立に、炭素原子または窒素原子を示す。
B1が炭素原子であって、B2が窒素原子である場合、B1とB2との間の結合は、二重結合となってもよい。
B3は、炭素原子または酸素原子を示す。
R1は、水素原子、ハロゲン原子、または無置換のもしくは置換基を有するC1〜6アルキル基を示す。
X0は、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
m1は、X0の置換数を示し且つ0〜3のいずれかの整数である。m1が2以上のとき、X0同士は互いに同一でも異なっていてもよい。
R11は、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するアミノ基、または無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基を示す。
R12は、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、またはハロゲン原子を示す。
また、R11とR12とが繋がって、それらが結合する炭素原子と一緒になって、置換基R20を有する5〜8員の炭化水素環または置換基R20を有する5〜8員のヘテロ環を形成してもよい。
R20は、ハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、シアノ基、無置換のもしくは置換基を有するC1〜7アシル基、無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基、アミノ基、または−N(R2)COR3で表される置換基を示す。
R2は、水素原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC1〜7アシル基、または無置換のもしくは置換基を有するC1〜6アルコキシカルボニル基を示す。
R3は、水素原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、無置換のもしくは置換基を有するC3〜8シクロアルキル基、無置換のもしくは置換基を有するC1〜6アルコキシ基、無置換のもしくは置換基を有するC2〜6アルケニルオキシ基、無置換の若しくは置換基を有するC2〜6アルキニルオキシ基、無置換のもしくは置換基を有するC6〜10アリール基、または無置換のもしくは置換基を有するヘテロ環基を示す。
Eは、炭素原子または窒素原子を示す。) An animal ectoparasite control agent comprising, as an active ingredient, at least one compound selected from the heterocyclic compounds represented by formula (I) and salts thereof.
(In the formula (I), X is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2 -6 alkynyl group, a hydroxyl group, an unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
n shows the substitution number of X and is an integer in any one of 0-5. When n is 2 or more, Xs may be the same as or different from each other.
A 1 and A 2 each independently represent a carbon atom or a nitrogen atom.
B 1 and B 2 each independently represent a carbon atom or a nitrogen atom.
When B 1 is a carbon atom and B 2 is a nitrogen atom, the bond between B 1 and B 2 may be a double bond.
B 3 represents a carbon atom or an oxygen atom.
R 1 represents a hydrogen atom, a halogen atom, or an unsubstituted or substituted C 1-6 alkyl group.
X 0 is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, a hydroxyl group , An unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
m1 represents the number of substitutions of X 0 and is an integer from 0 to 3. When m1 is 2 or more, X 0 may be the same or different from each other.
R 11 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted amino group, or an unsubstituted or substituted group A C1-6 alkylaminocarbonyl group having
R 12 represents an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, or a halogen atom.
Further, connected is R 11 and R 12, together with the carbon atoms to which they are attached 5-8 membered having a hydrocarbon ring or a substituent R 20 5-8 membered having a substituent R 20 A heterocycle may be formed.
R 20 is a halogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, a hydroxyl group An unsubstituted or substituted C1-6 alkoxy group, a nitro group, a cyano group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted C1-6 alkylaminocarbonyl group , An amino group, or a substituent represented by —N (R 2 ) COR 3 .
R 2 represents a hydrogen atom, an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-7 acyl group, or an unsubstituted or substituted C1-6 alkoxycarbonyl group. Indicates.
R 3 represents a hydrogen atom, an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, an unsubstituted or substituted C 2-6 alkynyl group, A substituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C2-6 alkenyloxy group, an unsubstituted or substituted group; And a C2-6 alkynyloxy group having an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted heterocyclic group.
E represents a carbon atom or a nitrogen atom. )
(式(II)中、Dは、5〜8員の炭化水素環または5〜8員のヘテロ環を示す。
R21は、Dに結合する置換基であり且つ無置換のもしくは置換基を有するC1〜7アシル基、無置換のもしくは置換基を有するC1〜6アルキルアミノカルボニル基、アミノ基、または−N(R2)COR3で表される置換基を示す。
X1は、Dを含む縮合環に結合する置換基であり且つハロゲン原子、無置換のもしくは置換基を有するC1〜6アルキル基、無置換のもしくは置換基を有するC2〜6アルケニル基、無置換のもしくは置換基を有するC2〜6アルキニル基、水酸基、無置換のもしくは置換基を有するC1〜6アルコキシ基、ニトロ基、またはシアノ基を示す。
mは、X1の置換数を示し且つ0〜6のいずれかの整数である。mが2以上のとき、X1同士は互いに同一でも異なっていてもよい。
X、n、A1、A2、R1、E、R2およびR3は、式(I)におけるそれらと同じ意味を示す。) The animal ectoparasite control agent according to claim 1, wherein the formula (I) is the formula (II).
(In formula (II), D represents a 5- to 8-membered hydrocarbon ring or a 5- to 8-membered heterocycle.
R 21 is a substituent bonded to D and is an unsubstituted or substituted C 1-7 acyl group, an unsubstituted or substituted C 1-6 alkylaminocarbonyl group, an amino group, or —N ( R 2 ) represents a substituent represented by COR 3 .
X 1 is a substituent bonded to the condensed ring containing D and is a halogen atom, an unsubstituted or substituted C 1-6 alkyl group, an unsubstituted or substituted C 2-6 alkenyl group, unsubstituted Or a substituted C2-6 alkynyl group, a hydroxyl group, an unsubstituted or substituted C1-6 alkoxy group, a nitro group, or a cyano group.
m represents the number of substitutions of X 1 and is an integer of 0 to 6. When m is 2 or more, X 1 may be the same as or different from each other.
X, n, A 1 , A 2 , R 1 , E, R 2 and R 3 have the same meaning as in formula (I). )
(式(III)中、pは括弧内のメチレン基の繰り返し数を示し且つ1または2のいずれかである。
X、n、A1、A2、R1、X1、m、R2、R3およびEは、式(II)におけるそれらと同じ意味を示す。) The animal ectoparasite control agent according to claim 2, wherein the formula (II) is the formula (III).
(In formula (III), p represents the number of repeating methylene groups in parentheses and is either 1 or 2.
X, n, A 1 , A 2 , R 1 , X 1 , m, R 2 , R 3 and E have the same meaning as in formula (II). )
(式(IV)中、X、n、R1、X1、m、E、R2、R3およびpは、式(III)におけるそれらと同じ意味を示す。) The animal ectoparasite control agent according to claim 3, wherein the formula (III) is the formula (IV).
(In the formula (IV), X, n, R 1 , X 1 , m, E, R 2 , R 3 and p have the same meaning as in formula (III).)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011153870A JP2014015397A (en) | 2010-11-04 | 2011-07-12 | External parasite controlling agent for animals |
| PCT/JP2011/075049 WO2012060317A1 (en) | 2010-11-04 | 2011-10-31 | Ectoparasite control agent for animals |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010247936 | 2010-11-04 | ||
| JP2010247936 | 2010-11-04 | ||
| JP2011153870A JP2014015397A (en) | 2010-11-04 | 2011-07-12 | External parasite controlling agent for animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2014015397A true JP2014015397A (en) | 2014-01-30 |
Family
ID=46024430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011153870A Withdrawn JP2014015397A (en) | 2010-11-04 | 2011-07-12 | External parasite controlling agent for animals |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2014015397A (en) |
| WO (1) | WO2012060317A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI487486B (en) | 2009-12-01 | 2015-06-11 | Syngenta Participations Ag | Insecticidal compound based on isoxazoline derivatives |
| WO2013087710A2 (en) * | 2011-12-14 | 2013-06-20 | Syngenta Participations Ag | Pesticidal mixtures |
| EP2900065A1 (en) * | 2012-09-04 | 2015-08-05 | Zoetis LLC | Spirocyclic isoxazoline derivatives for treatment of sea lice |
| ES2748631T3 (en) | 2012-09-07 | 2020-03-17 | Zoetis Services Llc | Parasiticidal combinations of spirocyclic isoxazoline |
| JP2015003900A (en) * | 2013-05-23 | 2015-01-08 | 宮崎みどり製薬株式会社 | Dermanyssus gallinae control agent |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| US12497370B2 (en) | 2019-12-18 | 2025-12-16 | Elanco Tiergesundheit Ag | Isoxazoline derivatives |
| UY39309A (en) | 2020-07-02 | 2021-12-31 | Pi Industries Ltd | ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS |
| AR126996A1 (en) | 2021-09-08 | 2023-12-06 | Pi Industries Ltd | ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102558082B (en) * | 2004-03-05 | 2015-09-30 | 日产化学工业株式会社 | Isoxazoline-substituted benzamide compound prepare intermediate |
| JP5164510B2 (en) * | 2006-10-06 | 2013-03-21 | 日本曹達株式会社 | Nitrogen-containing heterocyclic compounds and pest control agents |
| JP5164525B2 (en) * | 2006-11-01 | 2013-03-21 | 日本曹達株式会社 | Nitrogen-containing heterocyclic compounds and pest control agents |
| JP2010116389A (en) * | 2008-10-17 | 2010-05-27 | Bayer Cropscience Ag | Insecticidal arylpyrrolidines |
| JP5184057B2 (en) * | 2007-08-10 | 2013-04-17 | 日本曹達株式会社 | Nitrogen-containing heterocyclic compounds and pest control agents |
| EP2186804B1 (en) * | 2007-08-10 | 2015-06-17 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic compound and pest control agent |
| TWI556741B (en) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | Isoxazoline compositions and their use as antiparasitics |
| JP2011136928A (en) * | 2009-12-28 | 2011-07-14 | Bayer Cropscience Ag | Insecticidal arylpyrrolidines |
| JP2011178673A (en) * | 2010-02-26 | 2011-09-15 | Nissan Chem Ind Ltd | Control method for non-agricultural/horticultural insect pest |
-
2011
- 2011-07-12 JP JP2011153870A patent/JP2014015397A/en not_active Withdrawn
- 2011-10-31 WO PCT/JP2011/075049 patent/WO2012060317A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012060317A1 (en) | 2012-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111132549B (en) | Long-term control agent for ectoparasites for animals | |
| JP2014015397A (en) | External parasite controlling agent for animals | |
| CN112189011A (en) | Heteroaryl triazole and heteroaryl tetrazole compounds as pesticides | |
| CN110248941B (en) | Aryl-or heteroaryl-substituted imidazopyridine derivatives and their use as pesticides | |
| WO2012086462A1 (en) | Isoxazoline compound and pest control agent | |
| WO2016174049A1 (en) | Anti-parasitic combinations including halogen-substituted compounds | |
| CN106103414A (en) | The substituted benzamides processed for arthropod | |
| MXPA06009360A (en) | Anthranilamides, process for the production thereof, and pest controllers containing the same | |
| KR101755145B1 (en) | Aryloxyurea compound and pest control agent | |
| JP2014028758A (en) | Agent for controlling parasite and sanitary insect pest | |
| WO2013047144A1 (en) | Cyclic amine compound and pest control agent | |
| KR20140128995A (en) | Aryloxyacetamide compound and pesticide | |
| EP2654425A2 (en) | Ectoparasiticidal active substance combinations | |
| KR20140145145A (en) | Aryloxyurea compound and pest control agent | |
| MX2011005158A (en) | Pyridine derivative or its salt, pesticide containing it and process for its production. | |
| AU2017203019B2 (en) | Ectoparasite control agent | |
| JP2010138082A (en) | Cyclic amine compound or salt thereof, and noxious organism-controlling agent | |
| JP2013241352A (en) | Pest controlling agent composition and pest controlling method | |
| WO2026004779A1 (en) | Triazolylpyridine compound, parasite control agent for animals, method for controlling animal parasite, and method for preventing and treating parasitic disease | |
| HK40034369A (en) | N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides | |
| HK40037130A (en) | Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides | |
| HK40034732A (en) | Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides | |
| HK40036701A (en) | Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides | |
| JP2009137910A (en) | Ectoparasite-controlling agent for animal, and method for treating infectious disease by parasite of animal | |
| BR112020005628B1 (en) | PROLONGED ECTOPARASITE CONTROL AGENT FOR ANIMALS, PREPARATION FOR SYSTEMIC APPLICATION AND USE OF A COMPOUND |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20141007 |
